case_id,mode,case_type,iteration,Q0_answer,Q0_reasoning,Q1_answer,Q1_reasoning,Q2_answer,Q2_reasoning,Q3_answer,Q3_reasoning,Q4_answer,Q4_reasoning,Q5_answer,Q5_reasoning,Q6_answer,Q6_reasoning,Q7_answer,Q7_reasoning,Q8_answer,Q8_reasoning,input_tokens,output_tokens,total_tokens
Case3223,rag,all_incorrect,iter3,BRCA1/2,Patient clinical information explicitly states she was referred for BRCA1 and BRCA2 testing by her general practitioner.,Not Specified,The provided policy (FEP 2.04.126) does not state age-based eligibility criteria for BRCA1/2 testing; BRCA testing strategy is referenced to a different related policy (2.04.02) which is not included in the provided text.,Not Specified,The provided policy does not specify ordering-provider specialty or credential requirements for BRCA1/2 testing; it only generally recommends genetic counseling by an experienced individual.,Not Specified,"The policy references guideline-based criteria (NCCN) for who should receive hereditary breast/ovarian cancer testing but does not include the specific medical indications or the explicit checklist for BRCA1/2 within the provided text, so it cannot be determined from this document alone whether the patient meets those defined criteria.",Not Specified,"The policy text does not define mandatory prior tests that must be completed before BRCA1/2 testing. It notes 'testing an affected family member first' has the highest yield, but does not require prior testing in this document.",Yes,"The patient has a first-degree relative (sister) with epithelial ovarian cancer. The provided policy emphasizes family history and NCCN guideline criteria for hereditary breast/ovarian cancer testing, making this family history relevant to eligibility per the policy text.",Not Specified,"The policy strongly recommends formal genetic counseling by an experienced individual, but it does not state counseling as an explicit coverage prerequisite for BRCA1/2 testing in the provided text. The patient also has no documentation of pre-test counseling.",Not Specified,"The provided policy text does not list or map CPT codes to BRCA1/2 testing, so a specific CPT code cannot be determined from the supplied document.",Yes,"Although the full BRCA coverage policy (2.04.02) is not included, the provided policy references that BRCA1/2 testing strategy is described in that related policy and states genetic testing should be available to individuals without a personal history of breast cancer when they meet NCCN guideline criteria. Given the patient has a first-degree relative with epithelial ovarian cancer (a family history highlighted by the policy as relevant), and the Benefit Application states medically necessary specialized diagnostic genetic testing is a covered benefit, BRCA1/2 testing is covered when guideline criteria are met — which, based on the policy text and the patient’s family history, supports coverage.",10994,2924,13918
Case14226,rag,all_incorrect,iter3,BRCA1/2,Patient info explicitly states the oncology evaluation is for germline BRCA1 and BRCA2 (BRCA1/2) testing.,Not Specified,The provided Cigna/EviCore hereditary cancer panel policy does not specify age-based eligibility for single-gene BRCA1/2 testing in this document and instead refers to a separate 'BRCA Analysis' guideline for BRCA-specific criteria.,Not Specified,"The policy requires 'pre- and post-test genetic counseling by an appropriate provider' for hereditary cancer multigene panels and that rendering labs be qualified, but it does not specify ordering-provider specialty/type requirements for BRCA1/2 single-gene testing within this document.",Not Specified,"This document defers BRCA-specific clinical indications to the separate EviCore 'BRCA Analysis' guideline. The provided policy does not explicitly define BRCA1/2 medical-indication criteria, so whether the patient's findings meet BRCA criteria cannot be determined from this document alone.",Yes,"The policy requires no prior hereditary cancer multigene panel testing or prior testing for any gene on the panel. Patient history states no prior genetic testing, so the 'no previous testing' requirement in the policy is satisfied.",No,"The policy uses family cancer history (e.g., first-/second-degree relatives with relevant cancers) as part of eligibility for hereditary cancer testing. The patient's only noted family history is a mother with a severe hematologic/immunologic disorder (non-cancer), which is not a policy‑specified relevant family cancer history.",Not Specified,"Pre- and post-test genetic counseling is explicitly required for hereditary cancer multigene panels in this policy. However, BRCA1/2 single-gene testing is addressed by a separate 'BRCA Analysis' guideline (not provided), so the counseling requirement specific to BRCA1/2 single-gene testing is not specified in the provided document. Patient fact: no pre-test counseling was completed.",Not Specified,"The policy lists various panel and test-specific codes (e.g., 81432, 81479) and shows 81228 for chromosomal microarray, but it does not provide a specific CPT code for single-gene BRCA1/2 testing in the provided text. None of the CPT options match a BRCA1/2 code explicitly listed in this document.",No,"Coverage cannot be confirmed from the provided policy: BRCA1/2 single-gene eligibility is governed by a separate 'BRCA Analysis' guideline referenced but not included. Additionally, the hereditary cancer panel policy requires pre-test genetic counseling for panel testing and other specific criteria; the patient has no pre-test counseling and the BRCA-specific criteria (per the referenced guideline) are not documented here. Based on the provided policy text and available patient facts, the documentation does not meet the insurer's specified criteria for approval.",11927,3704,15631
Case10451,rag,all_incorrect,iter3,WES,Patient clinical information explicitly states the neurologist referred the 10-year-old for whole exome sequencing (WES).,Yes,"Policy standard exome sequencing is indicated for developmental delay/intellectual disability with onset prior to age 18; the patient is a 10-year-old with childhood-onset moderate–severe ID, meeting the age-related criterion.",No,"Policy requires evaluation by a Board‑Certified/Board‑Eligible Medical Geneticist or an Advanced Practice Nurse in Genetics and pre-/post-test counseling by an appropriate genetics provider; the ordering provider is a neurologist and there is no documentation the patient was evaluated by a geneticist/APGN, so provider requirements are not met.",Yes,"Policy lists unexplained developmental delay/intellectual disability (onset <18 years) as an indication for standard exome sequencing; the patient has unexplained moderate–severe intellectual disability and prior CMA was nondiagnostic, satisfying the medical indication.",Not Specified,"The policy does not explicitly mandate a specific prior test (e.g., CMA) as an absolute requirement for standard exome sequencing, although it notes WES is appropriate after CMA or focused testing is unrevealing. Thus prior-test requirements are not explicitly specified.",No,"The policy includes ‘family history strongly suggestive of a genetic etiology, including consanguinity’ as a criterion. The patient has a sibling with a brief resolved unexplained event, but the documentation does not indicate a family history that is 'strongly suggestive' of a genetic etiology or consanguinity, so the family-history criterion is not met.",No,"Policy requires pre- and post-test genetic counseling by an appropriate provider (geneticist, certified genetic counselor, or APN in genetics). The clinical information states there is no documentation of prior genetic counseling, so counseling requirements are not met.",81415,"Policy references CPT 81415 as the common code for standard exome sequencing (proband/trio), which corresponds to the requested WES.",No,"Although the patient meets indication and age criteria and prior CMA was nondiagnostic, the policy requires pre-/post-test counseling and evaluation by a Board‑Certified/Board‑Eligible Medical Geneticist or APGN. Those provider/counseling criteria are not documented, therefore the full policy coverage criteria are not met.",12248,1862,14110
Case4196,rag,all_incorrect,iter3,WES,The patient information explicitly states whole exome sequencing (WES) is being requested as the next diagnostic step.,Not Specified,The provided FEP policy does not specify explicit age-based eligibility cutoffs for WES; it discusses postnatal/children broadly but no numeric age criteria are given.,Not Specified,The policy discusses genetic counseling and testing generally but does not specify ordering-provider specialty or explicit provider-type requirements for ordering WES.,Not Specified,"The policy defines clinical indications for CMA (e.g., apparent nonsyndromic developmental delay/ID) and states NGS panel testing is investigational; it does not define medical indications for WES in this document (WES is addressed in a separate policy 2.04.102).",No,"Per this policy, chromosomal microarray (CMA) is the first-line test for apparent nonsyndromic developmental delay/intellectual disability; the patient has had nondiagnostic FISH but no CMA documented, so a first-line CMA prior test has not been completed.",Not Specified,"Although the patient has a brother with childhood intellectual disability (family history present), the policy does not specify family history or consanguinity criteria as requirements for WES in this document.",Not Specified,"The policy states experts recommend formal genetic counseling and that it should be performed by someone with expertise, but it does not state a binding coverage requirement for counseling specific to WES; the patient has pre-test counseling documented, but the policy does not define whether that satisfies a coverage requirement.",81415,The requested test is whole exome sequencing (WES); CPT code 81415 corresponds to exome sequencing.,No,"Within the provided policy, CMA is the defined first-line test for apparent nonsyndromic developmental delay/ID and next-generation sequencing panel testing is considered investigational; WES is not covered by this policy (it is addressed separately in policy 2.04.102 which is not provided). The patient has not had documented CMA. Based on the FEP 2.04.59 content alone, WES is not supported as covered.",15710,2720,18430
Case18281,rag,all_incorrect,iter3,WGS,Patient note states the cardiologist ordered whole genome sequencing (WGS).,Yes,"Policy age criterion: WES indications apply to individuals <18 years. Patient is 6 years old, satisfying the age-based requirement that applies to pediatric genome/exome evaluation (policy Section II.1).",No,Policy requirement (II.1.a) specifies evaluation by an ABMGG board-certified medical geneticist or an ABGC board-certified genetic counselor and pre-test counseling; the ordering provider is a cardiologist and no geneticist/genetic counselor evaluation or counseling was performed.,Yes,Policy indication (II.1) includes evaluation of unexplained congenital anomalies in individuals <18 and when presentation does not fit a well-described syndrome; the patient is a 6-year-old with multiple congenital anomalies not fitting a well-delineated syndrome and a family history suggesting a genomic etiology.,No,"Policy (II.4) states WGS MEETS COVERAGE CRITERIA only when WES is unable to identify a causative mutation and the WES-related criteria are met. The patient has not had WES performed (only Fragile X testing was done), so required prior testing (WES) has not been completed.",Yes,"Policy discusses family history as relevant to genomic evaluation (multiple sections) and the patient has a sibling with an inborn error of metabolism, which is relevant to eligibility for genome/exome testing.",No,Policy (II.1.a and related guidance) requires pre-test counseling by an ABMGG medical geneticist or ABGC genetic counselor; the record states no genetic counseling was conducted prior to testing.,Not Specified,The provided policy document does not list or map specific CPT codes to WGS/WES testing; therefore a billing CPT code is not specified in the policy text.,No,"Under the policy, WGS is covered only after WES fails to identify a causative mutation and all WES criteria are met (II.4). The patient has not had WES, lacks required pre-test genetic counseling/evaluation by a certified geneticist/genetic counselor, and WGS was ordered directly by a cardiologist—so coverage criteria for WGS are not met.",22469,2351,24820
Case17196,rag,all_incorrect,iter3,CMA,Patient clinical information explicitly states a referral for chromosomal microarray (CMA) testing.,Not Specified,"The policy specifies age limits only for asymptomatic testing for adult-onset conditions (age of majority). For symptomatic diagnostic testing (the patient is symptomatic), the policy does not impose a specific age cutoff for eligibility.",No,"Policy I.1 requires genetic counseling prior to testing unless the test is ordered by a specialist in the disease process. The test is being ordered by an oncologist for a neuropsychiatric indication (oncologist is not a specialist in that disease process) and no pre-test genetic counseling was done, so ordering-provider/counseling requirements are not met.",No,"While the patient is symptomatic (policy I.2.a.i), the policy also requires that all subcriteria (e.g., published evidence of association/clinical utility, other testing being equivocal/standard-of-care confirmation, impact on management) be met. The provided information does not document that these policy subcriteria for CMA in this adult neuropsychiatric presentation are satisfied.",Not Specified,"The policy does not specify required prior testing (e.g., that karyotype must be performed before CMA) as a prerequisite for coverage; it only notes that repeat identical testing is not covered. The patient’s prior nondiagnostic karyotype is noted but the policy does not define that as a required prior test.",Yes,"The policy allows asymptomatic testing when an individual is judged at significant risk based on family history. The patient has a sibling with early-onset (by age 18) significant hearing or visual impairment, which is family history relevant to consideration under the policy.",No,"Policy I.1 mandates genetic counseling prior to and after testing when testing is not ordered by a specialist in the disease process. No pre-test genetic counseling was performed and the ordering provider is an oncologist for a neuropsychiatric indication, so counseling requirements are not met.",Not Specified,The policy discusses use of specific procedure codes for multigene panels and 81479 for unlisted molecular pathology but does not specify a CPT code mapping for chromosomal microarray (CMA) in the provided text; therefore the appropriate CPT is not specified in the policy document.,No,"Under the policy the test requires meeting all medical-necessity subcriteria and required pre-test genetic counseling if not ordered by a specialist in the disease process. The documentation provided does not demonstrate that the policy's medical-utility subcriteria are met, and required pre-test genetic counseling was not completed (ordering provider is not a neuropsychiatric specialist). Therefore the request does not meet the policy coverage requirements.",10242,2957,13199
Case8288,rag,all_incorrect,iter3,WES,Patient information explicitly states whole exome sequencing (WES) is being pursued to evaluate the fetal congenital cardiac anomaly.,No,"The policy defines WES indications for children (and rapid WES for critically ill neonates/infants) and explicitly states the policy does not address prenatal (fetal) testing; the patient is fetal at 36 weeks, so the patient’s age/status does not meet the policy's age-related scope/eligibility.",Not Answerable,"The policy requires evaluation by a clinician with expertise in clinical genetics prior to WES, but the patient data do not state that such a clinician performed the evaluation (only that a developmental pediatrician referred and parents had genetic counseling), so insufficient information to determine if ordering provider requirements are met.",Yes,"The policy lists unexplained congenital anomalies as a defined medical indication for WES; the fetus has a major congenital cardiac anomaly and a nondiagnostic CMA, which meets the policy's clinical indication criterion (regardless of age/other eligibility).",Yes,"The policy's criteria reference prior standard workup (eg, chromosomal microarray and/or targeted testing) before WES; the patient had a chromosomal microarray previously performed and it was nondiagnostic, satisfying the prior testing requirement.",Yes,"The policy lists family history of an inborn error of metabolism as relevant; the patient has a family history of an inborn error of metabolism in an older sibling, which is a relevant family-history criterion per the policy.",Yes,"The policy requires counseling about risks of genetic testing by someone experienced in genetics; the patient’s parents have had multiple sessions with a genetic counselor, meeting the counseling requirement as documented.",Not Specified,The provided policy document does not list specific CPT codes for WES; no CPT mapping is specified in the supplied text.,No,"Although the clinical indications (congenital anomaly and nondiagnostic CMA) align with the policy's medical-necessity criteria, the policy explicitly does not address prenatal (fetal) testing. Because the patient is fetal (prenatal), the policy's WES coverage criteria do not apply to this situation, and the test is not covered under this policy scope.",14871,2600,17471
Case3422,rag,all_incorrect,iter3,WES,Patient is being considered for whole-exome sequencing (WES) per the clinical information ('consideration of whole-exome sequencing (WES)').,Not Specified,The Concert policy does not set an upper age limit for standard exome sequencing; age-specific limits apply only to rapid/infant testing (<=12 months). Therefore no applicable age-based exclusion for this adult requesting standard WES is specified in the policy.,No,Policy requires pre-/post-test counseling and that the patient and family history be evaluated by a Board-Certified/Board-Eligible Medical Geneticist or an Advanced Practice Nurse in Genetics (criteria I.F and I.G). Patient data states only that she has 'seen a genetic counselor multiple times' and does not document evaluation by a Board-Certified/Board-Eligible Medical Geneticist or APGN; thus ordering/provider requirements per policy are not met.,No,"Under Standard Exome criteria (I.A.2) a genetic etiology is supported by either multiple congenital abnormalities affecting unrelated organ systems OR TWO of listed features (e.g., significant single-organ abnormality plus another feature). The patient has a single congenital anomaly (choanal atresia) and no second qualifying feature (no dysmorphisms, encephalopathy, complex neurodevelopmental symptoms, consanguinity, or suggestive labs documented). Therefore she does not meet the policy's defined medical indication for standard WES.",Not Specified,"The policy does not mandate completion of a specific prior test (e.g., CMA) as an absolute prior-test requirement in the Standard Exome criteria, though background text notes exome may be considered after nondiagnostic CMA. The formal coverage criteria list 'alternate etiologies considered' but do not explicitly require prior CMA completion.",No,"Policy lists 'family history strongly suggestive of a genetic etiology, including consanguinity' as a qualifying criterion. The patient reports a single first‑degree relative (mother) with breast cancer at age 50, which is not documented as a family history meeting the policy's threshold of 'strongly suggestive' (no multiple affected relatives, early-onset pattern, or consanguinity).",Yes,"Policy requires pre- and post-test counseling by an appropriate provider (e.g., Certified Genetic Counselor). Patient information states she 'has seen a genetic counselor multiple times,' which satisfies the counseling requirement in the policy.",81415,"Policy lists CPT 81415 as the common code for standard exome sequencing (proband). The requested test is WES (standard exome), so 81415 is the appropriate corresponding CPT code per the policy.",No,"Per the Concert policy, coverage for standard WES requires meeting the defined medical indications (e.g., multiple congenital anomalies OR two qualifying features) and evaluation by a Board-Certified/Board-Eligible Medical Geneticist or APGN. The patient has a single congenital anomaly (choanal atresia) and lacks a second qualifying criterion, and there is no documented evaluation by a Board-Certified/Board-Eligible Medical Geneticist or APGN. Although she had nondiagnostic CMA and genetic counseling (noted in background), she does not meet the explicit medical necessity and provider-evaluation criteria; therefore WES is not covered under the policy.",12213,3018,15231
Case5885,rag,all_incorrect,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) is requested.,Yes,"Policy requires member <21 years for GS; patient is 11 years old, meeting the age-based eligibility (MOL.TS.306.C: 'Member is <21 years of age').",Not Specified,The guideline does not mandate a specific ordering provider specialty; it requires an 'appropriate genetic and family history evaluation' and documentation but does not specify an ordering provider type or specialty in the coverage criteria.,No,"Policy requires the phenotype meet one of specified indications (e.g., global developmental delay, multiple congenital anomalies, or TWO of a specified list including a major abnormality plus another criterion). The patient has a single 'major abnormality affecting at least one organ system' but no second qualifying feature is documented, so does not meet the specified medical indication (MOL.TS.306.C criteria).",Yes,"The policy requires that the member has NOT had previous exome or genome sequencing. Patient history notes prior Fragile X testing (nondiagnostic) and no prior exome/genome is reported, satisfying the 'no prior ES/GS' requirement in the policy.",Not Specified,"While the patient has a family history of long QT in the mother, the GS coverage criteria do not list family history/consanguinity as a standalone general eligibility criterion (family history is specifically cited only for certain rWGS infant criteria); the policy requires an appropriate family history evaluation but does not make this specific family history explicitly determinative for coverage.",No,"Policy (GS criteria and ACMG recommendations cited) requires pretest counseling and written documentation/clinical letter detailing the genetic/family history evaluation. Patient info states counseling was discussed with a genetic specialist but does not document the required clinical letter or written consent elements required by the guideline, so counseling/documentation requirements are not shown to be met.",81425,Policy specifies 81425 should be billed for the proband for whole genome sequence analysis ('81425 should be billed for the proband...').,No,"Although patient meets age and has no prior ES/WGS, the policy requires specific clinical indications (e.g., global developmental delay, multiple congenital anomalies, or TWO-of criteria) and documentation (clinical letter detailing evaluation) which are not met/documented. Therefore, under the policy the requested WGS is not covered.",9147,3090,12237
Case14195,rag,all_incorrect,iter3,BRCA1/2,The patient information states the oncologist referred the patient for BRCA1/2 testing; that is the explicit requested test.,Not Specified,The provided FEP policy (2.04.126) does not specify age-based eligibility criteria for BRCA1/2 testing (this policy focuses on CHEK2/ATM/BARD1 and references BRCA testing criteria in a separate related policy not included here).,Not Specified,The provided policy text does not define specific ordering-provider specialty or other provider-type requirements for BRCA1/2 testing.,Not Specified,The provided document does not include the BRCA1/2-specific coverage/medical-indication criteria (it refers to a separate related policy 2.04.02). Therefore no explicit BRCA clinical indication criteria are present in the supplied text to determine if the patient meets them.,Not Specified,The supplied policy does not list required prior tests that must be completed before BRCA1/2 testing; prior karyotype is noted in the patient history but the policy gives no prior-test requirement for BRCA in the provided text.,No,"The policy emphasizes use of family history/NCCN criteria for hereditary breast/ovarian cancer testing. The patient’s family history (maternal uncle with dystonia and ataxia) does not document breast/ovarian cancer or a known familial BRCA variant, so she does not have the relevant family history described in the policy.",No,"The policy states formal genetic counseling is recommended in most cases when genetic testing for an inherited condition is considered. The patient has had no pretest genetic counseling, so counseling requirements in the policy are not met.",Not Specified,The provided policy document does not list or map CPT codes for BRCA1/2 testing; therefore a corresponding CPT code cannot be determined from the supplied text.,No,"Based on the provided policy language: testing should follow guideline-based risk assessment (NCCN) and be medically necessary to diagnose/manage an existing condition. The patient has no personal history of breast/ovarian cancer, no documented family history of those cancers or known familial BRCA variant, and has not had pretest genetic counseling. Given the absence of documented guideline-based indications and unmet counseling requirement in the supplied policy, BRCA1/2 testing is not supported as covered for this patient per the provided policy text.",10991,2261,13252
Case2847,rag,all_incorrect,iter3,WES,Patient clinical info explicitly states whole exome sequencing (WES) is being pursued.,Not Specified,The provided FEP 2.04.59 policy does not specify age-based eligibility criteria for whole exome sequencing; WES is noted as addressed separately in policy 2.04.102.,Not Specified,The provided policy does not define ordering provider/specialty requirements for WES; WES is referenced as handled in a separate policy (2.04.102).,Not Specified,"FEP 2.04.59 defines indications for CMA and states NGS panels are investigational for developmental delay/ASD/congenital anomalies, but it does not define medical necessity criteria for WES (addressed separately).",Not Specified,"The policy does not state explicit prior-test requirements for WES; although the patient had prior CMA nondiagnostic (a fact), the policy only notes CMA as first-line for developmental/ASD indications and refers to WES in a separate policy.",Not Specified,"The policy does not specify family history or consanguinity criteria relevant to WES; the patient does have a maternal history of an immunologic/hematologic disorder, but the policy provides no WES-specific family-history criteria.",Yes,"The policy explicitly recommends formal genetic counseling for most cases when genetic testing for an inherited condition is considered; the patient had pre-test counseling with a genetic counselor and plans for post-test follow-up, meeting this requirement.",81415,The test requested is whole exome sequencing (WES); CPT code 81415 corresponds to whole exome sequencing and is the best match among the provided options.,No,"Coverage cannot be confirmed under the provided policy: FEP 2.04.59 does not provide coverage criteria for WES (it states WES/WGS are addressed separately in policy 2.04.102). Because WES criteria are not included in this policy document, the policy does not authorize coverage for WES based on the information provided.",15712,2636,18348
Case11855,rag,all_incorrect,iter3,CMA,Patient information states chromosomal microarray (CMA) is being ordered to assess for copy number variants.,Not Specified,"The policy defines clinical indications (developmental delay/ID, ASD, multiple congenital anomalies) but does not specify age-based eligibility cutoffs for CMA.",Not Specified,The policy discusses genetic counseling and geneticist involvement but does not state explicit ordering-provider specialty or credential requirements for CMA.,No,"Policy coverage is limited to apparent nonsyndromic developmental delay/intellectual disability, ASD, or multiple congenital anomalies. The patient has a single-organ congenital anomaly (no documented global developmental delay/ID, ASD, or multiple congenital anomalies), so the defined medical indications are not met.",Not Specified,"The policy does not require completion of specific prior tests before CMA (it states CMA may be first-line); although fragile X was previously done, no prerequisite testing sequence is mandated in the policy.",Not Specified,The policy does not make family history or consanguinity a defined eligibility criterion for CMA; the patient’s reported family history (a maternal aunt with breast cancer) is not addressed as relevant in the policy.,Not Specified,"The policy recommends formal genetic counseling and that it be performed by experienced personnel, but it does not state genetic counseling as an explicit coverage precondition for CMA.",Not Specified,The policy document does not provide or map specific CPT codes to CMA testing; therefore a specific CPT code cannot be determined from the policy text.,No,"Per the policy, CMA is medically necessary only for developmental delay/ID, ASD, or multiple congenital anomalies. The patient has a single-organ congenital anomaly without documented developmental delay/ID or ASD, so the policy criteria for coverage are not met.",15724,1871,17595
Case3465,rag,all_incorrect,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) has been ordered.,Not Specified,"The UnitedHealthcare 'Genetic Testing for Cardiac Disease' policy defines age recommendations for some cardiac tests (e.g., predictive testing in children for specific syndromes) but does not specify age-based eligibility for WGS; the policy does not address WGS for a 2-year-old with developmental delay.",Not Specified,"The policy recommends pre-test genetic counseling and discusses clinical settings/providers but does not specify required ordering provider type or specialty for WGS; patient is being seen by a medical geneticist, but the policy does not define ordering-provider requirements for WGS.",Not Specified,"The policy specifies medical indications for cardiac multi-gene panels (e.g., confirmed/suspected arrhythmia or asymptomatic individuals with a first-degree relative with LQTS), but it does not define clinical indications for WGS in a child with developmental delay; the requested test (WGS for developmental delay) is not explicitly addressed in this cardiac testing policy.",Not Specified,"The policy does not state prior-test requirements specific to WGS. Although it defines criteria for cardiac panel testing, it does not list prerequisite tests required before WGS for developmental delay.",Yes,"Patient has a first-degree relative (father) with Long QT syndrome. The policy explicitly states multi-gene panel testing is medically necessary for asymptomatic individuals who have a first-degree or second-degree relative with congenital LQTS; thus the family history is relevant to cardiac genetic testing (though for panels, not specifically WGS).",Yes,"The policy states pre-test genetic counseling is strongly recommended for genetic testing. Patient had pre-test counseling with a genetic counselor and plans for post-test counseling, satisfying the policy's counseling expectation.",Not Specified,The policy's Applicable Codes list describes many cardiac panel CPT codes but does not list a CPT code corresponding to whole genome sequencing (WGS) among the provided answer options; thus the policy does not specify which of the listed CPT options maps to the requested WGS.,No,"Under this UnitedHealthcare cardiac genetic testing policy, medically necessary coverage is defined for targeted multi-gene panels for inherited arrhythmias when specific criteria are met (including testing of asymptomatic first-degree relatives for LQTS). The requested test is WGS for developmental delay (not a targeted cardiac multi-gene panel). The policy does not establish coverage criteria for WGS in this clinical scenario; therefore, based on this policy text the requested WGS is not covered. (If cardiac testing were sought based solely on the father's LQTS, the policy supports targeted multi-gene panel testing rather than WGS.)",39571,2769,42340
Case15557,rag,all_incorrect,iter3,WGS,Patient information explicitly states testing is being pursued with whole genome sequencing (WGS).,No,Policy allows rapid WGS/WES only for critically ill infants in NICU/PICU and otherwise describes WGS as investigational; the patient is a 15-year-old non-critically ill child and does not meet the narrow age/acuity criteria for medically necessary WGS per the policy statement.,Not Specified,The policy specifies clinician-with-genetics-expertise and counseling requirements for WES but does not provide explicit ordering-provider specialty/type requirements specific to WGS in the policy statement.,No,"Policy defines medical indications for rapid WGS in critically ill infants only; for non-critically ill children WGS is stated as investigational. Although the patient has congenital anomalies, she is not critically ill and therefore does not meet a medical indication for WGS per the policy.",Yes,"Policy requires prior genetic testing failed to yield diagnosis (eg, CMA and/or targeted testing) or standard workup; the patient had prior FISH testing that was nondiagnostic, which meets the policy's requirement of previous genetic testing failing to yield a diagnosis.",Yes,"Policy highlights family history (eg, affected siblings) as relevant to suspected genetic disorders; the patient has a sibling with a similar congenital anomaly, which is relevant to eligibility considerations.",Yes,"Policy requires genetic counseling prior to testing; the patient has been seen multiple times by a genetic counselor with planned post-test counseling, satisfying the counseling requirement described in the policy.",Not Specified,"The provided policy document text does not list or map specific CPT codes for WGS/WES, so a best-fit CPT code is not specified in the policy content.",No,"Per the policy statement, whole genome sequencing is considered investigational for diagnosis in all other situations outside the rapid-critically-ill-infant indication; the 15-year-old non-critically ill patient requesting WGS therefore does not meet coverage criteria.",14831,3199,18030
Case4982,rag,all_incorrect,iter3,WES,Patient is being considered for whole exome sequencing (WES) per the clinical information.,Yes,Policy eligibility is specified for 'children' with unexplained congenital or neurodevelopmental disorders; the patient is an 11-year-old child and thus meets the age-related description.,Not Answerable,Policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics; the record shows referral by a developmental pediatrician and genetic counseling sessions but does not explicitly state evaluation by a clinician with expertise in clinical genetics.,Yes,Policy indicates WES is medically necessary for children with unexplained congenital anomalies or neurodevelopmental disorders; the patient has Hirschsprung disease (listed in Policy Guidelines as an example of a malformation highly suggestive of genetic etiology) and concern for a syndromic/neurodevelopmental condition (sibling with early epileptic encephalopathy).,Yes,"Policy allows WES when previous genetic testing has failed to yield a diagnosis; the patient had prior FISH testing that was nondiagnostic, meeting the 'previous genetic testing failed' criterion.",Yes,"Policy lists relevant family history (eg, developmental delay, early severe neurologic disease in siblings); the patient has a sibling with epileptic encephalopathy before age 3, which is relevant per the policy.",Yes,"Policy requires genetic counseling by an individual with experience; the patient/family has met with a genetic counselor multiple times for pre-test counseling and plans for post-test disclosure, satisfying the counseling requirement in the record.",81415,"The requested test is whole exome sequencing; among the provided CPT options, 81415 corresponds to exome sequencing.",No,"Policy requires ALL listed criteria for WES to be met. Although age, medical indication, prior testing failure, family history, and genetic counseling are documented, the record does not explicitly document evaluation by a clinician with expertise in clinical genetics as required by the policy; because that required criterion cannot be confirmed, coverage per the policy is not met.",14860,2311,17171
Case14371,rag,all_incorrect,iter3,WES,Patient clinical info states the general pediatrician ordered whole exome sequencing (WES).,Yes,"Policy requires member <21 years for ES; patient is 11 years old, meeting the age criterion.",Not Specified,The policy requires an appropriate genetic and family history evaluation and a clinical letter but does not explicitly mandate a specific ordering provider specialty; the ordering provider is a general pediatrician and the policy does not explicitly forbid this.,Yes,"Policy allows ES when TWO of listed features are present; patient has a formal diagnosis of autism and a complex neurodevelopmental disorder, satisfying the 'TWO criteria' clause that would support a genetic etiology.",Not Specified,"The policy does not list specific mandatory prior tests for all cases (it prohibits prior ES/GS but does not require a particular panel universally). Patient had Fragile X testing (nondiagnostic), but the guideline does not mandate Fragile X specifically as a required prior test.",Not Specified,"While the policy requires an appropriate genetic and family history evaluation, it does not list family history or consanguinity as a standalone coverage criterion for ES; patient does have a maternal aunt with an immunologic disorder but the policy does not treat family history alone as an explicit eligibility criterion.",Yes,"Policy (ACMG guidance cited) specifies pretest counseling by a geneticist or affiliated genetic counselor; patient/family met with a genetic counselor prior to testing, meeting the counseling requirement.",81415,Policy billing section specifies CPT 81415 should be billed for the proband when analyzing the entire exome (WES).,No,"Although age, clinical indication (two criteria), absence of prior ES/GS, and pretest genetic counseling are satisfied, the policy requires ALL criteria including provision of a clinical letter detailing differential diagnoses, testing algorithm, prior tests/results, statement that a genetic etiology is most likely and that ES is the most appropriate test, predicted impact on plan of care, and that alternate etiologies have been considered. The provided patient information does not document that required clinical documentation/letter and other administrative criteria have been provided, so the full ALL-criteria requirement is not demonstrably met per the policy.",10483,2538,13021
Case15202,rag,all_incorrect,iter3,BRCA1/2,Patient clinical information explicitly states she was referred for BRCA1 and BRCA2 testing to evaluate hereditary breast/ovarian cancer risk.,Not Specified,The provided FEP policy document (2.04.126) does not specify age-based eligibility criteria for BRCA1/2 testing; BRCA testing guidance is referenced in a separate related policy (2.04.02) that is not provided.,Not Specified,The provided policy discusses the importance of genetic counseling by experienced providers but does not specify ordering-provider specialty or credential requirements for BRCA1/2 testing in this document.,Yes,"Policy text (American Society of Breast Surgeons guidance cited in the document) states genetic testing should be made available to all individuals with a personal history of breast cancer. The patient has a personal history of a malignant breast tumor (malignant phyllodes), so she meets the policy-cited indication for offering BRCA testing.",Not Specified,"The provided policy does not list specific required prior tests that must be completed before BRCA1/2 testing (it only notes testing an affected family member first has the highest likelihood of a positive result, but does not make it a prerequisite).",No,"The policy specifies family history of breast/ovarian cancer is relevant to risk assessment. The patient reports a sister with an immunologic/hematologic disorder, not a family history of breast or ovarian cancer; thus she does not have the family-history criteria described.",Yes,"The policy explicitly recommends formal genetic counseling by an experienced provider when genetic testing for an inherited condition is considered. The patient completed pre-test counseling with a genetic specialist and plans post-test follow-up, meeting the counseling expectation in the policy.",Not Specified,The provided policy document does not list or map CPT codes to BRCA1/2 testing; therefore no specific CPT from the supplied options can be determined from the policy text.,Yes,"Based on the policy citations (American Society of Breast Surgeons guidance noted in the document) that genetic testing should be made available to individuals with a personal history of breast cancer, and given the patient has a personal history of a malignant breast tumor and has completed pre-test genetic counseling, BRCA1/2 testing would be considered covered as medically necessary per the policy's cited guidance and the Benefit Application clause that genetic testing is covered when medically necessary.",11021,2832,13853
Case8621,rag,all_incorrect,iter3,WES,Patient information states whole exome sequencing (WES) is being performed. Policy document addresses WES/WGS; thus WES is the requested test.,Yes,"Policy specifies WES may be medically necessary for children with unexplained neurodevelopmental disorders. The patient is a 2-year-old child, which meets the policy's child/ pediatric age criterion.",No,"Policy criterion 1 requires evaluation by a clinician with expertise in clinical genetics. The ordering provider is the child's oncologist; there is no documentation that the oncologist is a clinician with expertise in clinical genetics, so the ordering provider does not meet the policy-specified requirement.",Yes,"Policy indicates WES is medically necessary for children with unexplained neurodevelopmental disorders after standard workup. The patient has a complex neurodevelopmental disorder (autism) that remains unexplained, matching the defined indication.",Yes,"Policy requires prior genetic testing (eg, chromosomal microarray) failed to yield a diagnosis. The patient had prior CMA testing that was nondiagnostic, satisfying the prior-test requirement.",Yes,"Policy guidance notes family history is relevant and should be documented. The patient has an uncle with a congenital anomaly, which is relevant family history per the policy's family-history considerations.",Yes,"Policy requires counseling by an individual with experience/expertise in genetic medicine. The family met with a genetic counselor multiple times with pre-test counseling completed and plans for post-test follow-up, satisfying the counseling requirement.",Not Specified,The provided policy document does not list or specify CPT codes corresponding to WES; therefore a specific CPT from the provided options is not specified in the policy.,Yes,"Under the policy, standard WES may be medically necessary for children with unexplained neurodevelopmental disorders when ALL criteria are met. The patient: is a child with an unexplained neurodevelopmental disorder (meets indication), had prior CMA nondiagnostic (meets prior-testing criterion), and has completed pre-test genetic counseling. Although the ordering provider is an oncologist (Q2), documentation shows evaluation/counseling by a genetic counselor meeting the policy's counseling/expertise requirement. The family seeks a unifying diagnosis (implying potential to change management). Therefore the case meets the policy's criteria for coverage.",14841,2171,17012
Case14141,rag,all_incorrect,iter3,WES,Patient information explicitly states whole exome sequencing (WES) is planned. (Patient fact: 'whole exome sequencing (WES) is planned').,Yes,"Policy criteria apply to 'children' with unexplained congenital or neurodevelopmental disorders; patient is 7 years old (a child), so age meets the policy population. (Policy: '...for the evaluation of unexplained congenital or neurodevelopmental disorders in children'; Patient age: 7 years.)",No,"Policy requires documentation that the individual 'has been evaluated by a clinician with expertise in clinical genetics' (including family history and phenotype) prior to WES. The ordering/referring provider is an oncologist and the record does not document evaluation by a clinician with expertise in clinical genetics; therefore ordering provider requirements are not met. (Policy criterion #1; Patient fact: referred by an oncologist, no explicit genetics clinician evaluation documented.)",No,"Policy requires ALL listed criteria for medical necessity (including evaluation by a clinician with expertise in clinical genetics). Although prior CMA was nondiagnostic (meets the 'previous testing failed to yield a diagnosis' criterion), there is no documentation that a clinician with expertise in clinical genetics evaluated and documented phenotype as required; thus not all medical indication criteria are satisfied. (Policy criteria #1 and #3; Patient facts: CMA nondiagnostic, but no explicit genetics clinician evaluation documented.)",Yes,"Policy allows WES when 'previous genetic testing has failed to yield a diagnosis (e.g., chromosomal microarray analysis...)'. Patient had prior CMA reported as nondiagnostic, satisfying the prior testing requirement. (Policy criterion #3; Patient fact: 'prior chromosomal microarray (CMA) testing reported as nondiagnostic').",Yes,"Policy notes family history (e.g., developmental delay in a sibling) as relevant to the evaluation and examples include family history of developmental delay. Patient has a family history of global developmental delay in a sibling, which is relevant per policy. (Policy 'Examples...Family history of: Developmental delay'; Patient fact: sibling with global developmental delay.)",Yes,"Policy states 'Documentation of individualized genetic counseling is required before any genetic testing.' Patient information documents pre-test genetic counseling completed with arrangements for post-test counseling, meeting the counseling requirement. (Policy 'Genetic Counseling... Documentation of individualized genetic counseling is required'; Patient fact: 'pre-test genetic counseling has been completed with arrangements for post-test counseling').",81415,CPT 81415 is the code listed in the policy for exome sequence analysis (WES). (Policy Codes table: CPT 81415 'Exome ... sequence analysis').,No,"Under the policy WES may be medically necessary only when ALL criteria are met (including evaluation by a clinician with expertise in clinical genetics). Although the patient meets several criteria (child; multiple congenital anomalies; prior CMA nondiagnostic; genetic counseling completed; relevant family history), there is no documentation that a clinician with expertise in clinical genetics evaluated the patient (policy criterion #1). Additionally, the policy notes it 'may not apply to all lines of business such as the Federal Employee Program (FEP)', which further requires member-specific benefit plan verification. Based on the policy AND lack of documented genetics evaluation (and the FEP exception), coverage cannot be approved per the policy. (Policy criteria #1 and Benefit Exceptions; Patient facts as above.)",56577,2337,58914
Case6747,rag,all_incorrect,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) was ordered by the medical geneticist.,Not Specified,The provided BCBS_FEP policy discusses CMA as first‑line in children and refers generally to 'infants or children' but contains no explicit age-based eligibility criteria for WGS.,Not Specified,The policy does not specify ordering‑provider (specialty/type) requirements for WGS; it mentions genetic evaluation/counseling generally but no explicit ordering provider criteria for WGS.,Not Specified,The policy defines medical indications for CMA and states NGS panel testing is investigational; it does not define clinical indications or medical necessity criteria for WGS (WES/WGS are addressed in a separate policy not provided).,Not Specified,"The policy does not state required prior testing specifically before WGS. It does state CMA is first‑line for the listed indications; the patient has a prior nondiagnostic CMA, but no explicit prior‑test requirement for WGS is provided in this document.",Not Specified,"The policy does not specify family history or consanguinity criteria for WGS. (Patient has a sibling with developmental delay, but the policy does not link this to WGS eligibility.)",Not Specified,"The policy recommends formal genetic counseling generally when genetic testing is considered, but it does not state a specific coverage/counseling requirement for WGS in this document. The patient did receive pre‑test counseling.",Not Specified,The provided policy text does not map WGS to any CPT code; no CPT code correspondence for WGS is specified in this document.,No,"The policy provided does not authorize WGS. It designates CMA as medically necessary for multiple congenital anomalies and states NGS panel testing is investigational; WES/WGS are addressed in a separate policy not provided. The Benefit Application states experimental/investigational procedures are not covered. Based on the provided policy text (no coverage criteria for WGS and investigational stance for NGS testing), WGS is not covered.",15679,2641,18320
Case811,rag,all_incorrect,iter3,WES,Patient information states 'whole exome sequencing (WES) is being pursued' — the requested test is explicitly WES.,Not Specified,The provided BCBS_FEP_20459 policy does not state age-based eligibility for whole exome sequencing; the policy notes WES is addressed in a separate policy (2.04.102).,Not Specified,The policy document does not specify ordering-provider specialty or credential requirements for WES; WES is referred to a different policy (2.04.102).,Not Specified,"The current policy defines medical indications for CMA (developmental delay/ID, ASD, multiple congenital anomalies) and states WES is addressed separately; it does not specify clinical indication criteria for WES in this document.",Not Specified,"Although the patient had CMA which the policy identifies as first-line for developmental delay/ congenital anomalies, the policy does not state specific required prior testing before WES here (WES is handled in a separate policy).",Not Specified,"The policy does not define family-history or consanguinity criteria specific to WES; while the patient has a positive family history (older sibling with multiple congenital anomalies), the document does not specify this as an eligibility criterion for WES in this policy.",Yes,"The policy states genetic counseling 'should be performed' by experienced personnel for inherited-condition testing. The patient had pre-test counseling with a genetic counselor and post-test follow-up planned, meeting the policy's counseling expectation.",Not Specified,"The provided policy text does not map or list CPT codes for whole exome sequencing; WES coverage is referenced to a separate policy, so no CPT code is specified here.",No,"Based solely on this policy document: whole exome sequencing is not addressed in this policy (it is handled in a separate policy 2.04.102), and the policy states that next-generation sequencing panel testing is considered investigational for children with developmental delay/ID/ASD/congenital anomalies. Therefore, under this policy text alone, WES is not supported as covered.",15731,2262,17993
Case7604,rag,all_incorrect,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) has been ordered.,Yes,"Policy defines age-based application to infants/neonates (rapid sequencing indications apply to neonatal/pediatric ICU). The patient is a neonate, so the age criterion (being an infant/neonate) is met per the policy's age scope for neonatal/pediatric sequencing.",No,Policy requires evaluation by a clinician with expertise in clinical genetics (including family history and phenotype description) and counseling prior to standard testing. The patient was referred by a neurologist and there is no documentation of evaluation by a clinical genetics specialist; family declined genetic counseling.,Yes,"Policy lists 'multiple congenital anomalies' as a qualifying clinical criterion for rapid WES/WGS and for consideration of WES in unexplained congenital anomalies. The neonate has multiple congenital anomalies affecting several organ systems, so the medical-indication criterion is met.",No,"For standard WES the policy requires prior genetic testing (eg, chromosomal microarray analysis and/or targeted single-gene testing) or prior testing failing to yield a diagnosis. The patient had FISH only (nondiagnostic); there is no documentation of CMA or targeted single-gene testing, so required prior testing has not been completed.",Yes,"Policy guidance lists relevant family history (eg, developmental delay or genetic disease in family) as pertinent. The patient has an older sibling with multiple congenital anomalies, which is relevant per the policy.",No,"Policy states genetic counseling should be performed by someone with expertise and is part of the requirements for standard testing. The family declined genetic counseling, so counseling requirements are not met.",Not Specified,The provided policy document does not list or map CPT codes to WGS or WES; therefore a best-fit CPT code is not specified in the policy text.,No,"Per the policy, whole genome sequencing is covered as rapid WGS only for critically ill infants in the NICU/PICU meeting specific criteria. The neonate is not documented as critically ill or in NICU/PICU, prior required testing (eg, CMA) and genetic counseling/clinical genetics evaluation are not documented. The policy states WGS is investigational in other situations, so the requested WGS is not covered.",14826,2677,17503
Case950,rag,all_incorrect,iter3,WES,Patient clinical information explicitly states whole exome sequencing (WES) is being pursued to look for an underlying genetic cause.,Not Specified,The policy discusses age and that testing should not be limited by age (NSGC/ILAE statements) but does not specify an explicit age-based eligibility requirement for WES in the coverage criteria.,Not Specified,The guideline requires the rendering laboratory be a qualified provider per the Health Plan but does not specify ordering-provider specialty or other ordering-provider requirements for WES.,Yes,"Policy defines medical indications for genetic epilepsy testing and specifically supports testing in individuals with early-onset epileptic encephalopathy; the patient has unexplained epileptic encephalopathy with onset before age 3 and no known underlying cause, meeting that clinical indication.",Not Specified,"The policy does not list specific prior diagnostic genetic tests that must be completed before performing WES; it only notes some limits (e.g., single gene/panel reimbursable once) and that the member has no known cause for seizures.",No,"The policy includes family history criteria for some panel indications (e.g., focal epilepsy with positive family history suggestive of monogenic inheritance). The patient's family history (an uncle with prostate cancer) is not suggestive of monogenic epilepsy per the policy.",Not Specified,"While the policy cites professional guidelines (NSGC) and discusses counseling recommendations, it does not state a formal coverage requirement that genetic counseling must have been completed prior to testing for WES.",81415,The requested test is whole exome sequencing (WES); CPT 81415 corresponds to exome (WES) sequencing and is the best match among the listed CPT options.,Yes,"Per the policy the patient has unexplained early-onset epileptic encephalopathy (onset <3 years), no known underlying cause, and has not had prior epilepsy panel testing — criteria supported by the guideline for genetic NGS-based testing (and the guideline references ES/GS as appropriate). Therefore WES is covered.",12786,2827,15613
Case17822,rag,all_incorrect,iter3,WGS,The clinical information states whole genome sequencing (WGS) has been ordered as the next-tier diagnostic test after a nondiagnostic CMA.,No,"Per the policy, whole genome sequencing is only described as medically necessary in the rapid/critically ill infant context; otherwise WGS is considered investigational. The patient is a 13-year-old who is not a critically ill infant, so the age/acuity-specific eligibility for covered WGS is not met.",Yes,"Policy requires evaluation by a clinician with expertise in clinical genetics; the order was placed by a medical geneticist, which satisfies the clinician/expertise requirement.",No,"Policy states WGS is investigational for diagnosis in situations other than rapid use in critically ill infants. The patient (13 y/o, not critically ill) does not meet the policy's medical-indication criteria for covered WGS.",Yes,"Policy requires prior appropriate genetic testing (eg, chromosomal microarray) before escalation to exome/genome testing; the patient had a nondiagnostic CMA, meeting the prior-test requirement.",Not Specified,"The policy specifies family-history examples relevant to some rapid-sequencing indications, but does not define family-history/consanguinity criteria specific to non-rapid WGS for non-critically ill children. The provided family history (sibling short stature) is not one of the explicit family-history examples for eligibility.",No,"Policy for WES/WGS evaluation requires counseling about risks of genetic testing by someone with genetics expertise. The patient declined genetic counseling prior to testing, so counseling requirements were not met.",81425,The requested test is whole genome sequencing; CPT 81425 corresponds to clinical whole genome sequence analysis/interpretation.,No,Under the policy WGS is considered investigational for diagnosis in situations other than rapid testing of critically ill infants. The patient is a non-critically ill 13-year-old with nondiagnostic CMA; therefore WGS is not covered per the policy (additionally genetic counseling requirement was not met).,14838,3785,18623
Case9408,rag,all_incorrect,iter3,WES,Patient information states the 17-year-old is undergoing whole exome sequencing (WES) ordered by a medical geneticist.,Yes,"Policy age-related criterion is onset of seizures in early childhood (before age 5). The patient had onset before 3 years, so meets the policy's age/onset criterion (policy basis: 'Onset of seizures in early childhood (ie, before the age of 5 years)').",Not Specified,The epilepsy policy does not specify required ordering-provider specialty or type for coverage (it discusses availability at tertiary/quaternary centers and genetic counseling but does not mandate an ordering provider type).,Yes,"Policy medically necessary indication covers infantile- and early-childhood-onset epileptic encephalopathies. The patient has epileptic encephalopathy with onset before age 3, which fits the policy's clinical indication (policy basis: medically necessary statement and application to epileptic encephalopathies).",Not Specified,"The policy does not mandate specific prior tests (eg, CMA) as a required prerequisite for WES; it describes testing strategies and that CMA may be considered but does not require prior testing for coverage.",Not Specified,The policy does not define family history or consanguinity criteria as part of eligibility for epilepsy genetic testing; the patient’s reported maternal immunologic/hematologic disorder is not an explicit policy criterion.,Not Specified,"The policy strongly recommends formal genetic counseling by experienced personnel but does not state an explicit coverage requirement or documentation standard; patient had pre-test counseling and plans post-test follow-up, but the policy does not prescribe specific required counseling documentation for coverage.",81415,The requested test is whole exome sequencing; CPT code 81415 corresponds to exome sequencing and is the best match for WES.,Yes,"Under the FEP policy, genetic testing is considered medically necessary for infantile/early-childhood-onset epileptic encephalopathies. The patient has early-onset epileptic encephalopathy (onset <5 years), prior nondiagnostic CMA, and pre-test counseling — meeting the policy indication for medically necessary testing.",15092,2528,17620
Case3592,rag,all_incorrect,iter3,CMA,The patient information explicitly states chromosomal microarray (CMA) testing is being requested.,Not Specified,"The policy defines clinical indications (e.g., neonatal seizures, early infantile epileptic encephalopathy) but does not provide explicit numeric age-based eligibility criteria for CMA specifically.",Not Specified,"The guideline requires the rendering laboratory be a qualified provider per the Health Plan, but it does not specify ordering-provider specialty or other ordering-provider requirements for CMA.",Not Specified,"The policy provides specific medical necessity criteria for epilepsy single-gene and multi-gene panel testing (e.g., early infantile epileptic encephalopathy, intractable neonatal seizures) but does not define explicit clinical/medical-necessity criteria for CMA in the guideline text provided.",Not Specified,"The policy does not list required prior tests that must be completed before CMA. It does note limits on repeat testing for individual genes or panels, but it does not specify prior-test prerequisites for CMA.",Not Specified,"While the policy references family history as relevant for panel testing (e.g., positive family history suggestive of monogenic inheritance), it does not define family-history or consanguinity criteria specific to CMA; the patient does have a family history but the policy does not specify how that applies to CMA eligibility.",Not Specified,The policy discusses professional guidelines and the value of genetic counseling but does not state an insurance coverage requirement that pre- or post-test genetic counseling must be documented for CMA reimbursement.,Not Specified,"The policy's procedure lists and tables do not include a specific CPT code corresponding to chromosomal microarray (CMA) in the provided text, so a best-corresponding CPT from the given options cannot be identified from the policy alone.",No,"The guideline provides explicit coverage criteria for epilepsy single-gene and multi-gene panels but does not define CMA-specific coverage criteria. The patient already had a prior CMA that was nondiagnostic and the policy restricts repeat testing for the same test (retesting generally not reimbursed except for explicit technical-advance exceptions). Based on the policy text provided, CMA coverage is not supported for repeat testing and CMA-specific coverage criteria are not specified, so the requested CMA is not covered.",12764,2868,15632
Case17929,rag,all_incorrect,iter3,CMA,Patient information states 'tumor chromosomal microarray (CMA) testing has been requested' — CMA is the explicit test ordered.,Not Specified,The policy discusses CMA as appropriate in children but does not provide explicit age cutoffs or age-based eligibility criteria; the document does not specify an age threshold.,Not Specified,The policy recommends genetic counseling by experienced individuals but does not specify ordering-provider specialty or explicit provider-type requirements for ordering CMA.,No,"Policy states CMA is medically necessary for apparent nonsyndromic developmental delay/intellectual disability, ASD, or multiple congenital anomalies. The record documents a single 'major abnormality affecting at least one organ system' and does not document developmental delay, ASD, or multiple congenital anomalies; therefore the patient does not meet the policy's specified medical indications.",Not Specified,The policy designates CMA as a first-line/postnatal test and does not require completion of specific prior tests before CMA; it therefore does not define mandatory prior testing requirements.,Not Specified,"The policy does not list family history or consanguinity as specific eligibility criteria for CMA. Although the patient has a family BRCA1/2 pathogenic variant, that is not addressed as relevant to CMA eligibility in the policy.",Not Specified,The policy emphasizes that genetic counseling is recommended and should be performed by experienced individuals but does not state counseling as an explicit coverage requirement; thus counseling requirements for coverage are not specified.,Not Specified,The policy document does not provide or map specific CPT codes to CMA testing; no CPT code is specified in the provided policy text.,No,"Based on the policy, CMA is covered when medical necessity criteria are met (developmental delay/ID, ASD, or multiple congenital anomalies). The patient's documentation does not meet those specified indications (no developmental delay/ASD and only a single-organ system abnormality noted), so per the policy the test is not covered.",15707,2293,18000
Case12834,rag,all_incorrect,iter3,CMA,Patient information states chromosomal microarray (CMA) testing has been ordered; policy addresses CMA for developmental delay/intellectual disability/ASD.,Not Specified,The policy defines CMA as first-line for individuals with developmental delay/ID/ASD but does not specify explicit age cutoffs; the patient is 16 but no age-based limits are stated.,Not Specified,The policy discusses genetic counseling expertise but does not specify required ordering provider specialty or provider-type requirements for CMA ordering.,Yes,Policy lists CMA as medically necessary as first-line testing for individuals with developmental delay/intellectual disability or ASD; the patient is a 16-year-old with a complex neurodevelopmental disorder meeting this indication.,Not Specified,Policy references a stepwise approach (fragile X and CMA are part of first-tier testing) but does not mandate completion of a specific prior test before performing CMA; fragile X was already nondiagnostic.,Not Specified,"The policy does not specify family history or consanguinity as eligibility criteria for CMA in this context; although a maternal uncle has neurologic disease, the policy's listed indications are phenotype-based.",Not Specified,"The policy recommends formal genetic counseling in most cases and that it be performed by an experienced individual, but it does not state genetic counseling is a formal coverage precondition for CMA.",Not Specified,"The provided policy document does not list or map specific CPT codes to CMA or other tests, so no CPT code can be determined from these materials.",Yes,"Under the policy, CMA may be considered medically necessary as first-line testing for individuals with developmental delay/intellectual disability/ASD; the patient meets that clinical indication (16-year-old with complex neurodevelopmental disorder and prior nondiagnostic fragile X).",15704,1812,17516
Case4604,rag,all_incorrect,iter3,WES,Patient information explicitly states whole exome sequencing (WES) is being requested.,Not Specified,The provided FEP 2.04.59 policy discusses testing in children but does not state an explicit age-based eligibility cutoff for WES; WES is addressed in a separate policy (2.04.102).,Not Specified,The policy recommends genetic counseling by experienced personnel but does not specify ordering-provider specialty or explicit ordering requirements for WES in this document.,Not Specified,FEP 2.04.59 defines medical necessity for CMA and states NGS panels are investigational; it does not provide explicit medical-indication criteria for WES (WES is referenced as addressed in a separate policy).,Not Specified,"The policy states CMA (and fragile X) are first-tier tests for developmental delay/ID but does not specify required prior testing for WES in this document; the patient has had nondiagnostic CMA, but the policy does not define prior-test requirements for WES here.",Not Specified,"Although the patient has an affected sibling, the policy does not specify family-history or consanguinity criteria that govern eligibility for WES within this document.",Yes,"The policy states formal genetic counseling is recommended/appropriate when genetic testing is considered and should be performed by experienced personnel; the patient completed pre-test counseling with a genetic counselor and plans post-test follow-up, meeting the policy's counseling expectations.",81415,"81415 corresponds to whole exome sequencing; among the listed CPT options, 81415 best matches the requested WES.",No,"Under FEP 2.04.59, chromosomal microarray is defined as medically necessary for developmental delay/ID but next-generation sequencing panel testing is considered investigational; WES is not addressed for coverage in this policy and is referenced to a separate policy (2.04.102). Based solely on the provided policy text, WES coverage is not established in this document and thus is not supported.",15708,1797,17505
Case8661,rag,all_incorrect,iter3,WGS,The patient clinical information explicitly states 'whole genome sequencing (WGS) is requested to investigate a possible genetic cause.',No,"Policy specifies whole-genome sequencing as medically necessary only as rapid WGS for critically ill infants in NICU/PICU. The patient is a 7-year-old child not critically ill, so the age/setting requirement for the medically‑necessary rapid WGS is not met (policy: rapid WGS for critically ill infants).",No,"Policy criterion 1 requires evaluation by a clinician with expertise in clinical genetics and counseling about risks. The ordering provider is the child's neurologist and pre-test genetic counseling was declined, so the policy-specified requirement (evaluation/counseling by genetics‑expert clinician) is not satisfied.",No,"Policy states WGS is considered investigational for diagnosis in situations other than rapid WGS in critically ill infants. The patient is not a critically ill infant in an intensive care unit, so the medical indication for WGS per the policy is not met.",Not Specified,"The policy lists prior testing requirements (eg, CMA and/or targeted single‑gene testing) for standard WES eligibility, but does not specify prior-test requirements for non‑rapid WGS in the policy text; therefore specific prior-test requirements for the requested WGS are not specified in the policy.",Yes,"Policy guidelines list relevant family history (eg, developmental delay, early severe neurologic disease in a sibling) as pertinent. The patient has a sibling who developed epileptic encephalopathy before age 3, which is a relevant family history per the policy.",No,"Policy requires genetic counseling by an individual experienced in genetic medicine prior to testing. The family declined pre-test genetic counseling, so the policy-required pre‑test counseling criterion is not met.",81425,The test requested is whole genome sequencing (WGS); the CPT code among the options that corresponds to whole genome sequencing is 81425.,No,"Per the policy, WGS is considered investigational for diagnosis except as rapid WGS for critically ill infants in NICU/PICU. The patient is a non‑critically ill 7‑year‑old; criteria for medically necessary WGS are not met (and pre‑test genetics evaluation/counseling requirement is not met), so WGS is not covered under this policy.",14854,3532,18386
Case6451,rag,all_incorrect,iter3,WGS,Patient record explicitly states 'whole genome sequencing (WGS) is being pursued.',Yes,"Policy addresses infants/children (including infants <1 year) as candidates for WES/WGS; the patient is a 7‑week‑old infant, meeting the age-based scope in the policy.",Not Answerable,"Policy requires evaluation by a clinician with expertise in clinical genetics. The record shows evaluation by a developmental pediatrician and that pre‑test counseling was completed and genetics follow‑up is planned, but it does not document who ordered the test or explicitly that a clinical genetics evaluation was performed by a genetics clinician; therefore provider eligibility cannot be determined from provided information.",Yes,"Policy lists 'significant hypotonia' as a clinical feature suggesting a genetic disease and supports WES/WGS for unexplained congenital/neurodevelopmental disorders; the infant has significant hypotonia and an unexplained presentation, meeting the medical indication criterion.",No,"Policy indicates prior genetic testing such as chromosomal microarray analysis (CMA) and/or targeted single‑gene testing is expected before standard WES/WGS. The record documents a nondiagnostic karyotype but not prior CMA or targeted single‑gene testing, so required prior testing is not documented as completed.",No,"The policy specifies relevant family history items (e.g., developmental delay, inborn errors, arrhythmia, BRUE, early sudden death). The record notes the mother has an immunologic/hematologic disorder, which is not one of the specific family history criteria listed in the policy.",,,,,,,14828,3179,18007
Case19255,rag,all_incorrect,iter3,BRCA1/2,Patient was referred for BRCA1/2 testing to evaluate hereditary breast/ovarian cancer predisposition (clinical note explicitly requests BRCA1/2 testing).,Yes,"Policy age requirement for BRCA testing is ≥18 years for full sequence/other BRCA analyses; patient is 38, which meets the age criterion.",Not Specified,The policy requires pre- and post-test genetic counseling and a qualified rendering laboratory but does not specify a required ordering provider specialty; the ordering provider (neurologist) is not addressed explicitly in the policy.,Yes,Under 'Full Sequence Analysis' the policy lists 'Diagnosed with two or more primary breast cancers at any age' as an indication; the patient has two separate primary breast cancers and therefore meets a defined medical indication.,Yes,"Policy requires no previous full sequencing of BRCA1/2 for full sequence analysis; the record only notes prior nondiagnostic FISH (not BRCA sequencing), so the patient has no prior BRCA full sequencing and meets the prior-testing requirement.",Yes,"Policy includes 'metastatic ... prostate cancer in at least 1 close blood relative' as a qualifying family-history criterion; the patient reports a father with metastatic prostate cancer, which is a relevant family history.",No,"The policy requires pre- and post-test genetic counseling by an appropriate provider; the patient completed pre-test counseling with a genetic specialist but post-test counseling is not documented, so the policy-stated counseling requirement is not fully met.",81162,Policy maps BRCA1/2 full sequencing and duplication/deletion analysis (when performed concurrently) to CPT 81162; patient meets criteria for full sequence analysis and deletion/duplication may be performed concurrently.,Yes,"Patient meets policy criteria for BRCA full sequence testing: age ≥18, documented pre-test genetic counseling, no prior BRCA full sequencing, medical indication of two separate primary breast cancers, and relevant family history (father with metastatic prostate cancer). Therefore testing is covered per the BRCA Analysis criteria.",10259,2125,12384
Case2211,rag,all_incorrect,iter3,BRCA1/2,Patient was referred for BRCA1 and BRCA2 (breast cancer susceptibility) testing per the clinical information; request explicitly names BRCA1/2.,Yes,Policy states testing in minors is investigational; the patient is age 21 (adult). There is no adult age exclusion and being an adult satisfies age-related criteria in the policy.,Yes,"Policy requires testing be performed in a setting with suitably trained providers who can give pre- and post-test counseling. The patient completed pre-test counseling with a genetic specialist and plans post-test follow-up, satisfying the policy's provider/counseling setting requirement.",Yes,Policy explicitly lists as medically necessary genetic testing for individuals with any close blood relative with a known BRCA1/BRCA2/PALB2 pathogenic/likely pathogenic variant. The patient reports the mother carries a known BRCA2 pathogenic variant.,Not Specified,Policy recommends targeted testing when a familial BRCA/PALB2 variant is known but does not mandate prior testing steps the proband must complete before testing; the policy does not specify additional required prior tests for this scenario.,Yes,"Policy defines close relatives and includes family history criteria. The patient reports a mother with a known BRCA2 pathogenic variant and at least two additional affected blood relatives on the same side, meeting family-history-based criteria.",Yes,"Policy states genetic counseling should be performed by an individual with experience and expertise and testing should be in a setting with appropriate pre-/post-test counseling. The patient completed pre-test counseling with a genetic specialist and plans post-test follow-up, meeting counseling requirements.",Not Specified,The provided policy document does not list or reference specific CPT codes for BRCA1/2 testing; CPT mapping is not specified in the policy text.,Yes,"Per the policy, genetic testing for BRCA1/2 is medically necessary for individuals with any close blood relative with a known pathogenic BRCA variant. The patient is an adult, has a mother with a known BRCA2 pathogenic variant, has appropriate pre-test genetic counseling, and therefore meets coverage criteria.",18964,2008,20972
Case18882,rag,all_incorrect,iter3,WES,Patient information explicitly states whole exome sequencing (WES) is being requested.,Yes,"Policy states WES may be medically necessary for evaluation of unexplained congenital or neurodevelopmental disorders in children. The patient is an 8-year-old child, which meets the policy's pediatric (child) age applicability.",No,"Policy criterion #1 requires the individual be evaluated by a clinician with expertise in clinical genetics and counseled about risks. The patient was referred by a developmental pediatrician and the family declined pre-test genetic counseling, so the required genetics evaluation/counseling documentation is not met.",Yes,"Policy lists multiple congenital anomalies in children as an indication for WES. The patient has multiple congenital anomalies affecting several organ systems, meeting the policy's medical indication requirement (assessed regardless of other eligibility criteria).",No,"Policy expects prior genetic testing (eg, chromosomal microarray and/or targeted single-gene testing) or previous genetic testing that failed to yield a diagnosis. The only prior test noted is nondiagnostic FISH; the record does not document completion of the CMA/targeted testing examples cited by the policy.",Yes,"Policy lists family history of long QT syndrome as relevant. The family reports the mother has long QT syndrome, which is a relevant family history per the policy.",No,"Policy requires counseling by someone experienced in genetic medicine prior to testing (criterion #1 and the Genetic Counseling section). The family declined pre-test genetic counseling, so counseling requirements are not met.",Not Specified,The provided policy document does not specify CPT codes for WES or map the requested test to any CPT; therefore a CPT code is not specified in the policy text.,No,"Although the patient is a child with multiple congenital anomalies (meeting the medical indication and age), the policy requires ALL listed criteria be met (including documented evaluation by a clinician with expertise in clinical genetics and pre-test counseling, and appropriate prior testing). Those required elements (genetics evaluation/counseling and prior CMA/targeted testing) are not documented, so the policy criteria for coverage are not fully met.",14831,2010,16841
Case14408,rag,all_incorrect,iter3,BRCA1/2,The patient was referred specifically for BRCA1/2 testing per the clinical information.,Not Specified,The provided Cigna/EviCore hereditary cancer syndrome policy does not state any age-based eligibility limits for BRCA1/2 testing in the excerpts provided; BRCA-specific criteria are referenced to a separate 'BRCA Analysis' guideline not included here.,Not Specified,The policy requires pre- and post-test genetic counseling by an appropriate provider but does not specify ordering provider specialty or type for BRCA testing in the provided text; the ordering provider is a family medicine physician but the policy does not define explicit ordering-provider requirements here.,Not Answerable,"The policy states that coverage for panels requires the member to 'meet criteria for BRCA Analysis based on current EviCore guideline BRCA Analysis,' but the specific BRCA medical-necessity criteria are not included in the provided document, so it is not possible to determine whether this patient meets those BRCA-specific criteria from the supplied text.",Not Specified,"The provided guideline specifies prior-testing restrictions for multigene panels (e.g., no previous panel or hereditary cancer testing for genes on the panel) but does not provide explicit prior-test requirements for standalone BRCA1/2 testing in the excerpts given; the patient does have no prior genetic testing, but the policy's BRCA-specific prior-test rules are not present here.",Not Specified,"The policy emphasizes the importance of family history and references BRCA criteria (which are in a separate guideline), but the provided text does not explicitly define which family-history constellations (e.g., a male first‑degree relative with breast cancer) satisfy BRCA eligibility; thus relevance cannot be confirmed from the supplied policy text alone.",Yes,"The guideline requires pre- and post-test genetic counseling by an appropriate provider; the clinical information states pre-test counseling was completed and post-test follow-up with a genetic counselor is planned, meeting that requirement per the policy.",Not Specified,"The provided policy lists several procedure codes for panels and microarray (e.g., 81228, 81432) but does not provide the single-gene BRCA CPT code mapping in the supplied text; none of the BRCA-specific CPT codes appear in the excerpts, so an appropriate CPT from the given options cannot be determined from the document.",No,"Per the provided policy, authorization/coverage for BRCA testing requires meeting the specific 'BRCA Analysis' criteria (referenced but not included). The supplied documentation does not demonstrate that the patient meets those BRCA-specific medical-necessity criteria, so coverage cannot be approved based on the available policy text.",11858,3402,15260
Case4262,rag,all_incorrect,iter3,WES,Patient record explicitly states 'diagnostic whole exome sequencing (WES)' is being requested.,Not Specified,"The policy does not impose a general age limit for standard WES; age limits are specified for rapid exome (≤12 months) but the order is for WES (not specified as rapid). Patient is 5 weeks old but the request doesn't state rapid sequencing, so no age-based requirement is explicitly applicable.",No,"Policy criteria (Standard and Rapid Exome sections, criteria F and G) require pre-/post-test counseling and that the patient/family history be evaluated by a Board-Certified/Board-Eligible Medical Geneticist or an APN in Genetics. Patient info documents pre-test genetic counseling and planned post-test genetics follow-up but does not state the patient/family history was evaluated by a Board-Certified/Board-Eligible Medical Geneticist or APGN, so ordering/provider-specific requirements are not met per policy.",Yes,"Policy Standard Exome criterion A.2.b lists 'Multiple congenital abnormalities affecting unrelated organ systems' as an indication. Patient is a five-week-old with multiple congenital anomalies that do not fit a well-delineated syndrome, matching this criterion.",Not Specified,"The policy requires alternate etiologies to be considered (criterion B) and notes that ES is often considered after nondiagnostic chromosome microarray or focused testing, but it does not mandate a specific prior test as an absolute prerequisite in the stated criteria. Patient had nondiagnostic karyotype; no mandatory prior-test requirement is explicitly defined.",No,"The policy specifies family history 'strongly suggestive of a genetic etiology, including consanguinity' as a relevant criterion. Although the patient has a sibling with a brief resolved unexplained event, the record does not document a family history that meets the policy's threshold of 'strongly suggestive' or consanguinity.",Yes,"Policy requires pre- and post-test genetic counseling by an appropriate provider (criteria F). The patient record states pre-test genetic counseling has been completed and post-test follow-up with genetics is planned, satisfying the counseling requirement.",81415,The policy lists CPT 81415 as the common code for standard (and rapid) exome sequencing proband testing; the requested test is WES for the proband.,No,"Although the patient meets a medical indication for WES (multiple congenital anomalies) and counseling is documented, the policy also requires that the patient and family history be evaluated by a Board-Certified/Board-Eligible Medical Geneticist or an APGN (criterion G). The record does not document such an evaluation (only that pre-test counseling occurred and post-test genetics follow-up is planned). Because not all policy-required provider/evaluation criteria are met, coverage criteria are not fully satisfied per the policy.",12239,3240,15479
Case10363,rag,all_incorrect,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) is being pursued.,No,Policy age-based eligibility for WGS is limited to rapid WGS for critically ill infants in NICU/PICU. The patient is a 7-year-old non-critically ill child and therefore does not meet the age/acuity-based criteria for medically necessary WGS per the policy (WGS is investigational in all other situations).,No,"Policy criterion #1 requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics. Patient data show referral by a general practitioner and pre-test counseling by a genetic counselor, but no documentation of evaluation by a clinician with expertise in clinical genetics; thus ordering/provider requirements are not met per policy text.",No,"The policy defines medical indications for WGS only for rapid testing in critically ill infants. The patient (7-year-old, not critically ill) does not meet the specific medical indication for WGS; although the phenotype fits indications for WES, the requested test is WGS which policy treats as investigational in non-rapid situations.",Not Specified,"For standard WGS (the requested test) the policy does not specify required prior tests for non-rapid use because WGS is investigational in these situations. The patient did have prior targeted testing (FISH) that was nondiagnostic, which would satisfy prior-testing language for WES, but the policy does not define prior-test requirements specifically for non-rapid WGS.",No,"The policy lists specific family-history examples relevant to testing (eg, developmental delay, inborn errors, sudden unexplained death) but does not list a maternal aunt with pancreatic cancer as a qualifying family-history criterion. Patient's family history does not match the policy-specified relevant family-history examples.",Yes,"Policy requires genetic counseling and that testing candidates be counseled about risks. Patient has been seen multiple times by a genetic counselor for pre-test counseling and has plans for post-test follow-up, satisfying the policy's counseling requirement.",81425,The requested test is whole genome sequencing; CPT code 81425 corresponds to whole genome sequencing.,No,"Per the policy statement, whole genome sequencing is considered investigational for the diagnosis of genetic disorders in all other (non-rapid, non-critically ill) situations. The patient is a non-critically ill 7-year-old; therefore WGS is not covered.",14852,3483,18335
Case9349,rag,all_incorrect,iter3,WES,Patient clinical information explicitly states whole exome sequencing (WES) is being pursued.,Not Specified,The BCBS_FEP policy discusses pediatric testing considerations but provides no explicit numeric age-based eligibility cutoffs for the requested test (WES); therefore age-based criteria are not specified for WES in the policy.,Not Answerable,"Policy states testing should be performed by an expert in genetic testing and/or cardiac ion channelopathies; the record notes referral by a cardiologist but does not state whether the ordering provider meets the policy's 'expert' requirement, so there is insufficient information to determine compliance.",Not Specified,"The policy defines medical indications for targeted genetic testing for channelopathies (LQTS, BrS, CPVT, SQTS) but does not define indications for broad tests like WES. Thus specific medical indications for the requested WES are not specified in the policy.",Not Specified,"The policy outlines prior diagnostic evaluation (ECG, stress test, echocardiography) and starting with a known familial variant for targeted testing, but it does not define specific required prior tests for WES. The patient has prior nondiagnostic FISH, but the policy does not specify FISH as a required prior test for WES.",Yes,"Policy lists family history (eg, sudden cardiac death in a family member younger than 45) as a relevant criterion for considering genetic testing for channelopathies; the patient has a paternal uncle with sudden unexplained death before age 35 (a second-degree relative), which meets the family-history criterion in the policy.",Yes,"Policy requires/strongly recommends genetic counseling by experienced personnel when genetic testing for inherited cardiac conditions is considered. The patient completed pre-test counseling with a genetic counselor and has planned post-test follow-up, satisfying the policy's counseling requirement.",81415,"The requested test is whole exome sequencing (WES); the CPT option in the list corresponding to WES is 81415 (whole exome sequencing). The policy itself does not enumerate CPT codes, but WES best maps to 81415.",No,"The BCBS_FEP policy supports targeted genetic testing for cardiac ion channelopathies when specific clinical criteria are met and recommends testing focused on known familial variants or targeted panels after comprehensive evaluation. The policy does not specify coverage for broad testing such as WES; it also states benefits are not provided for genetic panels/tests when included tests are not covered or are investigational. The patient lacks documentation in the record of a known familial pathogenic variant, a documented comprehensive channelopathy workup meeting the policy's described pretest criteria, and the policy does not authorize broad exome sequencing in this scenario. Therefore, under the policy the requested WES would not be covered.",15898,3358,19256
Case1428,rag,all_incorrect,iter3,WGS,Patient information states 'whole genome sequencing (WGS) has been ordered.',Not Specified,The policy describes tests for 'children' and for 'infants' but does not give a specific numeric age cutoff for WGS eligibility; age alone is not a clearly defined numeric criterion in the policy.,Yes,"Policy requirement #1: individual must be evaluated by a clinician with expertise in clinical genetics. Patient is being evaluated by a medical geneticist, which meets this provider requirement.",No,"Policy: Whole genome sequencing is considered investigational for diagnosis in all other situations; rapid WGS is medically necessary only for critically ill infants in NICU/PICU meeting specific criteria. This infant is not described as critically ill or in intensive care, so the medical-indication criteria for WGS are not met.",No,"Policy for standard sequencing requires prior standard workup (eg, CMA and/or targeted single-gene testing) or previous testing failure. Patient only had nondiagnostic Fragile X testing; there is no documentation of prior CMA or targeted testing required by the policy.",Yes,"Policy lists family history of developmental delay as relevant. Patient has an older sibling with severe intellectual disability, which is a relevant family history per the policy.",No,Policy criterion #1 requires counseling about risks of genetic testing by a clinician experienced in genetics. The patient record states there is no documented pre-test genetic counseling.,81425,"The requested test is whole genome sequencing (WGS); among the provided CPT options, 81425 corresponds to whole genome sequencing.",No,"Per the policy, WGS is investigational for diagnosis except as rapid WGS for critically ill infants in NICU/PICU. The infant is not described as critically ill or in intensive care, required prior testing (eg, CMA) and pre-test genetic counseling are not documented; therefore WGS is not covered under the policy.",14822,2672,17494
Case3359,rag,all_incorrect,iter3,WES,Patient information states 'Whole exome sequencing (WES) is being requested' for evaluation of developmental concerns.,Yes,"Policy applies to 'children' with unexplained congenital or neurodevelopmental disorders. The patient is a 4-year-old child, meeting the policy's age-based reference to children.",No,"Policy criterion 1 requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics. Patient info documents referral by a developmental pediatrician and genetic counseling, but does not document evaluation by a clinician with expertise in clinical genetics, so ordering provider requirement is not satisfied per policy.",Yes,"Policy permits WES for children with unexplained neurodevelopmental disorders when a genetic etiology is considered likely despite prior testing. The patient has significant hypotonia (listed in policy examples), ongoing developmental concerns, and a nondiagnostic CMA, meeting the medical indication criteria.",Yes,"Policy requires prior genetic testing (eg, CMA and/or targeted testing) to be nondiagnostic or genetic etiology still likely. Patient had chromosomal microarray (CMA) previously performed and nondiagnostic, satisfying the prior test requirement.",Yes,"Policy lists family history of developmental delay as relevant. Patient has a sibling with developmental delay, which is a relevant family history per the policy.",Yes,"Policy criterion 1 requires counseling about risks of genetic testing by someone with expertise. Patient had pre-test counseling with a genetic counselor on multiple occasions, satisfying the policy's genetic counseling requirement.",81415,"The requested test is whole exome sequencing (WES); of the provided CPT options, 81415 corresponds to exome sequencing and is the best match for WES.",No,"Per the policy 'ALL of the following criteria are met' for coverage. Although age, medical indication (including nondiagnostic CMA), prior testing, family history, and genetic counseling are met, the policy requires documented evaluation by a clinician with expertise in clinical genetics (criterion 1), which is not documented in the patient information. Therefore coverage criteria are not fully met.",14846,1804,16650
Case9978,rag,all_incorrect,iter3,WES,Patient information states the 53-year-old is undergoing whole exome sequencing (WES) at the request of the neurologist.,Yes,"Policy age-related criterion is onset of seizures in early childhood (before age 5). Patient had onset before age 3, so meets the policy's age/onset requirement (FEP 2.04.109 Policy Guidelines).",Not Specified,The policy discusses genetic counseling and testing strategy but does not state specific ordering-provider specialty or provider-type requirements for ordering WES within this epilepsy policy.,Yes,"Policy states testing for infantile- and early-childhood-onset epileptic encephalopathies may be medically necessary. The patient has epileptic encephalopathy with onset before age 3 and persistent disease, matching the policy's clinical indication.",Not Specified,"The policy describes testing strategies (eg, targeted gene testing or multigene panels) and references separate criteria for WES (2.04.102) but does not state specific required prior tests that must be completed before ordering WES in this policy.",Not Specified,"The policy does not define family history or consanguinity as explicit eligibility criteria for epilepsy genetic testing; although the patient has a brother with an inborn error, the policy's coverage criteria do not hinge on family history.",Not Specified,"The policy recommends formal genetic counseling and states it should be performed by experienced personnel, but it does not explicitly make completion of counseling a stated coverage requirement for the test in this policy. (Patient has completed pre-test counseling.)",Not Specified,The policy does not provide or map specific CPT codes for WES within this document; CPT coding is not specified in the provided policy text.,Yes,"Under FEP 2.04.109, genetic testing for genes associated with infantile- and early-childhood-onset epileptic encephalopathies may be considered medically necessary when criteria are met (onset <5 years, severe epilepsy/encephalopathy, no better explanatory syndrome). Patient had seizure onset before age 3 with an epileptic encephalopathy diagnosis, and thus meets the policy's medically necessary indication for genetic testing (basis: Policy Statement and Policy Guidelines).",15067,2033,17100
Case22,rag,all_incorrect,iter3,BRCA1/2,Patient clinical information explicitly states he is undergoing BRCA1/2 testing.,Not Specified,The provided policy (FEP 2.04.126) addresses CHEK2/ATM/BARD1 and references a separate BRCA1/2 policy (2.04.02) but does not specify age-based eligibility criteria for BRCA1/2 testing in the text provided.,Not Specified,The provided policy discusses genetic counseling and generally recommends counseling by experienced providers but does not specify ordering-provider specialty or explicit ordering requirements for BRCA1/2 testing in the text provided.,Not Specified,The policy text provided addresses indications for CHEK2/ATM/BARD1 and references BRCA1/2 guidance in a separate policy (2.04.02) but does not include explicit medical-indication criteria for BRCA1/2 testing within the supplied document.,Not Specified,"The provided policy does not define required prior tests for BRCA1/2 testing. The patient had a nondiagnostic CMA, but the policy does not state that any prior test is required before BRCA1/2 testing.",Not Specified,"While the policy notes that family history is important generally, the provided text does not specify family-history or consanguinity criteria for BRCA1/2 testing; the patient does have a relevant family history (father with metastatic high-risk prostate cancer) but the policy does not define how that affects BRCA1/2 eligibility in this document.",Yes,"The policy's 'Genetic Counseling' section recommends formal genetic counseling by individuals experienced in genetic medicine. The patient completed pre-test counseling and will return for post-test follow-up with a genetic counselor, meeting the counseling recommendation in the provided policy text.",Not Specified,The supplied policy document does not list or map CPT codes to BRCA1/2 testing; no CPT guidance is provided in the text supplied.,No,"The provided policy (FEP 2.04.126) does not provide coverage criteria for BRCA1/2 testing (it addresses CHEK2/ATM/BARD1 and references a separate BRCA policy not included). Because BRCA1/2 coverage criteria and medical-necessity rules are not present in the supplied document, coverage cannot be confirmed under the provided policy text; therefore, based strictly on the provided policy text, BRCA1/2 testing is not authorized.",11042,2651,13693
Case5605,rag,all_incorrect,iter3,WGS,Patient information explicitly states the patient was referred for whole genome sequencing (WGS).,Yes,"Policy: standard WES or WGS may be medically necessary for pediatric patients under 21 with unexplained congenital disorders. Patient is 11 years old, which meets the <21 age criterion.",Yes,"Policy requires the individual be evaluated by a clinician with expertise in clinical genetics and counseling provided. Patient had pre-test counseling completed with a genetic specialist, satisfying the provider/counseling requirement.",Yes,"Policy medical indications: unexplained congenital disorder in pediatrics <21 AND one of: previous genetic testing non-diagnostic. Patient has a major congenital cardiac anomaly, is 11, and prior CMA was nondiagnostic, meeting the policy's indication criteria.",Yes,"Policy allows WES/WGS when previous genetic testing is non-diagnostic. Patient had a prior chromosomal microarray (CMA) that was nondiagnostic, meeting the prior testing requirement.",No,"Policy lists relevant family-history examples (arrhythmia, BRUE in sibling, developmental delay, inborn errors, LQTS, early sudden unexplained death). Patient’s family history is a maternal aunt with pancreatic cancer, which is not among the policy’s listed relevant family-history criteria.",Yes,"Policy requires genetic counseling by someone with expertise; patient information documents that pre-test counseling was completed with a genetic specialist, meeting this requirement.",81425,Policy coding lists 81415/81425 among covered procedure codes; 81425 corresponds to whole genome sequencing in the coding context and is included as covered when medically necessary.,Yes,"Based on policy, standard WGS is medically necessary for pediatric patients <21 with unexplained congenital anomalies when evaluated by a genetics expert, prior genetic testing is nondiagnostic, and there is potential to change management. Patient is 11, had nondiagnostic CMA, received genetics counseling, and meets the policy criteria; therefore WGS is covered.",14852,1977,16829
Case19162,rag,all_incorrect,iter3,WGS,Patient clinical information explicitly states whole genome sequencing (WGS) was ordered by the medical geneticist.,Not Specified,The provided BCBS_FEP_20459 policy discusses CMA and NGS panels and references a separate policy for WES/WGS (2.04.102) but does not specify age-based eligibility criteria for WGS within this document.,Not Specified,The policy discusses the role of genetics professionals and counseling but does not define ordering-provider (specialty/type) requirements for WGS in this document; WES/WGS ordering requirements would be in the separate related policy (2.04.102) which is not provided.,Not Specified,"The policy defines medical indications for CMA (developmental delay/ID, ASD, multiple congenital anomalies) and states NGS panels are investigational; it does not define specific clinical indication criteria for WGS in this document (those are in the separate WES/WGS policy).",Not Specified,"The policy references a stepwise approach (first-tier fragile X and CMA) for developmental presentations, and the patient had fragile X testing nondiagnostic, but the document does not state explicit prior-test requirements for WGS itself (WGS criteria are in the separate policy).",Not Specified,"Although the patient has a family history of an inborn error of metabolism in a sibling, the provided policy does not specify family-history or consanguinity criteria for WGS within this document.",Not Specified,"The policy endorses formal genetic counseling in most cases and describes recommended counseling practice, but it does not state explicit counseling requirements for WGS coverage in this document; the patient did receive pre-test counseling per chart.",81425,The requested test is whole genome sequencing (WGS); among the given CPT options 81425 corresponds to whole genome sequencing.,No,"Within the provided BCBS_FEP_20459 policy, NGS panel testing is considered investigational and WGS/WES are not addressed as covered in this document (they are referenced to a separate policy 2.04.102). The Benefit Application also states experimental/investigational procedures are not covered. Because WGS is not supported as covered in this policy and is handled in a separate, not-provided policy, the test is not covered per the provided document.",15712,2372,18084
Case15834,rag,all_incorrect,iter3,WES,Patient information explicitly states whole exome sequencing (WES) has been ordered to assess for an underlying genetic etiology.,Not Specified,The policy indicates WES is for 'children' with unexplained congenital or neurodevelopmental disorders but does not specify a precise age cutoff for standard (non-rapid) WES eligibility.,Yes,"Policy criterion 1 requires evaluation by a clinician with expertise in clinical genetics and counseling; patient facts state pre-test counseling was completed with a genetic specialist, meeting this ordering/evaluation requirement.",Yes,"Policy lists neurodevelopmental disorders in children as an indication for WES when criteria are met. The infant has early signs concerning for autism spectrum disorder (a neurodevelopmental concern) and prior Fragile X testing was nondiagnostic, consistent with the policy's target population.",Yes,"Policy criterion 3 requires prior genetic testing (eg, targeted single-gene testing) failed to yield a diagnosis OR genetic etiology is considered most likely despite prior testing. Patient completed Fragile X testing which was nondiagnostic, satisfying the 'previous genetic testing failed to yield a diagnosis' element.",Yes,"Policy notes relevant family history (including congenital anomalies) supports consideration of genetic testing; patient has a maternal aunt with a congenital anomaly, which is relevant per policy.",Yes,"Policy requires genetic counseling by an individual with genetics expertise; patient facts state pre-test counseling was completed with a genetic specialist, meeting this requirement.",Not Specified,The provided policy document does not specify CPT or billing codes for WES; no CPT mapping is included in the policy text supplied.,Yes,"Per policy, standard WES may be considered medically necessary for children with unexplained neurodevelopmental disorders when all criteria are met. Patient facts document: evaluation/counseling by a genetic specialist, prior targeted testing (Fragile X) nondiagnostic, a neurodevelopmental concern (early ASD signs), and relevant family history—together satisfy the policy's stated criteria for coverage.",14827,2241,17068
Case13,rag,all_incorrect,iter3,WES,Patient information states the newborn 'has been referred for whole exome sequencing (WES) after karyotype testing was nondiagnostic.',Not Specified,The provided FEP 2.04.59 policy does not specify age-based eligibility criteria for the requested WES; it addresses CMA first-line in postnatal patients but gives no age limits for WES.,Not Specified,"The policy discusses genetic counseling and that testing should be performed when medically necessary, but it does not specify ordering-provider specialty/credential requirements for WES or for ordering NGS in this document.",Not Specified,"The policy explicitly defines clinical indications for CMA (e.g., multiple congenital anomalies) but does not define specific medical-necessity criteria for WES in this document (WES is addressed in a separate policy 2.04.102).",No,Policy Guidelines recommend a stepwise approach with CMA (and fragile X testing) as first-tier testing for congenital anomalies/developmental delay. Patient info notes only a nondiagnostic karyotype and referral for WES; CMA is not reported as completed.,Not Specified,"While the patient has a sibling with unexplained developmental regression, the provided policy does not define family-history or consanguinity criteria applicable to WES or require family-history elements for coverage in this document.",Not Specified,"The policy recommends formal genetic counseling and notes it should be performed by qualified individuals, but it does not state genetic counseling as a defined coverage precondition for WES in this policy; patient has completed pre-test counseling per the clinical info.",Not Specified,"The provided FEP 2.04.59 policy text does not list or map CPT codes to WES or other genetic tests, so a specific CPT from the provided options cannot be determined from this document.",No,"Under this policy CMA is the indicated first-line test for multiple congenital anomalies; the policy states 'Panel testing using next-generation sequencing is considered investigational in all cases' and WES is not authorized in this document (addressed in a different policy not provided). The patient was referred for WES without documented completion of recommended first-tier CMA, so based solely on this policy the requested WES is not covered.",15689,2293,17982
Case16487,rag,all_incorrect,iter3,WES,Patient information states whole exome sequencing (WES) has been ordered.,Yes,"Policy defines BRUE as occurring in an infant younger than 1 year and WES indications in infants/children are described; the patient is a newborn, meeting the age-based criteria for infant BRUE evaluation per the policy.",Not Answerable,"Policy requires evaluation by a clinician with expertise in clinical genetics (including family history, phenotype description, and counseling). Patient data note an oncologist ordered WES and pre-test counseling was completed, but do not explicitly state a clinician with clinical genetics expertise performed the documented evaluation, so available information is insufficient to determine if ordering/provider requirements are met.",Yes,"Policy lists 'Infant with high risk stratification on evaluation for a BRUE' (including 'recurrent events without respiratory infection') as a clinical feature suggesting a genetic disease. The patient is a newborn with high-risk BRUE characterized by recurrent events without respiratory infection, and prior genetic testing (FISH) was nondiagnostic, matching policy medical-indication criteria.",Yes,"Policy allows WES when previous genetic testing has failed to yield a diagnosis (e.g., CMA and/or targeted testing). The patient had nondiagnostic FISH testing, which satisfies the policy condition that previous genetic testing failed to yield a diagnosis.",Yes,"Policy identifies relevant family history (e.g., inborn error of metabolism or genetic disease) as a supportive feature. The patient has a maternal aunt with a persistent severe immunologic/hematologic disorder, which is a relevant family history per the policy examples.",Yes,"Policy requires documentation of individualized genetic counseling before testing. Patient information states pre-test counseling was completed with plans for post-test genetic follow-up, meeting the counseling requirement.",81415,"CPT 81415 is the code listed in the policy for exome sequence analysis (proband), which corresponds to the requested WES.",Yes,"Per policy, WES may be medically necessary when all criteria are met: (1) evaluation/counseling by genetics (documentation required) — patient has pre-test counseling and planned post-test genetic follow-up; (2) potential for change in management — high-risk BRUE diagnosis can affect management; and (3) prior genetic testing failed to yield a diagnosis — nondiagnostic FISH. The phenotype (high-risk BRUE with recurrent events without respiratory infection) is specifically listed in policy examples. Based on these facts and the policy criteria, the test is covered.",56579,3428,60007
Case3677,rag,all_incorrect,iter3,BRCA1/2,Patient information states she is undergoing BRCA1/2 testing. The policy (AHS–M2003) specifically addresses BRCA1/2 testing for breast/pancreatic cancer risk.,Yes,"Policy specifies age-related criteria (e.g., individuals ≥18 years and breast cancer diagnosed before 51 meets criteria). The patient is 46 with a personal history of breast cancer, meeting the age-based eligibility in the policy.",Not Specified,"The policy requires that individuals have received genetic counseling but does not impose a specific restriction on the ordering provider type; the patient was referred by an NP and completed pre-test counseling, which the policy requires.",Yes,"Under the policy, multi-gene or BRCA1/2 testing meets coverage when the individual has breast cancer and has a close blood relative with pancreatic cancer. The patient has a personal history of breast cancer and a mother with pancreatic cancer, satisfying the medical indication.",Not Specified,The policy does not mandate specific prior tests before BRCA1/2 testing for this scenario. (Prior CMA was nondiagnostic but policy does not require CMA or other prior testing.),Yes,"Family history criteria are specified in the policy. The patient has a mother with pancreatic cancer and additional affected maternal relatives on the same side, which is relevant and meets family-history criteria.",Yes,"The policy requires that individuals have received genetic counseling prior to testing. The patient completed pre-test genetic counseling with plans for post-test follow-up, meeting this requirement.",Not Specified,The provided policy document does not list or specify CPT billing codes for BRCA1/2 testing; therefore a specific CPT code cannot be determined from the policy text.,Yes,"Per the policy (AHS–M2003), BRCA1/2 testing meets coverage for an individual with breast cancer who has a close blood relative with pancreatic cancer; the patient meets these criteria and has completed required pre-test counseling.",18254,1659,19913
Case3474,rag,all_incorrect,iter3,WGS,Patient information states 'whole genome sequencing (WGS) is being ordered.',No,"Policy only supports rapid WGS/WES for critically ill infants in NICU/PICU; for non-critically ill children the policy treats WGS as investigational. The patient is a non-critically ill 5-year-old, so the age/acuity-based criteria for covered rapid WGS are not met (policy requires critically ill infants).",Not Specified,The policy specifies ordering-provider/evaluation requirements (evaluation by a clinician with expertise in clinical genetics and counseling) in the context of WES; it does not define specific ordering-provider requirements for WGS in non-rapid/ non-critically-ill situations.,No,"While choanal atresia is listed in Policy Guidelines as a malformation suggestive of genetic etiology (supporting genomic testing generally), the policy explicitly states 'Whole genome sequencing is considered investigational for the diagnosis of genetic disorders in all other situations.' The patient is a non-critically ill child, so the medical-indication criteria for a covered WGS are not met.",Not Specified,"Policy prior-test requirements are described for WES (eg, prior CMA and/or targeted testing or previous testing failed to yield a diagnosis). The policy does not explicitly list required prior tests for WGS in non-rapid, non-critically-ill scenarios.",Yes,"Policy Guidelines list family history of developmental delay as relevant. The patient has an older sibling with developmental delay, which meets the family-history criterion described in the policy.",Not Specified,"The policy requires documentation of counseling/evaluation by a genetics clinician for WES; it does not explicitly state counseling requirements for WGS in non-rapid situations. (Patient has had pre-test counseling, but the policy does not specify counseling criteria for the requested WGS.)",Not Specified,The provided policy text does not specify or map CPT codes to WGS/WES services; no CPT code is indicated in the policy document.,No,"Per the policy statement, whole genome sequencing is considered investigational for the diagnosis of genetic disorders in all other situations. This patient is a non-critically ill 5-year-old with congenital choanal atresia; the policy therefore does not support coverage for the requested WGS.",14835,3080,17915
Case15938,rag,all_incorrect,iter3,WGS,Patient info states whole-genome sequencing (WGS) is being considered to identify a genetic cholestatic/metabolic etiology.,Yes,"Policy age-based criteria apply to individuals <18 years for genomic testing (WES/WGS pathway). Patient is a one-week-old infant (<18 years), so age meets the policy's age criterion.",No,"Policy requires evaluation/counseling by an ABMGG board‑certified medical geneticist or an ABGC board‑certified genetic counselor for WES (and WGS only if WES criteria are met in their entirety). The ordering provider is a neonatologist and no genetics evaluation/counseling is documented, so ordering/provider requirements are not met.",No,"Policy permits WGS only when WES was unable to identify a causative mutation and the WES criteria (including genetics evaluation/counseling) are met. The patient has not had WES (only a nondiagnostic karyotype), so the WGS-specific medical indication in policy is not met.",No,Policy requires prior WES (and comparator/trio analysis where indicated) before WGS (WGS meets coverage only if WES unable to identify causative mutation). The patient has not completed WES; only karyotype was nondiagnostic.,Not Specified,Policy discusses family history and trio testing in general but does not list family history/consanguinity as a required eligibility criterion for WGS in the section applicable to this scenario; therefore family history criteria are not specified for coverage determination here.,No,"Policy explicitly requires pretest counseling by an ABMGG geneticist or ABGC genetic counselor for WES (and WGS when WES criteria are invoked). No pretest genetic counseling is documented for this patient, so counseling requirements are not met.",Not Specified,The provided policy document does not specify CPT or billing codes for WGS/WES; thus a corresponding CPT code cannot be determined from the policy text.,No,"Per policy, WGS coverage is contingent on prior nondiagnostic WES and meeting all WES coverage criteria (including genetics evaluation/counseling). The patient has not had WES, has no documented genetics counseling, and the ordering/provider requirements are unmet, so WGS is not covered under the policy.",22474,2306,24780
Case4067,rag,all_incorrect,iter3,WES,Patient information explicitly states 'whole exome sequencing (WES) has been ordered.',Yes,Policy covers WES 'for the evaluation of unexplained congenital or neurodevelopmental disorders in children'; the patient is a 5-year-old child and therefore meets the age category in the policy.,Not Answerable,Policy requires the individual be 'evaluated by a clinician with expertise in clinical genetics' and counseled. Patient data only notes referral by a developmental pediatrician and that WES was ordered; there is no documentation that the ordering provider is a clinician with expertise in clinical genetics or that the genetics evaluation occurred.,Yes,"Policy guidelines list 'significant hypotonia' as an example of clinical features suggesting a genetic disease; the patient has significant hypotonia, satisfying a defined clinical indication.",No,"Policy indicates prior genetic testing (eg, chromosomal microarray analysis and/or targeted single-gene testing) should have been performed or prior testing failed to yield a diagnosis. The record documents a nondiagnostic chromosomal karyotype but does not document CMA or targeted single-gene testing, so required prior tests are not shown as completed.",Yes,Policy lists 'sudden unexplained death ... in first- or second-degree family members before age 35' as relevant family history. The patient has a paternal uncle who died suddenly before age 35 (a second-degree relative).,Not Answerable,Policy requires genetic counseling by someone with experience/expertise in genetic medicine. The patient information does not document whether formal genetic counseling was performed or meets the policy's counseling requirement.,81415,The test requested is whole exome sequencing (WES); CPT 81415 corresponds to exome sequencing.,No,"Although the patient is a child with significant hypotonia (a policy-listed clinical indication) and relevant family history, the policy requires ALL listed criteria be met (including documented evaluation by a clinician with expertise in clinical genetics and counseling and appropriate prior genetic testing such as CMA/targeted testing). There is no documentation of a genetics evaluation/counseling and CMA/targeted testing is not documented; therefore the policy's all-criteria requirement is not satisfied and the test is not covered per the policy.",14823,3058,17881
Case11514,rag,all_incorrect,iter3,WES,Patient record explicitly states whole exome sequencing (WES) was requested to investigate a genetic cause of cholestatic liver disease.,Yes,"Policy II.1 specifies an age criterion of 'individuals less than 18 years' for WES; the patient is 10 years old, therefore the patient's age meets the policy's age-related eligibility requirement.",No,"Policy II.1(a) requires evaluation by an ABMGG board-certified medical geneticist or an ABGC board-certified genetic counselor and that the individual be counseled. The test was ordered by the patient's oncologist and there is no documentation of pre-test genetic counseling, so ordering/provider requirements are not met.",No,"Policy II.1 limits covered WES to evaluation of 'unexplained congenital or neurodevelopmental disorder' in individuals <18. The patient's presentation is conjugated hyperbilirubinemia/cholestatic liver disease (not described as congenital or neurodevelopmental), so the clinical indication does not meet the specific covered indication in the policy. (Policy II.1 and II.7: 'for all other situations not described above, WES DOES NOT MEET COVERAGE CRITERIA').",Not Specified,"Policy II.1 for pediatric WES does not explicitly require prior diagnostic tests such as CMA for non-fetal indications (the fetal WES section II.2.b does require prior CMA/karyotype). The patient did have a nondiagnostic CMA, but the policy does not specify CMA as a required prior test for the pediatric indication.",Not Specified,"The policy does not list family history/consanguinity as a required eligibility criterion for pediatric WES in II.1 (although family history may support a genomic etiology). The patient does have a cousin with an inborn error of metabolism, but family history is not a specified coverage requirement in the pediatric WES criteria.",No,"Policy II.1(a) explicitly requires that the individual 'has been evaluated by an ABMGG board-certified medical geneticist or an ABGC board-certified genetic counselor (CGC) and has been counseled about the potential risks of genetic testing.' The record documents no pre-test genetic counseling, so the counseling requirement is not met.",81415,"The requested test is whole exome sequencing (WES). The CPT option provided that corresponds to clinical exome sequencing/WES is 81415, so 81415 best maps to the requested test.",No,"Although the patient meets the age criterion (II.1), the clinical indication (cholestatic liver disease/conjugated hyperbilirubinemia) is not one of the policy's covered indications (II.1: 'unexplained congenital or neurodevelopmental disorder' for <18). Additionally, required pre-test evaluation/counseling by a board-certified genetics professional per II.1(a) is not documented. Under Policy II.7 ('for all other situations not described above, WES DOES NOT MEET COVERAGE CRITERIA'), the requested WES is not covered.",22494,2332,24826
Case11981,rag,all_incorrect,iter3,WGS,Patient information states 'Whole genome sequencing (WGS) is being requested.',Yes,"Policy age criterion: WES coverage is defined for individuals <18 years; WGS coverage is allowed only after WES criteria are met. Patient is 9 years old, which satisfies the <18 age criterion in the policy.",Not Answerable,"Policy requires evaluation/counseling by an ABMGG board-certified medical geneticist or an ABGC board-certified genetic counselor. The patient record only states 'pre-test discussion with a genetic specialist' without specifying ABMGG/ABGC certification, so there is insufficient information to confirm provider meets policy requirements.",No,"Policy explicitly limits WGS coverage to situations where 'WES is unable to identify a causative mutation and the clinical suspicion of a genomic etiology remains' and the WES criteria are met in entirety. The patient has not had WES performed or documented as nondiagnostic, so they do not meet the policy's defined medical indication for WGS.",No,Policy requires prior WES (and that WES be unable to identify a causative mutation) before WGS meets coverage criteria. Patient history documents fragile X testing only and no prior WES; required prior test (WES) has not been completed.,Not Specified,"The policy's formal coverage criteria for WES/WGS do not require family history or consanguinity as a standalone eligibility criterion. Although family history is noted in the clinical narrative (maternal uncle with severe immunologic disorder), the policy does not specify family history/consanguinity as a required criterion for WGS coverage.",Not Answerable,Policy requires pre-test counseling by an ABMGG board-certified medical geneticist or an ABGC board-certified genetic counselor. The patient note indicates 'pre-test discussion with a genetic specialist' but does not document the counselor's board certification or that counseling covered the specific risks required by policy; insufficient information to determine compliance.,Not Specified,"The provided policy document does not list or map CPT codes to WES/WGS services, so a specific CPT code cannot be determined from the policy text alone.",No,Under the policy WGS 'MEETS COVERAGE CRITERIA' only when WES has been performed and failed to identify a causative mutation and the WES coverage criteria are fully met. The patient has not had WES documented as performed/negative; therefore the requested WGS is not covered per the policy.,22479,2403,24882
Case7682,rag,all_incorrect,iter3,WES,Patient information explicitly states whole exome sequencing (WES) is being requested.,Not Specified,The policy refers to 'children' but does not give a specific numeric age cutoff for WES eligibility; no explicit age-based requirement is specified that would disqualify or confirm eligibility for a 9-year-old.,Yes,"Policy criterion 1 requires evaluation by a clinician with expertise in clinical genetics and counseling. Patient had pre-test counseling completed with a genetic specialist and plans for post-test follow-up, satisfying the provider/counseling requirement in the policy.",Yes,"Policy indicates WES is medically necessary for children with unexplained congenital or neurodevelopmental disorders when criteria met. The patient has multiple congenital anomalies, a family history of developmental delay, and prior genetic testing (karyotype) was nondiagnostic, consistent with the policy's indication.",Not Specified,"The policy cites prior testing (eg, CMA and/or targeted single-gene testing) as examples but does not mandate specific prior tests universally; it allows WES when previous genetic testing has failed to yield a diagnosis. The provided patient info lists a nondiagnostic karyotype but not CMA, and the policy does not strictly require CMA first.",Yes,"The policy lists family history of developmental delay as relevant. The patient has a sibling with developmental delay, meeting the family-history criterion noted in the policy.",Yes,"The policy requires genetic counseling by an experienced clinician. The patient received pre-test counseling from a genetic specialist and plans post-test follow-up, meeting the counseling requirement.",Not Specified,The provided policy document does not list or map specific CPT codes to WES; therefore a CPT code cannot be determined from the policy text alone.,Yes,"Based on the policy, WES (with trio testing when possible) is medically necessary for children with unexplained congenital anomalies when criteria are met. The patient is a child with multiple congenital anomalies, prior genetic testing was nondiagnostic, a genetic specialist evaluated/counseled the family, and family history supports a genetic etiology—together satisfying the policy's required criteria.",14826,2200,17026
Case3494,rag,all_incorrect,iter3,WES,Patient information states whole exome sequencing (WES) is being requested for diagnostic clarification.,Yes,"Policy specifies WES may be medically necessary for evaluation of unexplained congenital or neurodevelopmental disorders in children; the patient is a six-week-old infant (a child), meeting the age-related requirement.",No,Policy criterion 1 requires evaluation by a clinician with expertise in clinical genetics and counseling; the record only notes referral by a general pediatrician and does not document evaluation by a clinical genetics expert.,Yes,"Policy defines the medical indication as unexplained congenital anomalies or neurodevelopmental disorder in children; the infant has a congenital abnormality and concern for evolving complex neurodevelopmental disorder, meeting the clinical indication.",No,"Policy criterion 3 references prior genetic testing (eg, chromosomal microarray and/or targeted single-gene testing) or prior testing having failed; the patient has had no prior genetic testing.",Yes,"Policy lists relevant family history (eg, developmental delay, genetic disease); the patient has a sibling with dysmorphic features, which is a relevant family history per policy.",No,"Policy requires counseling about potential risks of genetic testing by a clinician experienced in genetics; the family declined genetic counseling, so the counseling requirement is not met.",81415,The requested test is whole exome sequencing; CPT 81415 corresponds to exome sequencing and is the appropriate code per the request.,No,"Although the infant meets the clinical indication and age criteria, the policy requires ALL listed criteria (evaluation by a clinician with expertise in clinical genetics including counseling, potential for management change, and prior genetic testing or failed prior testing). The record lacks documented genetics specialist evaluation and counseling and shows no prior genetic testing, so policy conditions are not met and WES is not covered as requested.",14828,2395,17223
Case7014,rag,all_incorrect,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) is being requested to identify an underlying genetic etiology.,Yes,"Policy allows WGS/WES for children/infants with multiple unexplained congenital anomalies; the patient is a seven-week-old infant with multiple congenital anomalies, so age meets the policy's child/infant criteria.",Yes,"Policy criterion #1 requires evaluation by a clinician with expertise in clinical genetics and counseling. Patient had pre-test genetic counseling completed with a genetic specialist, satisfying the provider/counseling requirement.",Yes,"Policy medical necessity for WGS requires multiple unexplained congenital anomalies and prior standard workup without diagnosis. The patient has multiple congenital anomalies not fitting a syndrome and prior karyotype was nondiagnostic, meeting the clinical indication.",Yes,"Policy requires that previous genetic testing failed to yield a diagnosis (eg, CMA and/or targeted testing) or that further testing would be invasive. Patient had prior karyotype testing that was nondiagnostic, which constitutes prior genetic testing that failed to yield a diagnosis.",Yes,"Policy guidance lists relevant family history items for consideration. The patient has a maternal aunt with a congenital anomaly, which is a relevant family history noted in the clinical information.",Yes,"Policy states genetic counseling should be performed by an individual with genetic expertise. Patient received pre-test genetic counseling with a genetic specialist, meeting the counseling requirement.",Not Specified,The provided FEP policy document does not list or map specific CPT codes to WGS/WES testing; therefore a specific CPT code cannot be determined from the policy text.,Yes,"Based on the FEP policy, WGS may be considered medically necessary for children with multiple unexplained congenital anomalies after standard workup when all criteria are met. The patient is an infant with multiple congenital anomalies, prior genetic testing nondiagnostic, evaluated/counseled by a genetic specialist, and therefore meets the policy's stated criteria for coverage.",14836,2485,17321
Case13517,rag,all_incorrect,iter3,WES,Patient note explicitly states 'whole exome sequencing (WES) was ordered.' Basis: patient clinical information.,Yes,Policy specifies WES coverage criteria for 'children' and the patient is 16 years old (a child). Basis: policy statement that standard WES may be medically necessary for children and patient age = 16.,No,Policy criterion 1 requires evaluation by a clinician with expertise in clinical genetics (including family history and phenotype) and counseling. The record shows referral by a developmental pediatrician and pre-test counseling by a genetic counselor but does not document evaluation by a clinician with expertise in clinical genetics; therefore ordering-provider requirement is not met per policy.,No,"Policy limits standard WES to evaluation of unexplained congenital or neurodevelopmental disorders in children. The patient presents with conjugated hyperbilirubinemia (an abnormal lab) and a sibling with suggestive labs, but no documented unexplained congenital anomalies or neurodevelopmental disorder in the patient; rapid WES criteria that list conjugated hyperbilirubinemia apply to critically ill NICU/PICU infants, which this 16-year-old is not. Basis: policy statements and guidelines.",No,"Policy requires prior appropriate genetic testing (e.g., chromosomal microarray and/or targeted single-gene testing) unless other criteria apply. The only prior test documented is Fragile X testing (nondiagnostic), not the CMA/targeted testing named; therefore required prior testing per policy is not documented as completed.",Yes,"Policy lists family history of an inborn error of metabolism as a relevant family-history criterion. The patient has a sibling with laboratory abnormalities suggestive of an inborn error of metabolism, meeting the family-history criterion in the policy.",Yes,"Policy states genetic counseling should be performed and is part of criterion 1. The record documents pre-test counseling completed with a genetic counselor and post-test counseling planned, satisfying the counseling requirement.",81415,The ordered test is whole exome sequencing (WES); the CPT code that best corresponds to clinical exome sequencing is 81415 (exome sequence analysis). Basis: mapping of requested WES to standard exome CPT code.,No,"Per the policy, standard WES is medically necessary only for children with unexplained congenital or neurodevelopmental disorders who meet ALL listed criteria (including evaluation by a clinician with expertise in clinical genetics and appropriate prior testing). This patient does not have documented unexplained congenital anomalies or a neurodevelopmental disorder, is not a critically ill infant eligible for rapid WES, lacks documented evaluation by a clinical genetics clinician, and has incomplete prior genetic testing per policy. Therefore WES is not covered under the policy for this situation.",14844,2771,17615
Case14127,rag,all_incorrect,iter3,WES,Patient information explicitly states 'whole exome sequencing (WES) is being pursued to investigate an underlying genetic etiology.',Yes,"Policy limits the medically necessary indication to 'children' with unexplained congenital or neurodevelopmental disorders; the patient is 17 years old (a child/adolescent) with global developmental delay, so age-based eligibility is met per policy.",Yes,"Policy criterion #1 requires evaluation by a clinician with expertise in clinical genetics and counseling; the patient is being coordinated by a medical geneticist and has seen a genetic counselor, satisfying ordering/provider requirements in the policy.",Not Answerable,"The policy requires (among other things) that 'there is potential for a change in management' and that a genetic etiology is considered most likely despite previous testing or prior testing failed. The record documents prior nondiagnostic FISH and clinical suspicion (GDD), but the chart does not explicitly document whether a change in management is expected; thus there is insufficient patient-specific information to confirm all required medical-indication criteria.",Not Specified,"The policy allows WES when prior genetic testing has failed or 'despite previous genetic testing (eg, CMA and/or targeted single-gene testing)'; it does not mandate a specific prior test (such as CMA) in all cases, so specific prior-test requirements are not defined.",Yes,"Policy guidelines list family history (eg, developmental delay, epileptic disorders) as relevant. The patient has a sibling with early-onset epileptic encephalopathy, which is a relevant family history per the policy.",Yes,"Policy requires genetic counseling and states it should be performed by someone with experience; the patient had pre-test genetic counseling and will return for post-test counseling, meeting the counseling requirement.",Not Specified,The provided policy document does not specify CPT codes to bill for WES; no CPT mapping is included in the policy text supplied.,Yes,"Under the policy, standard WES 'may be considered medically necessary' for children with unexplained neurodevelopmental disorders when all criteria are met. The patient is a 17-year-old with global developmental delay evaluated by a medical geneticist, has pre-test counseling, prior genetic testing (FISH) was nondiagnostic (prior testing failed to yield diagnosis), and has a relevant family history (sibling with early epileptic encephalopathy). These facts satisfy the policy's required elements (evaluation by genetics, prior nondiagnostic testing, counseling, and age), supporting coverage under the policy.",14856,2599,17455
Case15820,rag,all_incorrect,iter3,CMA,Patient information states chromosomal microarray (CMA) has been ordered to evaluate for copy number variants.,Not Specified,The policy supports CMA as first-line for individuals with developmental delay/intellectual disability but does not set an explicit age cutoff in the policy statement; age-based eligibility is not specified.,Not Specified,The policy does not specify particular ordering-provider specialty or credential requirements for CMA testing; only that genetic counseling should be performed by someone with experience.,Yes,"Policy states CMA may be considered medically necessary as first-line testing in the initial evaluation of apparent nonsyndromic developmental delay/intellectual disability, which matches the patient's presentation.",Not Specified,The policy does not mandate completion of specific prior tests before CMA (it notes stepwise approaches and that fragile X and CMA may be first-tier in some guidelines) but does not require prior testing as a coverage condition.,Not Specified,The policy does not define family-history or consanguinity criteria relevant to eligibility for CMA; the patient’s family history of early breast cancer is not addressed as relevant in this CMA policy.,Yes,"The policy recommends formal genetic counseling for genetic testing and states it should be performed by someone with expertise; the patient completed multiple pre-test counseling sessions with a genetic counselor and plans post-test follow-up, meeting the policy's counseling recommendation.",Not Specified,The policy document does not provide or map specific CPT codes for CMA testing; CPT code options are not specified in the policy text.,Yes,"Under the policy, CMA may be considered medically necessary as first-line testing for individuals with apparent nonsyndromic developmental delay/intellectual disability. The patient has nonsyndromic developmental delay/intellectual disability and no prior genetic testing, and has had genetic counseling per policy recommendations; therefore CMA is covered per the policy.",15697,1885,17582
Case13675,rag,all_incorrect,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) is being pursued for diagnostic clarification.,Not Specified,"The policy addresses children/infants broadly (eg, 'children', 'infants', 'critically ill infants') but does not impose a specific numeric age cutoff; the patient (8-week-old infant) falls within the pediatric/infant population but no explicit age-based eligibility criterion is provided in the policy text.",No,"Policy requires documentation that the individual 'has been evaluated by a clinician with expertise in clinical genetics ... and counseled about the potential risks of genetic testing.' Patient record documents referral by a neonatologist and states there is no documentation of pre-test genetic counseling or genetics evaluation, so ordering/provider requirements are not met.",No,"The policy defines specific medical indications for WES/WGS (eg, unexplained congenital anomalies with all enumerated criteria). Although the infant has congenital hearing/visual impairment and prior FISH was nondiagnostic, the required policy elements (documented genetics evaluation/counseling, documentation that a genetic etiology is considered the most likely explanation or that prior testing failed and invasive testing is the next step, and potential for management change) are not documented; therefore the patient does not meet the policy's defined medical indication.",No,"The policy references prior genetic testing (eg, chromosomal microarray analysis and/or targeted single-gene testing) as part of the indications for standard testing. The patient had prior FISH only (nondiagnostic) and there is no documentation of CMA or the other referenced prior testing required by the policy criteria.",Yes,"The policy lists family history items relevant to consideration (including long QT syndrome). The patient has a father with long QT syndrome, which is a relevant family history per the policy.",No,"The policy requires genetic counseling by an individual with expertise; the clinical information states there is no documentation of pre-test genetic counseling, so counseling requirements are not met.",Not Specified,The provided policy document does not specify or list CPT codes corresponding to WES/WGS; no CPT mapping is provided in the policy text.,No,"Per the policy, rapid WGS is medically necessary only for critically ill infants in NICU/PICU meeting specific criteria; standard WGS is described as investigational in other situations. This patient is an 8-week-old infant with no documentation of critical illness, lacks required documented genetics evaluation and pre-test counseling, and has not completed referenced prior testing (eg, CMA). Based on the policy statements and missing required criteria, WGS is not covered.",14847,3514,18361
Case2162,rag,all_incorrect,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) was requested for the infant.,Yes,"Policy age criterion for genome-wide testing is specified via the WES criteria for individuals <18 years; the patient is 7 weeks old (<18), so the age criterion is met (policy I.2 and I.1).",Not Answerable,"Policy requires evaluation by an ABMGG board-certified medical geneticist or an ABGC board-certified genetic counselor for WES/WGS pathways (II.1.a). Patient record notes pre-test genetic counseling but does not specify the counselor's ABGC/ABMGG credentials, so adequacy cannot be confirmed from provided information.",Yes,"Policy defines as an indication unexplained congenital or neurodevelopmental disorder in persons <18 (II.1). The infant has multiple congenital anomalies affecting multiple organ systems identified at birth, which meets the defined clinical indication for genome-wide testing.",No,"Policy states WGS MEETS COVERAGE CRITERIA only when WES has been performed and was unable to identify a causative mutation (II.4). The patient has not had WES (only Fragile X testing nondiagnostic), so the required prior testing (WES) has not been completed.",Not Specified,Policy references family history in certain prenatal/recurrence contexts but does not list family history or consanguinity as a required criterion for WGS in this non‑prenatal infant scenario (II). The provided family history (sibling with ASD) is not a stated explicit requirement for coverage here.,Not Answerable,"Policy requires pre-test counseling by an ABMGG medical geneticist or ABGC board‑certified genetic counselor for WES/WGS pathways (II.1.a). Patient notes pre-test genetic counseling was completed but does not state the counselor's certification, so compliance with the policy's counseling/provider credential requirement cannot be confirmed.",81425,"The requested test is whole genome sequencing (WGS); among the provided CPT options, 81425 corresponds to whole genome sequencing (WGS).",No,"Per policy, WGS is covered only when WES has been performed and failed to identify a causative mutation and all WES criteria are met (II.4). The patient has not had WES; therefore the requested WGS does not meet the policy's coverage pathway and is not covered.",22452,2705,25157
Case7376,rag,all_incorrect,iter3,WES,Patient clinical information explicitly states whole exome sequencing (WES) has been ordered for diagnostic clarification.,No,Policy Clinical Guideline Coverage Criteria limits WES/WGS consideration to members under 18 years of age; the patient is 73 and therefore does not meet the age-based criterion.,Not Answerable,"Policy requires WES/WGS be ordered by a board-certified medical geneticist or a board-certified physician with specialty in the condition being tested. The patient record only notes the order/referral by a neurologist without stating board-certification status, so sufficiency cannot be determined from provided information.",No,"The policy defines specific medical indications (e.g., pediatric developmental delay, multiple congenital anomalies prior to age 1, fetal indications, early-onset epilepsy) for coverage and requires members under 18; the 73-year-old patient does not meet these defined indications.",Not Specified,"The policy notes conventional diagnostic testing may be relevant and documentation of prior testing should be included if performed, but it does not mandate specific prior tests as a universal requirement for WES; provided information (nondiagnostic FISH) does not establish a required prior-test pathway per the policy.",Yes,"The policy requires documentation of family history (three-generation pedigree) for authorization; the patient reports a sister with triple-negative breast cancer, which constitutes relevant family history.",Yes,"Policy requires pre- and post-test genetic counseling by specified providers; the patient received pre-test counseling with a genetic specialist, satisfying the counseling requirement in the record.",81415,"Policy lists CPT 81415 for Exome (e.g., unexplained constitutional or heritable disorder or syndrome) sequence analysis, which corresponds to the ordered WES.",No,Per the policy the Plan will not cover WES/WGS for members who do not meet the criteria (coverage is limited to members under 18 with specified indications). The patient is 73 and therefore does not meet the coverage criteria.,5341,2171,7512
Case11124,rag,all_incorrect,iter3,WES,Patient information explicitly states whole-exome sequencing (WES) has been ordered.,Yes,"Policy standard exome criteria allow testing for developmental delay/intellectual disability with onset prior to age 18; the patient is an infant with developmental delay, meeting the age/onset criterion (Policy: STANDARD EXOME SEQUENCING I.A.2.a).",No,"Policy requires the patient and family history be evaluated by a Board-Certified or Board-Eligible Medical Geneticist or an APGN (STANDARD EXOME SEQUENCING I.F–G). The patient was referred by an oncologist and there is no documentation that a Board-Certified/Eligible Medical Geneticist or APGN evaluated the patient, so ordering/provider requirements are not met per the policy.",Yes,"Policy lists 'apparently nonsyndromic developmental delay with onset prior to age 18' as an indication for exome sequencing (STANDARD EXOME SEQUENCING I.A.2.a). The infant has developmental delay and prior targeted FISH testing was nondiagnostic, supporting a likely genetic etiology.",Not Specified,"The policy discusses that exome sequencing may be considered after CMA or focused testing are unrevealing but does not state a strict, universal prior-test requirement (criteria emphasize ruling out alternate etiologies and that presentation not fit a syndrome with available single-gene/panel testing). Patient has prior nondiagnostic FISH, but policy does not mandate specific prior tests as an absolute requirement.",Yes,"Policy includes 'family history strongly suggestive of a genetic etiology' as one of the criteria supporting exome sequencing (STANDARD and RAPID EXOME SEQUENCING I.A.2.b and RAPID I.C.2.f). The patient has an older sibling with childhood hearing impairment, relevant to this criterion.",Not Answerable,"Policy requires pre- and post-test counseling by an appropriate provider (e.g., Board-Certified Medical Geneticist, Certified Genetic Counselor, or APGN) (STANDARD EXOME SEQUENCING I.F). The record states pre-test counseling was completed and post-test counseling is planned but does not specify the credential of the counselor, so it cannot be determined whether the counseling met the policy's provider requirements.",81415,Policy associates standard exome sequencing (proband) with CPT code 81415 in the Coverage Criteria / Policy Reference Table (see 'Standard Exome Sequencing' examples and coding).,No,"Although age and clinical indication (developmental delay, nondiagnostic prior testing, relevant family history) meet policy medical-necessity criteria, the policy explicitly requires evaluation by a Board-Certified/Board-Eligible Medical Geneticist or an APGN (STANDARD EXOME SEQUENCING I.F–G) and specified pre-/post-test counseling by an appropriate provider. The documentation does not show a geneticist/APGN evaluation nor the credentials of the counselor, therefore the policy requirements are not met and the test is not covered per the policy.",12227,2191,14418
Case8051,rag,all_incorrect,iter3,WES,Patient information explicitly states whole exome sequencing (WES) was ordered for the infant.,Not Specified,The BCBS_FEP policy (Genetic Testing for Cardiac Ion Channelopathies) does not set explicit age-based eligibility limits for testing; pediatric guidance is discussed but no concrete age cutoffs for WES are specified.,No,"Policy Guidelines state 'Genetic testing should be performed by an expert in genetic testing and/or cardiac ion channelopathies.' The ordering provider is a family medicine physician, which does not meet the policy's specified requirement that testing be performed by an expert.",No,"The policy defines medical indications for genetic testing focused on cardiac ion channelopathies (e.g., suspected LQTS, CPVT, BrS, SQTS with supporting signs/symptoms, arrhythmia, prolonged QT, resuscitated arrest, or family member with known variant). The infant has a major congenital cardiac anomaly (structural defect) with no documented clinical features of a channelopathy or family member with a known channelopathy variant, so the patient does not meet the specific channelopathy indications outlined in the policy.",Not Specified,"The policy recommends clinical evaluation (ECG, exercise testing, echo) and starting with a known familial variant when available, but it does not list a specific mandatory prior test (e.g., FISH) that must be completed before initiating genetic testing such as WES. Therefore specific prior-test requirements for WES are not specified in the policy.",No,The policy specifies family-history criteria relevant to channelopathy testing (close relative with known variant or diagnosed channelopathy). The provided family history (mother with short stature) does not meet the policy's specified family-history criteria for cardiac ion channelopathy testing.,Yes,"The policy states formal genetic counseling is recommended in most cases and should be performed by someone with expertise. The patient/family completed pre-test genetic counseling and will follow up, satisfying the policy's counseling expectation.",Not Specified,The BCBS_FEP policy document does not list or map specific CPT codes (such as for WES or panels). Therefore a specific CPT code cannot be selected from the policy text.,No,"Under the policy, coverage is limited to testing that meets defined indications for cardiac ion channelopathies and should be performed by experts; WES for an infant with a structural congenital cardiac anomaly (without clinical/ECG evidence of a channelopathy or a familial known variant) is not supported by the policy. Additionally, the ordering provider is not an expert per policy guidelines. Therefore the requested WES is not covered per the provided policy.",15895,1857,17752
Case19905,rag,all_incorrect,iter3,WES,Patient info states the child is being considered for whole exome sequencing (WES).,Yes,"Policy explicitly addresses WES for children with unexplained congenital or neurodevelopmental disorders; the patient is a 3-year-old child, which meets the age-related criterion in the policy.",No,"Policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics and counseled; the order is from a developmental pediatrician and no genetics evaluation or counseling is documented, so ordering-provider requirements are not met.",Yes,"Policy lists multiple congenital anomalies as an indication for WES in children; the patient has multiple congenital anomalies, meeting a defined medical indication.",No,"Policy examples specify prior genetic testing such as chromosomal microarray analysis and/or targeted single-gene testing; the record shows only a nondiagnostic karyotype (not CMA) and no other prior targeted testing documented, so required prior tests per policy have not been completed.",Yes,"Policy cites family history of conditions including long QT syndrome as relevant; the patient has a mother with long QT syndrome, which is a relevant family history per the policy.",No,"Policy requires counseling about risks of genetic testing by someone with expertise in genetic medicine; the patient has had no genetic counseling to date, so counseling requirements are not met.",Not Specified,"The provided policy document does not list or map specific CPT codes to WES, so a best-fit CPT code is not specified in the policy text.",No,"Although the patient meets the age and clinical-indication criteria (multiple congenital anomalies), the policy requires ALL criteria be met (including evaluation by a clinician with genetics expertise, documented genetic counseling, and appropriate prior testing such as CMA/targeted testing). Those required elements are not documented, therefore the WES request is not covered under the policy.",14808,2019,16827
Case10850,rag,all_incorrect,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) has been ordered.,Yes,"Policy M2032 specifies age-based WES/WGS criteria for individuals <18; patient is 13, meeting the age requirement in the policy (applies to pediatric neurodevelopmental evaluation).",No,"Policy requires evaluation by an ABMGG board-certified medical geneticist or an ABGC board-certified genetic counselor for WES (and WGS only if WES criteria met); the ordering provider is a developmental pediatrician and no ABMGG evaluation is documented, so provider requirements per policy are not satisfied.",No,"Policy defines covered indications for WGS only when WES was performed and was unable to identify a causative mutation and the WES criteria are fully met. The patient has not had WES performed, so the specific medical indication for WGS coverage in the policy is not met.",No,"Policy requires WES to be performed (and be nondiagnostic) before WGS meets coverage criteria. Patient has prior nondiagnostic FISH but no prior WES, so required prior testing for WGS per policy has not been completed.",Not Specified,"Policy does not explicitly make family history or consanguinity a required criterion for WGS coverage in this pediatric neurodevelopmental context. (Patient does have an aunt with dysmorphic features, but the policy does not specify family history as a required coverage criterion.)",Not Answerable,"Policy requires pre-test counseling by an ABMGG geneticist or ABGC board-certified genetic counselor for WES (and for WGS when WES criteria are implicated). Patient record notes pre-test genetic counseling was completed but does not specify the counselor's board certification, so sufficiency relative to the policy requirement cannot be determined from provided information.",Not Specified,The provided policy (M2032) does not list or map specific CPT codes to WGS/WES; no CPT code is specified in the policy text given.,No,"Per policy M2032, WGS MEETS COVERAGE CRITERIA only when WES was performed and failed to identify a causative mutation and all WES-related criteria are met. The patient has not had WES (only nondiagnostic FISH) and the WGS was ordered up front, so under the policy WGS is not covered.",22462,2440,24902
Case19321,rag,all_incorrect,iter3,WES,Patient information explicitly states whole exome sequencing (WES) is being pursued.,Yes,"Policy requires member be <21 years of age for ES; patient is 1 year old, meeting the age criterion (policy: 'Member is <21 years of age').",Not Specified,The policy requires 'appropriate genetic and family history evaluation' and a clinical letter but does not specify a required ordering provider specialty or explicit ordering-provider credential; thus ordering provider requirements are not specifically defined in the policy.,No,"Policy requires the genetic etiology be most likely based on specific listed indications (e.g., global developmental delay after formal assessment by a developmental pediatrician or neurologist, or meeting TWO specific criteria). The record documents 'features concerning for autism' and 'complex neurodevelopmental disorder' but does not document a formal assessment meeting the policy's global developmental delay definition nor two of the listed criteria; therefore the patient does not clearly meet the policy's specified medical indication.",Not Specified,"Policy does not mandate a specific prior test (except that prior ES/WGS must not have been performed). The patient has a nondiagnostic CMA and no prior ES/WGS, but the policy does not list a single required prior test universally for postnatal ES beyond documentation of prior testing in the clinical letter, so specific prior-test requirements are not explicitly defined.",Not Specified,"The policy requires appropriate genetic and family history evaluation be provided, but it does not define family history or consanguinity as a separate eligibility criterion for postnatal ES. The patient does have a maternal aunt with multiple congenital anomalies, but family-history-based criteria are not specified as a standalone coverage requirement in the exome criteria.",Yes,"Policy requires appropriate genetic/family history evaluation and documentation; ACMG-based statements within the policy recommend pretest counseling by a geneticist or genetic counselor. The patient had pre-test genetic counseling completed, satisfying the policy's counseling/documentation requirement.",81415,Policy specifies CPT 81415 should be billed for proband exome sequencing (policy billing section: '81415 should be billed for the proband').,No,"Although age, lack of prior ES/GS, prior nondiagnostic CMA, and pretest counseling are consistent with policy elements, the policy requires specific medical-indication criteria (e.g., global developmental delay after formal assessment or other listed indications). The patient record does not document meeting any of the policy's defined indication criteria (per policy: one of the listed indications or TWO specified criteria), so the request does not meet the policy's medical-necessity criteria for coverage.",10482,3070,13552
Case2496,rag,all_incorrect,iter3,WES,Patient information explicitly states whole exome sequencing (WES) is being requested for a prenatal evaluation at 32 weeks.,Not Specified,The policy provides age-based criteria for individuals <18 years and separate fetal (prenatal) WES criteria; it does not specify a gestational-age or other age cutoff for prenatal WES. Therefore age-related eligibility for this fetal WES request is not specifically limited in the policy.,No,"Policy requirement for fetal WES (II.2.a) requires pre-test counseling by an ABMGG board-certified medical geneticist or an ABGC board-certified genetic counselor. The patient information states no genetic counseling has been completed, so ordering/provider counseling requirements are not met.",No,"The policy's fetal WES coverage (II.2) requires a fetus with ultrasound anomalies and prior standard CMA and karyotype nondiagnostic, a likely genomic etiology, etc. The patient record only documents prior nondiagnostic FISH (not CMA/karyotype) and only references 'fetal imaging' (not explicit ultrasound anomalies). Thus the defined fetal WES clinical indications in the policy are not clearly met.",No,Policy II.2.b requires that standard chromosomal microarray (CMA) and karyotype analysis have failed to yield a diagnosis prior to fetal WES. The patient has only prior fluorescence in situ hybridization (FISH) testing documented as nondiagnostic; CMA and karyotype are not documented as completed and nondiagnostic.,Yes,"The patient has parental consanguinity and a family history of sudden unexplained death in a sibling. The policy and guideline sections acknowledge consanguinity and relevant family history as relevant to consideration of genomic testing (e.g., discussions of autosomal-recessive risk and ISPD scenarios), so relevant family/consanguinity information is present.",No,"The policy explicitly requires pre-test counseling by an ABMGG medical geneticist or ABGC genetic counselor for fetal WES (II.2.a). The patient information states no genetic counseling has been completed, so counseling requirements are unmet.",Not Specified,The provided policy document does not specify CPT or billing codes for WES; therefore the appropriate CPT code is not specified in the policy text.,No,"Per policy fetal WES coverage requires all fetal-specific criteria (II.2) be met, including pre-test counseling by an ABMGG/ABGC and prior nondiagnostic CMA and karyotype. The record documents no genetic counseling and only prior nondiagnostic FISH (not CMA/karyotype), so required coverage criteria are not satisfied and the test is not covered under the policy.",22482,2182,24664
Case6867,rag,all_incorrect,iter3,BRCA1/2,Patient statement: 'planned BRCA1/2 testing will be pursued' — the requested test is explicitly BRCA1 and BRCA2.,Not Specified,The provided BCBS_FEP policy (FEP 2.04.126) discusses CHEK2/ATM/BARD1 and references related BRCA policy (2.04.02) but does not state any age-based eligibility criteria for BRCA1/2 within the text supplied.,Not Specified,The provided policy emphasizes genetic counseling by an experienced provider but does not specify formal ordering-provider (specialty/type) requirements for BRCA1/2 testing in the supplied text; therefore ordering-provider requirements are not specified.,Yes,"The supplied policy text cites the American Society of Breast Surgeons guidance that 'genetic testing should be made available to all individuals with a personal history of breast cancer and that such testing should include BRCA1/BRCA2.' The patient is a woman with a personal history of breast cancer, so she meets a defined clinical indication in the policy.",Not Specified,"The provided policy does not define specific prior-test requirements that must be completed before BRCA1/2 testing (it notes testing an affected family member has highest yield, but does not mandate prior tests).",Yes,"The policy recognizes family history as relevant to hereditary cancer testing. The patient reports a mother with breast cancer at age 50 and a brother with metastatic prostate cancer with intraductal features, which are relevant family-history facts per the policy's emphasis on family history for testing decisions.",Yes,"The policy states genetic counseling is recommended and should be performed by an experienced individual. The patient had multiple pre-test counseling visits with a genetic counselor, satisfying the counseling expectation described in the policy.",Not Specified,The provided policy document does not list or map CPT codes to BRCA1/2 testing; therefore an appropriate CPT code cannot be determined from the supplied text.,Yes,"From an adjudication perspective using the supplied policy text: the policy references guidelines (American Society of Breast Surgeons and others) that BRCA1/2 testing should be made available to individuals with a personal history of breast cancer. The Benefit Application section indicates benefits are available for specialized diagnostic genetic testing when medically necessary. The patient has personal history of breast cancer, relevant family history, and completed pre-test genetic counseling — therefore BRCA1/2 testing is consistent with the coverage criteria in the provided policy.",11017,2086,13103
Case1130,rag,all_incorrect,iter3,WES,Patient information explicitly states the patient is undergoing whole exome sequencing (WES) to assess for an underlying genetic etiology.,No,"Policy’s medically necessary age criterion applies to infantile- and early-childhood-onset epilepsy with onset before age 5. The patient is 68, which does not meet the policy’s age-based requirement.",Not Specified,The policy discusses genetic counseling qualifications but does not specify ordering-provider specialty or other ordering-provider requirements for WES in this document.,No,Policy defines specific medical indications (infantile/early-childhood-onset epileptic encephalopathies with onset <5 years and severe features). The patient is an adult (68) with persistent seizures and does not meet the policy’s defined clinical indications.,Not Specified,The policy describes testing strategies (targeted gene testing or panels) and references separate criteria for WES (MP 2.324) but does not state explicit required prior tests for WES within this policy text.,Not Specified,The policy does not set family history or consanguinity as a specific eligibility criterion for WES in epilepsy; the patient’s reported family history (sister with ovarian/fallopian/peritoneal carcinoma) is not addressed as relevant in this policy.,Yes,"Policy states genetic counseling should be performed by an individual with experience in genetic medicine. The patient has seen a genetic counselor multiple times with plans for post-test follow-up, meeting the policy’s counseling expectation.",Not Specified,"The policy’s coding table lists covered procedure codes (e.g., 0231U, 0232U, 81401–81407, 81419, 81479) but none of the answer-option CPT codes (81162, 81277, 81228, 81415, 81425) are present in the provided policy text; therefore a best-match CPT from the provided options is not specified in the policy.",No,"Per the policy, genetic testing (including WES) is medically necessary only for infantile- and early-childhood-onset epilepsy (onset <5 years). Genetic testing for epilepsy is considered investigational for all other indications. The patient is 68 and does not meet the policy’s medically necessary indications, so the test is not covered under this policy.",16924,1861,18785
Case5303,rag,all_incorrect,iter3,BRCA1/2,Patient was referred specifically for BRCA1 and BRCA2 testing (clinical info states 'BRCA1 and BRCA2 testing'). Basis: patient clinical information.,Yes,"Policy age requirement: BRCA testing criteria state 'Age 18 years or older' for known familial, founder, and full sequence analyses. Patient is 37, which meets the >=18 requirement. Basis: BRCA guideline 'Age 18 years or older'.",No,"Policy requires pre- and post-test genetic counseling by an appropriate provider. Patient info states no pre-test genetic counseling was conducted, so ordering/provider requirements are not satisfied. Basis: BRCA guideline 'Genetic Counseling: pre- and post-test genetic counseling...'.",No,"Policy defines specific diagnostic/predisposition indications (personal history of defined cancers or family members with those cancers/known familial mutation). Patient has no personal history of BRCA-related cancers and family history is a brother who died suddenly (no cancer noted), so patient does not meet any listed medical/clinical indications. Basis: BRCA guideline 'Diagnostic Testing for Symptomatic Individuals' and 'Personal & Family History Combination' criteria.",Yes,"Policy prior-testing requirements generally require no previous BRCA full sequence/deletion-duplication testing. Patient has had no prior genetic testing, which satisfies the 'No previous genetic testing' requirement. Basis: BRCA guideline 'Previous Genetic Testing: No previous full sequencing...' (patient has none).",No,Policy family-history criteria require relatives with specified BRCA-related cancers or a known familial BRCA mutation. Patient's family history (brother died suddenly before 35) does not meet the policy's specified family-history criteria. Basis: BRCA guideline family-history definitions and listed cancer-family criteria.,No,"Policy requires pre- and post-test genetic counseling by an appropriate provider. Patient information explicitly states no pre-test genetic counseling was conducted, so counseling requirements are not met. Basis: BRCA guideline 'Genetic Counseling: pre- and post-test genetic counseling...'.",81162,"Policy lists CPT 81162 for 'BRCA1/2 full sequencing and duplication/deletion analysis (combined)'. The requested test is BRCA1/2 testing; when sequencing plus deletion/duplication is performed, 81162 is the likely appropriate code per policy. Basis: BRCA guideline CPT code table and billing section.",No,"Although age and absence of prior testing meet policy requirements, the patient does not meet the policy's medical indication/family-history criteria for BRCA testing and pre-test genetic counseling (required by policy) was not done. Therefore the test is not covered under the provided BRCA guideline. Basis: BRCA guideline diagnostic/predisposition criteria and 'Genetic Counseling' requirement.",10247,1954,12201
Case7447,rag,all_incorrect,iter3,WGS,Patient info states the cardiologist ordered whole genome sequencing (WGS) for the fetus at 33 weeks gestation.,Yes,"Policy explicitly addresses prenatal/fetal sequencing (fetus with ultrasound anomalies) as an allowed scenario for genome/exome testing; the patient is a fetus (33 wks), so the age/gestational status falls within the policy prenatal criteria that permit sequencing when other criteria are met.",No,"Policy requires pre-test counseling/evaluation by an ABMGG board-certified medical geneticist or an ABGC board-certified genetic counselor for fetal sequencing; the patient record states there is no documentation of pre-test genetic counseling, so ordering-provider requirements are not satisfied per policy.",No,"Policy's fetal indication requires all criteria (including pre-test counseling and prior CMA/karyotype non-diagnostic). Although the fetus has an ultrasound anomaly (severe CHD), required fetal- sequencing criteria are not fully met in the record (missing counseling and no documentation that CMA/karyotype were non-diagnostic).",No,"Policy for fetal sequencing requires standard chromosomal microarray (CMA) and karyotype analysis to have failed to yield a definitive diagnosis prior to WES (and WGS is allowed only after WES failure). The patient record does not document prior CMA/karyotype or prior WES, so required prior testing has not been completed.",No,"The policy includes specific family-history scenarios as potential indications (e.g., prior undiagnosed affected fetus/recurrence). The documented family history (maternal aunt with triple-negative breast cancer) is not the type of family/recurrence history cited by the policy and therefore does not meet the policy's family-history eligibility criteria.",No,"Policy explicitly requires pre-test counseling by an ABMGG medical geneticist or ABGC genetic counselor for fetal sequencing; the chart states there is no documentation of pre-test genetic counseling, so counseling requirements are not met.",Not Specified,The provided policy text does not specify or map particular CPT codes to WGS/WES testing; no CPT guidance is present in the document excerpt.,No,"Under the policy WGS is covered only when WES has been unable to identify a causative mutation and all fetal-sequencing criteria are met (including documented pre-test genetic counseling and prior CMA/karyotype non-diagnostic). The record lacks documentation of required pre-test counseling, prior CMA/karyotype results, and prior WES, so coverage criteria for WGS are not met.",22459,2280,24739
Case16126,rag,all_incorrect,iter3,BRCA1/2,Patient information explicitly states BRCA1 and BRCA2 testing has been ordered for the infant.,Not Specified,The provided FEP policy does not specify age-based eligibility limits for BRCA1/2 testing; no age-specific criteria are given in the policy text.,Not Specified,The policy discusses the importance of genetic counseling and qualified counselors but does not specify required ordering-provider specialties or restrict which provider types may order BRCA testing.,No,"The policy frames cancer susceptibility testing as appropriate for individuals with a personal and/or family history suggesting an inherited cancer syndrome (e.g., breast/ovarian cancer). The infant has multiple congenital anomalies but no personal or family history of breast/ovarian cancer is provided, so the documented clinical indication for BRCA1/2 testing is not met per the policy.",Not Specified,"The policy does not define specific required prior tests that must be completed before BRCA1/2 testing; while FISH was done clinically, the policy does not list it as a prerequisite.",No,"The policy makes family history of relevant cancers an important eligibility criterion for cancer susceptibility testing. The patient record notes parental consanguinity but no family history of breast/ovarian cancer is provided, so relevant family-history criteria for BRCA testing are not met.",Yes,"The policy states formal genetic counseling is recommended and should be performed by individuals with expertise. The patient has documented pre-test counseling and plans for post-test follow-up with a genetic counselor, meeting the counseling expectations in the policy.",Not Specified,"The policy document does not provide or reference CPT codes for BRCA1/2 testing or other genetic tests, so a specific CPT code cannot be determined from the provided text.",No,"Under the FEP policy, cancer susceptibility testing (including panels) is covered only when coverage criteria (e.g., personal/family history consistent with inherited cancer risk) are met; general panels are investigational otherwise. The infant has no documented personal or family history of breast/ovarian cancer to meet BRCA testing criteria per the policy, so the requested BRCA1/2 testing is not covered.",7671,2210,9881
Case4512,rag,all_incorrect,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) is being pursued.,Not Specified,"The Humana policy lists disease- and gene-specific criteria (eg, CPVT, HCM, LQTS, FH) and some age cutoffs for specific conditions (eg, LDL-C thresholds), but it does not specify age-based eligibility criteria for whole genome sequencing (WGS).",Not Specified,The policy does not specify ordering-provider specialty/type requirements for WGS; it only specifies who may perform pre-/post-test genetic counseling (Appendix A).,No,"The policy limits coverage to specific listed gene- or disease-specific tests (eg, CPVT gene testing, HCM genes, LQTS genes) and states members may NOT be eligible for tests other than those listed. WGS is not listed among covered tests, so the patient does not meet a covered medical indication per this policy.",Not Specified,"The policy defines prior testing requirements for specific covered conditions (eg, exclusion of secondary causes for FH, ECG/imaging for HCM/LQTS) but does not define prior testing requirements for WGS.",Not Specified,"The policy uses family-history criteria for certain covered tests (eg, affected first-degree relative with known pathogenic variant for KFV testing), but it does not specify family-history criteria applicable to WGS; WGS is not listed.",Not Answerable,"The policy requires pre- and post-test genetic counseling performed by qualified personnel (Appendix A: board-certified/board-eligible genetic counselor not employed by a commercial lab, etc.). Patient notes 'pre-test counseling was completed with a genetic counselor' but does not state the counselor's board status or employment, so sufficiency per the policy cannot be confirmed from provided information.",Not Specified,"The policy's CPT code table does not map any listed codes to whole genome sequencing (WGS), and no WGS-specific CPT code is specified in this policy document.",No,"Per the policy Coverage Limitations, Humana members may NOT be eligible for genetic tests other than the specific gene- or disease-based tests listed. WGS is not listed as a covered test; therefore, it is not covered under this policy.",12150,2098,14248
Case1778,rag,all_incorrect,iter3,WES,Patient clinical information explicitly states whole exome sequencing (WES) has been requested for diagnostic clarification of an ocular coloboma.,Yes,"Policy specifies WES may be medically necessary for children with unexplained congenital anomalies; the patient is a 14-year-old adolescent (child), so age meets policy criteria.",No,"Policy criterion 1 requires evaluation by a clinician with expertise in clinical genetics and counseling about risks. The patient was referred by a primary care physician but there is no documentation that a clinical genetics evaluation or counseling has occurred, so ordering/provider requirements are not met per policy.",Yes,"Policy lists coloboma as an example of a malformation highly suggestive of a genetic etiology and allows WES for unexplained congenital anomalies. The patient has an ocular coloboma with prior nondiagnostic testing, meeting the medical indication in the policy.",No,"Policy examples of previous genetic testing include chromosomal microarray analysis (CMA) and/or targeted single-gene testing as part of the standard workup. Patient history documents prior FISH only (nondiagnostic) and no CMA/targeted testing is documented, so required prior testing per policy is not shown to be completed.",Not Answerable,"Policy notes family history criteria in guidance, but the provided patient information does not include any family history or consanguinity details, so presence of relevant family history cannot be determined from the available facts.",No,"Policy criterion 1 requires that the individual be counseled about risks of genetic testing by someone with genetics expertise. The patient record does not document that genetic counseling occurred, so the counseling requirement is not met per policy.",Not Specified,The provided policy document does not list or map specific CPT codes to WES; therefore a corresponding CPT code is not specified in the policy text.,No,"Although the patient meets age and clinical-indication criteria (unexplained congenital coloboma), the policy requires ALL criteria be met including evaluation/counseling by a clinician with expertise in clinical genetics and appropriate prior genetic testing (e.g., CMA/targeted testing). Those required elements are not documented in the patient information, so under the policy the test is not covered.",14788,2221,17009
Case14155,rag,all_incorrect,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) has been requested to assess genetic contributors to the neurodevelopmental presentation.,Yes,Policy age-related language addresses 'children' for WES/WGS indications; the patient is a 7-year-old child and thus meets the policy's age category for pediatric sequencing considerations.,No,"The policy requires documentation that the individual has been evaluated by a clinician with expertise in clinical genetics (Policy Statement item 1). The record shows referral by neurology only and no documentation of a genetics evaluation, so provider requirements are not met.",No,"Policy Statement requires ALL criteria for medically necessary testing, including prior evaluation by genetics and either prior genetic testing (eg, CMA or targeted testing) with negative result or other specific circumstances. The patient has ASD but has had no prior genetic testing and no documented genetics evaluation, so the defined medical indications are not met.",No,"The policy expects prior genetic testing (eg, chromosomal microarray analysis and/or targeted single-gene testing) or prior negative testing as part of criteria. The patient has had no prior genetic testing, so required prior tests have not been completed.",Yes,"Policy Guidelines list relevant family history (eg, inborn error of metabolism or genetic disease) as pertinent. The patient has a maternal uncle with a persistent severe immunologic disorder, which the family raised as concern for inherited predisposition, meeting the policy's family-history relevance.",No,"Policy Statement item 1 and the Genetic Counseling section require counseling about risks of genetic testing by someone with genetics expertise. The family declined pre-test genetic counseling, so counseling requirements are not met.",81425,The requested test is whole genome sequencing (WGS); CPT code 81425 corresponds to genome sequence analysis and is the code that best aligns with WGS.,No,"Per the policy, WGS is considered investigational for diagnosis of genetic disorders in non-critically ill children in most situations and the Policy Statement requires genetics evaluation, counseling, and prior testing criteria which are not met here. Therefore the requested WGS is not covered.",14842,2838,17680
Case13406,rag,all_incorrect,iter3,WGS,"Patient information states: ""Whole genome sequencing (WGS) has been ordered by a medical geneticist."" This explicitly identifies WGS as the requested test.",Yes,"Policy GS criteria require the member to be <21 years of age. The patient is a 6‑week‑old infant, which satisfies the policy's age criterion (<21 years).",Yes,"Policy requires appropriate genetic/family history evaluation and ACMG guidance notes pretest counseling by a medical geneticist or affiliated genetic counselor. The test was ordered by a medical geneticist and pre‑test counseling was completed, meeting the provider/counseling requirement in the policy.",No,"Policy lists defined clinical indications for GS (e.g., global developmental delay following formal assessment by a developmental pediatrician or neurologist). The record documents concern for global developmental delay but does not document a formal assessment by a developmental pediatrician/neurologist or other policy‑specified indication; therefore the specific medical indication requirements as defined in the policy are not met.",Yes,"Policy requires the member not have prior exome or genome sequencing. Patient had prior chromosomal microarray (CMA) which was nondiagnostic and no prior exome/genome is reported, satisfying the policy requirement that prior ES/WGS not have been performed and showing at least CMA was done.",Yes,"Policy indicates family history evaluation is part of GS criteria and family history (including events suggestive of genetic etiology) can be relevant. The patient has a sibling with a brief resolved unexplained event (altered responsiveness with cyanosis/pallor), which is a relevant family history per the policy.",Yes,"Policy and ACMG guidance require pretest counseling by a medical geneticist or affiliated genetic counselor. The patient record states pre‑test counseling has been completed and the order was placed by a medical geneticist, meeting counseling requirements in the policy.",81425,"Policy billing section specifies CPT 81425 for proband whole genome sequencing (WGS). The requested test is WGS for the proband, so 81425 is the appropriate code per the policy.",No,"Although age, absence of prior ES/WGS, CMA nondiagnostic, provider type, and pretest counseling are consistent with policy, the GS medical‑necessity criteria require documented appropriate genetic/family history evaluation with a clinical letter (differential, testing algorithm, prior tests/results, statement that genetic etiology is most likely, recommendation that GS is most appropriate, and predicted impact on plan of care) and a policy‑specified clinical indication (e.g., GDD following formal assessment by a developmental pediatrician/neurologist). Those required documents/clinical assessments and demonstration of predicted impact on care are not present in the provided information, so the policy's all‑criteria requirement for coverage is not met.",9176,2153,11329
Case3581,rag,all_incorrect,iter3,BRCA1/2,Patient info states BRCA1 and BRCA2 testing was ordered. Policy: BRCA testing is addressed via hereditary breast cancer / BRCA Analysis (referenced in guideline). Decision based solely on patient clinical info.,Not Specified,The Cigna hereditary cancer panel policy does not state any explicit age-based eligibility for BRCA1/2 testing in the provided text; it references meeting BRCA Analysis criteria but no age limits are specified in this document.,No,"Policy requires pre- and post-test genetic counseling by an appropriate provider as part of criteria for hereditary cancer testing. Patient info states no pre-test genetic counseling was conducted, so ordering/provider-related counseling requirement is unmet.",No,The policy requires meeting criteria for BRCA Analysis or a personal diagnosis of cancer consistent with the syndrome. The patient has no personal history of cancer and the referral is for hearing/visual impairment; thus the patient does not meet the medical indications stated in the policy.,Not Specified,The guideline does not define any specific required prior diagnostic genetic tests that must be completed before BRCA1/2 testing in the provided text (it only states panels/genes should not have been previously tested). The prior FISH noted in the patient record is not specified by the policy as a required prior test.,No,"The policy specifies family history of relevant cancers is part of criteria (e.g., BRCA-related family history). The patient’s family history (sibling with a brief resolved unexplained event) is not a cancer history relevant to BRCA criteria per the policy, so relevant family history is absent.",No,"Policy explicitly requires pre- and post-test genetic counseling by an appropriate provider as part of eligibility. Patient info confirms no pre-test genetic counseling was conducted, so counseling requirement is unmet.",Not Specified,"The policy lists panel and certain procedure codes (e.g., 81432, 81479, U-codes) and lists 81228 for chromosomal microarray. The provided answer options do not include the BRCA-specific CPT/HCPCS codes referenced in the policy; therefore no provided CPT option directly corresponds to BRCA1/2 in the policy text.",No,"Per the Cigna policy, BRCA testing requires meeting BRCA Analysis criteria and pre-/post-test genetic counseling. The patient lacks a personal cancer diagnosis or documented BRCA criteria, has no relevant family cancer history, and did not have pre-test counseling — therefore the coverage criteria in the policy are not met.",11890,2537,14427
Case10529,rag,all_incorrect,iter3,WES,Patient information states 'whole exome sequencing (WES) is being pursued.',Yes,Policy medical necessity statement specifically addresses children with unexplained neurodevelopmental disorders; the patient is a 6-year-old child and therefore meets the age-based eligibility (policy applies to 'children').,Not Answerable,Policy requires 'documentation that the individual has been evaluated by a clinician with expertise in clinical genetics' plus counseling. The record documents pre-test genetic counseling but does not explicitly document evaluation by a clinician with expertise in clinical genetics (only referral by neurology). Insufficient information to confirm the required clinician evaluation.,Yes,"Policy lists unexplained neurodevelopmental disorders/intellectual disability in children as an indication for WES when criteria are met. The patient is a child with nonsyndromic developmental delay and intellectual disability and prior targeted testing (Fragile X) was nondiagnostic, consistent with the policy's clinical indication for WES.",Not Specified,"The policy gives examples of prior genetic testing (eg, chromosomal microarray and/or targeted single-gene testing) as part of the evaluation but does not mandate a single absolute prior test in all cases. The patient had Fragile X testing (nondiagnostic) but no documentation of CMA; the policy does not explicitly require one specific prior test in every situation, so specific prior-test completion is not definitively specified from the provided materials.",Yes,"Policy guidance notes family history of developmental or genetic disease as relevant. The patient has a maternal uncle with neurologic disease (dystonia and ataxia), which is relevant family history supporting a possible genetic etiology.",Yes,"Policy requires genetic counseling by an individual with genetics expertise. The patient/family 'has seen a genetic counselor multiple times and pre-test counseling is complete with plans for post-test follow-up,' meeting the policy's counseling requirement.",81415,"The requested test is whole exome sequencing (WES); among the listed CPT options, 81415 corresponds to exome sequencing and is the code that best corresponds to WES.",Yes,"Under the policy, standard WES with trio testing when possible may be medically necessary for children with unexplained neurodevelopmental disorders when criteria are met. The patient is a child with unexplained developmental delay/ID, prior targeted testing (Fragile X) was nondiagnostic, relevant family history is present, and genetic counseling has been completed. Although explicit documentation of evaluation by a clinician with expertise in clinical genetics is not provided in the record reviewed, the documented counseling, nondiagnostic prior testing, and clinical presentation satisfy the principal coverage indications in the policy; therefore WES is covered per policy criteria.",14840,3977,18817
Case18821,rag,all_incorrect,iter3,WES,Patient info explicitly states 'fetal whole exome sequencing (WES)' is requested.,Not Specified,The Concert policy does not specify an explicit prenatal/fetal age cut-off for standard exome sequencing; age-limited criteria apply to rapid/infant testing but standard ES has no explicit age exclusion applicable to a fetus in the provided text.,No,"Policy requires pre-/post-test counseling and that the patient and family history be evaluated by a Board-Certified/Board-Eligible Medical Geneticist or an APGN (criteria I.F and I.G). The ordering provider here is an obstetrician and there is no documentation of evaluation by a geneticist/APGN, so ordering-provider requirements are not met per the policy.",Yes,Under Standard Exome Sequencing criteria I.A.2 the presence of 'Multiple congenital abnormalities affecting unrelated organ systems' meets a defined medical indication; the fetal imaging identified multiple congenital anomalies affecting different organ systems.,Not Specified,"The policy states alternate etiologies should be considered/rule out when possible but does not mandate specific prior tests (e.g., CMA) as a required prerequisite for standard exome sequencing in the provided text.",Yes,"Family history (policy criterion I.A.2.b.(5): 'Family history strongly suggestive of a genetic etiology, including consanguinity') is an eligibility criterion; the patient has a maternal aunt with reported dysmorphic features, which constitutes a relevant family history per the policy.",No,"Policy criterion I.F requires pre- and post-test counseling by an appropriate provider (e.g., Board-Certified Medical Geneticist or Certified Genetic Counselor). The clinical info states there is no documentation of pre-test genetic counseling, so the counseling requirement is not met.",81415,"The policy lists CPT 81415 for standard exome sequencing (e.g., 'XomeDx - Proband (GeneDx) 81415'); WES requested corresponds to standard exome CPT 81415 in the document.",No,"Although the fetus meets a defined medical indication (multiple congenital anomalies), mandatory policy requirements (pre-/post-test genetic counseling and evaluation by a Board-Certified/Board-Eligible Medical Geneticist or APGN per I.F and I.G) are not satisfied according to the provided clinical information; therefore coverage is not supported under the policy as documented.",12240,2189,14429
Case5230,rag,all_incorrect,iter3,WES,Patient clinical info explicitly states the adolescent was referred for whole exome sequencing (WES) to evaluate a congenital anomaly.,Yes,"Policy states WES may be medically necessary for evaluation of unexplained congenital or neurodevelopmental disorders in children; the patient is a 15-year-old adolescent (a child under policy), so age criterion is met.",No,"Policy criterion 1 requires evaluation by a clinician with expertise in clinical genetics (and counseling). The order was from neurology and there is no documentation the patient was evaluated by a clinician with genetics expertise, so ordering/provider requirement is not met.",Yes,"Policy requires unexplained congenital or neurodevelopmental disorder and prior nondiagnostic testing; the patient has a congenital anomaly with a nondiagnostic CMA and a family history of an inborn error of metabolism, meeting the medical indication.",Yes,"Policy criterion 3 expects previous genetic testing (eg, CMA) to have failed to yield a diagnosis. The patient had a nondiagnostic chromosomal microarray (CMA), satisfying the prior test requirement.",Yes,"Policy guidelines list family history of an inborn error of metabolism as relevant; the patient has a sibling with an inborn error of metabolism, meeting the family-history criterion.",No,"Policy criterion 1 requires counseling about potential risks of genetic testing by someone experienced in genetic medicine. The patient declined genetic counseling, so counseling requirement is not met.",81415,The requested test is whole exome sequencing (WES); the CPT code among provided options corresponding to exome sequencing is 81415.,No,"Policy states ALL listed criteria must be met for WES to be medically necessary. Although the patient meets age, prior testing, medical indication, and has relevant family history, the required evaluation/counseling by a clinician with expertise in clinical genetics was not completed (patient declined counseling), so the ALL-criteria requirement is not satisfied and the test is not covered per policy.",14806,1592,16398
Case6478,rag,all_incorrect,iter3,BRCA1/2,Patient is being referred specifically for germline BRCA1 and BRCA2 testing per the clinical information; the policy addresses BRCA1/BRCA2 germline testing.,Yes,Policy states genetic testing is medically necessary for 'personal history of metastatic ... prostate cancer at any age'; the patient is 52 and therefore meets the 'at any age' criterion.,Not Specified,Policy requires testing be performed in a setting with suitably trained providers who can give pre- and post-test counseling but does not specify ordering-provider specialty or other explicit ordering-provider requirements.,Yes,"Policy lists 'personal history of metastatic ... prostate cancer at any age' and also 'personal history of prostate cancer at any age with ≥1 close blood relative with pancreatic cancer' as indications; the patient has metastatic prostate cancer and a father with pancreatic cancer, meeting the medical indication(s).",Not Specified,"Policy does not require completion of specific prior tests for a cancer-affected individual with metastatic prostate cancer; while it recommends testing an affected family member first when possible, no mandatory prior test is specified for this scenario.",Yes,"Policy explicitly considers a close blood relative with pancreatic cancer as relevant; the patient’s father had pancreatic cancer, which is a qualifying family history per the policy.",No,"Policy states testing should be performed in a setting that can provide appropriate pre- and post-test genetic counseling; the patient did not complete pre-test genetic counseling, so the patient's counseling status does not meet the policy's counseling expectation.",Not Specified,"The provided policy document does not list or map specific CPT codes to BRCA1/BRCA2 testing, so a CPT code is not specified in the policy text.",Yes,"Based on the policy, germline BRCA1/BRCA2 testing is medically necessary for individuals with metastatic prostate cancer (at any age) and for prostate cancer patients with a close relative with pancreatic cancer; the patient meets these criteria. Although pre-test counseling was not completed, the policy requirement is that testing be performed in a setting with access to counseling; the clinical indications in the policy support coverage.",18940,2652,21592
Case13613,rag,all_incorrect,iter3,WES,Patient record states whole exome sequencing (WES) was ordered for fetal evaluation of multiple structural anomalies.,No,Policy defines WES indications for children/critically ill infants and explicitly excludes prenatal (fetal) testing; the patient is a fetus and therefore does not meet the age/context specified in the policy.,Yes,"Policy requires evaluation and counseling by a clinician with expertise in clinical genetics; patient had pre-test discussion with a genetic specialist, meeting provider requirements.",No,"Although the fetus has multiple congenital anomalies (a criterion in the policy for neonates/infants), the policy explicitly does not address prenatal/fetal testing, so the patient does not meet an applicable medical indication per this policy.",No,"Policy requires previous standard testing (eg, chromosomal microarray and/or targeted single-gene testing) or prior negative testing; only Fragile X (nondiagnostic) is documented and CMA/targeted testing is not documented.",Yes,Policy requires documentation of family history and considers family history of congenital/developmental features relevant; patient has a maternal aunt with dysmorphic features.,Yes,"Policy requires genetic counseling by an expert; patient had pre-test discussion with a genetic specialist, satisfying counseling requirement.",81415,The requested test is whole exome sequencing; CPT 81415 corresponds to exome sequencing (clinical exome/WES) in the provided answer options.,No,The policy explicitly does not address prenatal (fetal) testing and limits WES indications to children/critically ill infants; therefore WES for prenatal fetal testing is not covered under this policy.,14831,2036,16867
Case5380,rag,all_incorrect,iter3,WGS,Patient record explicitly states whole genome sequencing (WGS) is requested to assess for an underlying genetic cause.,Yes,"Policy requires seizure onset before age 5 for infant/early-childhood testing; patient is 8 weeks old, which satisfies the age criterion (policy: ""onset of seizures in early childhood (i.e., before the age of 5 years)"").",Not Specified,The policy does not specify ordering-provider specialty or type requirements for genetic testing for epilepsy; it only recommends genetic counseling by experienced personnel.,Not Answerable,"Policy requires (1) onset <5 years, (2) clinically severe seizures affecting daily functioning and/or interictal EEG abnormalities, and (3) no other clinical syndrome better explaining symptoms. Patient meets age and has recurrent seizure-like events, but the chart does not document 'clinically severe' impact on daily functioning or EEG findings; insufficient information to confirm all required clinical criteria.",Not Specified,"The policy discusses testing strategy (panels, targeted testing, and references MP 2.324 for WES/WGS criteria) but does not state specific prior-test requirements that must be completed before WGS; patient did have a nondiagnostic CMA, which is noted but not required per this policy text.",Not Specified,The policy does not set family history or consanguinity as a required criterion for genetic testing for epilepsy; maternal short stature is documented but policy does not tie that family history element to eligibility.,Not Specified,"Policy states experts recommend formal genetic counseling and that it should be performed by experienced personnel, but it does not state counseling is a mandatory coverage prerequisite; the patient declined pre-test counseling, which the policy notes is generally recommended but not explicitly required for coverage.",81425,"The requested test is whole genome sequencing (WGS); of the CPT options provided, 81425 is the code that best corresponds to whole genome sequencing (the policy references WES/WGS testing strategies but does not directly map CPT codes to WGS in the text).",Yes,"Under the policy, genetic testing for infant/early-childhood-onset epilepsy may be medically necessary when it could change medication management or other care. The patient is an infant (<5 years) with recurrent, witnessed seizure-like events (high-risk BRUE) and a nondiagnostic CMA — a clinical scenario consistent with early-onset seizures where positive genetic results could affect management. Although some detailed items (e.g., EEG or explicit statement of daily-function impact) are not documented, the documented infant-onset recurrent seizure-like events and prior nondiagnostic CMA support that testing may meet the policy's medical-necessity intent.",16916,3081,19997
Case15570,rag,all_incorrect,iter3,BRCA1/2,The patient clinical information states the clinician requested BRCA1 and BRCA2 testing.,Not Specified,The provided FEP policy (2.04.126) does not define age-based eligibility criteria for BRCA1/2 testing; BRCA testing strategy is referenced to a different review (2.04.02) not included here.,Not Specified,The provided policy text does not specify ordering-provider specialty or other explicit ordering requirements for BRCA1/2 testing; it only generally recommends genetic counseling by an experienced provider.,No,"Applicable coverage criteria in the policy emphasize testing for individuals at high breast/ovarian cancer risk (personal history of cancer or meeting NCCN criteria). This patient is a 15-year-old with Hirschsprung disease and no personal or family history of cancer, so the patient does not meet the medical indications described in the policy.",Not Specified,The provided policy does not list specific required prior tests that must be completed before BRCA1/2 testing (the policy references testing affected family members first but does not mandate prior tests for BRCA1/2 in this text).,No,"The policy repeatedly notes family history (and NCCN criteria) is important for risk assessment for hereditary breast/ovarian cancer. The patient has no documented family history of cancer (mother has bipolar disorder only), so relevant family-history criteria are not met.",Not Specified,"The policy states genetic counseling is recommended and should be performed by someone with expertise, but it does not state in this text that documented pre-test genetic counseling is a formal coverage requirement for BRCA1/2 testing.",Not Specified,The provided policy document does not list or reference CPT codes for BRCA1/2 testing; no CPT mapping is available in the policy text.,No,"Per the policy, benefits are available only for specialized diagnostic genetic testing when medically necessary to diagnose/manage an existing condition and testing for hereditary breast/ovarian cancer is intended for individuals at high risk (personal history or meeting NCCN criteria). This 15-year-old has no personal or family history of breast/ovarian cancer and the BRCA test was ordered for an unrelated pediatric GI indication, so the test is not supported as medically necessary under the provided policy.",11010,2812,13822
Case5834,rag,all_incorrect,iter3,CMA,Patient is being referred for chromosomal microarray (CMA) testing to evaluate a genomic etiology for developmental disorder; the requested test is explicitly CMA.,Not Specified,The provided policy (BCBS_FEP_204102) addresses WES/WGS age-based criteria for children but does not specify age-based eligibility criteria for CMA.,Not Specified,The provided WES/WGS policy specifies ordering-provider requirements for WES (evaluation by clinician with genetics expertise) but does not specify ordering-provider requirements for CMA.,Not Specified,"The policy defines medical indications for WES/WGS (eg, unexplained congenital or neurodevelopmental disorders in children) but does not define explicit medical-indication criteria for CMA; although CMA is mentioned as CNV analysis in rWGS context, explicit CMA coverage criteria are not provided.",Not Specified,"The WES/WGS policy indicates prior testing (eg, CMA) is expected before WES in some situations, but the policy does not state specific prior-test requirements that must be completed before ordering CMA itself.",Not Specified,"The policy lists family-history items relevant to WES/WGS (eg, family history of developmental delay) but does not specify family-history or consanguinity criteria relevant to CMA; the patient's family history (mother with ovarian cancer) is not referenced in the policy as relevant.",Not Specified,"The policy emphasizes genetic counseling for WES/WGS and requires counseling for WES eligibility, but it does not state counseling requirements specific to CMA; although the patient had pre-test counseling, CMA-specific counseling criteria are not specified in the provided policy.",Not Specified,The provided policy document does not include or map CPT codes to chromosomal microarray (CMA); therefore a specific CPT code for the requested CMA is not specified in the supplied policy text.,No,"Based solely on the provided policy (BCBS_FEP_204102), coverage criteria for CMA are not specified. The WES/WGS policy does not establish CMA coverage rules for adults; therefore, under the supplied policy document there is no explicit basis to consider this CMA test covered.",14855,2527,17382
Case1501,rag,all_incorrect,iter3,WES,Patient info states 'Whole exome sequencing (WES) is being ordered.' Decision based strictly on the provided patient clinical information.,Not Specified,"The UnitedHealthcare cardiac testing policy defines age guidance for variant-specific/predictive testing for certain cardiac genes (e.g., LQTS predictive testing 'from birth onward' in guidance), but the policy does not specify age-based eligibility criteria for whole exome sequencing (WES) as the requested test.",Not Specified,The policy strongly recommends pre-test genetic counseling but does not impose or specify ordering-provider specialty or credential requirements for WES; therefore ordering provider requirements for WES are not specified in the policy.,Not Specified,"The policy defines medical indications for multi-gene cardiac panels (e.g., diagnosed or suspected LQTS, CPVT, Brugada, cardiomyopathies) but does not define specific clinical indications for WES. The patient's presentation (congenital anomalies, developmental concerns) is described in the clinical info, but WES-specific indications are not addressed in this cardiac policy.",Not Specified,"The policy does not state required prior tests before performing WES. It notes that some cardiac testing pathways use targeted panels or variant-specific testing when a familial mutation is known, but no prior-test requirement for WES is provided in the policy.",Yes,Patient has a first-degree relative (mother) with Long QT syndrome. The policy explicitly lists asymptomatic individuals with a first- or second-degree relative with congenital LQTS as an indication for multi-gene panel testing; the provided family history is therefore relevant per the policy.,Yes,"The policy 'strongly recommends' pre-test genetic counseling. Patient information documents that pre-test genetic counseling was completed and post-test follow-up is planned, meeting the policy's counseling recommendation.",Not Specified,The policy's 'Applicable Codes' section lists many cardiac panel CPTs but does not provide a CPT code mapping for whole exome sequencing (WES). Therefore a best-fit CPT from the provided options is not specified by this policy.,No,"Per the UnitedHealthcare 'Genetic Testing for Cardiac Disease' policy, coverage rationale addresses multi-gene panels for specific cardiac diagnoses and testing based on identified familial pathogenic variants. WES is not specified or listed as a covered test in this policy, and the patient does not meet the policy's defined cardiac diagnostic criteria (no documented QTc, no confirmed cardiac diagnosis). Therefore, based strictly on this policy and the provided patient facts, WES is not covered under this policy.",39565,2548,42113
Case10427,rag,all_incorrect,iter3,WGS,Patient record explicitly states whole genome sequencing (WGS) is being requested.,Yes,"Policy specifies pediatric eligibility (<18 years) for genomic sequencing indications; the patient is an 8‑week‑old infant (<18 years), so age meets the policy's age criterion.",Not Answerable,"Policy requires evaluation by an ABMGG board‑certified medical geneticist or an ABGC board‑certified genetic counselor. The patient note documents pre‑test counseling by a “genetic counselor” but does not state board certification or whether an ABMGG geneticist evaluated the infant, so available information is insufficient to determine if ordering/provider requirements are met.",Yes,"Policy indicates WES/WGS are indicated for unexplained congenital or neurodevelopmental disorders in <18-year-olds. The infant has significant unexplained hypotonia and a nondiagnostic FISH, consistent with an unexplained congenital/neurodevelopmental phenotype meeting the policy's medical indication.",No,"Policy allows WGS only when WES has been unable to identify a causative mutation and the other criteria are met. The record does not indicate prior WES was performed, so the required prior test (WES) for WGS coverage has not been completed.",Yes,"The policy recognizes family history/previous affected child as relevant to sequencing decisions; the patient has an older sibling with unexplained developmental regression, which is a relevant family history per the policy.",Not Answerable,"The policy requires pre‑test counseling by an ABMGG board‑certified medical geneticist or an ABGC board‑certified genetic counselor. The record notes pre‑test counseling by a genetic counselor but does not specify ABGC board certification, so it is not possible from provided information to confirm that the policy's counseling requirement is satisfied.",Not Specified,The provided policy document does not list or map CPT codes to WGS/WES; therefore a specific CPT code cannot be determined from the policy text.,No,Under the policy WGS only meets coverage criteria when WES has already been performed and was nondiagnostic and all other criteria are met. The request is for primary WGS with no documentation of prior WES; therefore WGS does not meet the policy's coverage criteria.,22480,3507,25987
Case8485,rag,all_incorrect,iter3,WES,The clinical information states whole exome sequencing (WES) has been ordered for this patient.,Yes,The policy medical necessity statement applies to 'children' with unexplained congenital or neurodevelopmental disorders. The patient is an 8‑year‑old child and therefore meets the age-related descriptor in the policy.,No,"Policy requirement #1: patient must be evaluated by a clinician with expertise in clinical genetics and counseled about risks. The ordering clinician is a general pediatrician and pre‑test genetic counseling was not performed, so ordering/provider requirements in the policy are not met.",Yes,"Policy lists 'significant hypotonia' and persistent neurodevelopmental abnormalities as clinical features suggesting a genetic disease. The patient has hypotonia and persistent motor delay, meeting the clinical indication for WES per the policy.",No,"Policy criterion #3 requires prior genetic testing (eg, chromosomal microarray analysis and/or targeted single‑gene testing) or failed prior testing with invasive next steps. Only nondiagnostic Fragile X testing is documented; no CMA or targeted testing is documented, so required prior testing is not completed.",Yes,"Policy examples of relevant family history include developmental delay. The family reports a sibling with autism spectrum disorder, which is a relevant family history per the policy.",No,"Policy criterion #1 requires counseling about the potential risks of genetic testing by a clinician with genetics expertise. Pre‑test genetic counseling was not performed, so the policy's counseling requirement is not met.",Not Specified,The provided policy document does not specify CPT or billing codes for WES; no CPT mapping is given in the policy text supplied.,No,"Although the patient meets the clinical indication (child with significant hypotonia/neurodevelopmental disorder) and age criteria, the policy requires ALL items (including evaluation by a clinician with genetics expertise and documented counseling, and appropriate prior genetic testing such as CMA/targeted testing). Those required elements are not met in the documentation provided, so the request does not meet the policy's medical necessity criteria and is not covered.",14824,1936,16760
Case11795,rag,all_incorrect,iter3,WES,Patient information explicitly states whole exome sequencing (WES) is being ordered after nondiagnostic CMA.,Not Specified,The provided FEP 2.04.59 policy does not specify age-based eligibility criteria for WES or for the testing described; it addresses postnatal CMA and general pediatric populations but gives no explicit age limits.,Not Specified,The policy discusses that genetic counseling should be performed by individuals experienced in genetic medicine but does not specify required ordering provider specialty or other ordering-provider constraints for WES.,Not Specified,"FEP 2.04.59 defines medical indications for CMA (developmental delay/ID, ASD, multiple congenital anomalies) and states NGS panels are investigational; it does not define coverage clinical indications for WES (WES is addressed in a separate policy not provided).",Yes,"The policy supports a stepwise approach with CMA as first-line for developmental delay/ID; the patient had CMA previously performed and nondiagnostic, satisfying the expected prior testing step before broader sequencing.",Yes,The patient has a family history (sibling with moderate–severe intellectual disability). The policy focuses on developmental delay/intellectual disability contexts where family history is relevant to genetic evaluation.,Yes,"The policy states formal genetic counseling is recommended/expected; patient’s record indicates pre-test genetic counseling was completed and post-test follow-up is planned, meeting the counseling expectation.",81415,"The requested test is whole exome sequencing (WES); of the provided CPT options, 81415 is the code that corresponds to exome sequencing.",No,"Under FEP 2.04.59, CMA is the covered first-line test for developmental delay/ID/ congenital anomalies; next-generation sequencing panels are labeled investigational for these indications, and WES coverage is addressed in a separate policy not provided. Because WES is not supported by the provided policy text and NGS approaches are noted investigational here, coverage is not supported based solely on this document.",15734,2179,17913
Case2007,rag,all_incorrect,iter3,BRCA1/2,Patient clinical information explicitly states referral for BRCA1 and BRCA2 testing.,Not Specified,The provided FEP policy (2.04.126) discusses CHEK2/ATM/BARD1 and references BRCA testing guidance in a separate review (2.04.02) but the supplied text does not specify age-based eligibility criteria for BRCA1/2.,Not Specified,The provided policy text recommends genetic counseling by an experienced provider but does not specify ordering-provider specialty or explicit ordering requirements for BRCA1/2 testing.,Yes,Policy excerpts (American Society of Breast Surgeons guidance cited in the document) state genetic testing should be made available to all individuals with a personal history of breast cancer and should include BRCA1/2; the patient has a personal history of metastatic breast cancer.,Not Specified,The provided policy does not list specific required prior tests before BRCA1/2 testing; the noted prior CMA was nondiagnostic but the policy does not require prior testing.,Yes,"The policy emphasizes family history in risk assessment and the patient has a relevant family history (mother with breast cancer at age ≤50), which is pertinent to eligibility.",Not Answerable,"The policy states genetic counseling should be performed by an individual with experience/expertise. The patient completed pre-test counseling and will return for post-test counseling, but the documentation provided does not state the counselor's qualifications, so sufficiency cannot be confirmed from available information.",Not Specified,The supplied policy text does not provide or map specific CPT codes for BRCA1/2 testing.,Yes,"Under the Benefit Application, specialized diagnostic genetic testing is covered when medically necessary to diagnose/manage an existing condition; the policy citations (American Society of Breast Surgeons, ASCO) in the document support that BRCA1/2 testing should be available to individuals with a personal history of breast cancer. The patient has metastatic breast cancer and a relevant family history, meeting clinical indications cited in the policy.",11011,2182,13193
Case7297,rag,all_incorrect,iter3,WES,Patient record explicitly states whole exome sequencing (WES) is being pursued.,Yes,"Policy defines standard WES as medically necessary for children with unexplained congenital or neurodevelopmental disorders; the patient is a 3-year-old child, meeting the age group specified in the policy.",Not Specified,"The policy requires the individual be evaluated by a clinician with expertise in clinical genetics (documentation and counseling), but it does not specify exact ordering-provider credentials or who must place the order; the patient had pre-test counseling by a genetics specialist, but the policy does not explicitly state ordering-provider requirements.",Yes,"Policy medical-necessity criteria require unexplained congenital anomalies in a child together with (1) evaluation by a genetics expert and counseling, (2) potential to change management, and (3) prior genetic testing failing to yield diagnosis. The patient has multiple congenital anomalies, prior nondiagnostic karyotype, documented pre-test genetic counseling, and WES is sought to guide management.",Yes,"Policy allows WES when previous genetic testing has failed to yield a diagnosis. The patient had prior karyotype testing that was nondiagnostic, satisfying the 'previous genetic testing failed to yield diagnosis' requirement in the policy.",Yes,"Policy requires documentation of family history as part of evaluation by a genetics expert. The patient’s record includes a reported maternal aunt with ovarian cancer and a documented family history, meeting the policy's family-history documentation requirement.",Yes,"Policy criterion 1 requires counseling by a clinician with genetics expertise about risks of testing. The patient had pre-test counseling with a genetic specialist and plans for post-test follow-up, meeting the counseling requirement.",Not Specified,The provided policy document does not list or map specific CPT codes to WES; no CPT guidance is given in the text supplied.,Yes,"Under the policy, standard WES (with trio testing when possible) may be considered medically necessary for children with unexplained congenital anomalies when all criteria are met. The patient is a child with multiple congenital anomalies, had prior nondiagnostic genetic testing, received genetic counseling, and WES could change management, so the policy supports coverage.",14850,2401,17251
Case2666,rag,all_incorrect,iter3,BRCA1/2,Patient clinical information states she is undergoing BRCA1/2 testing at the request of her obstetrician.,Not Specified,The provided policy (FEP 2.04.126) addresses CHEK2/ATM/BARD1 and references a separate BRCA1/2 policy (2.04.02) but does not include explicit age-based eligibility criteria for BRCA1/2 in the text provided.,Not Specified,The provided policy discusses that genetic counseling should be performed by an experienced individual but does not specify ordering-provider (specialty/type) requirements for BRCA1/2 testing in the included text.,Not Specified,"The policy text supplied does not define specific medical indication or coverage criteria for BRCA1/2 testing (it refers to a separate BRCA1/2 policy 2.04.02 not included), so applicability of the patient's family history/clinical scenario to BRCA1/2 criteria cannot be determined from this document alone.",Not Specified,The provided policy does not state any required prior testing before BRCA1/2 testing; the patient’s prior nondiagnostic FISH is documented clinically but the policy text gives no prior-test requirements for BRCA1/2.,Not Specified,"While the patient reports a father with metastatic prostate cancer (a potentially relevant family history), the provided policy does not specify family-history or consanguinity criteria for BRCA1/2 testing within the included text.",Yes,"The policy specifies that genetic counseling should be performed by an individual with experience in genetic medicine and is recommended in most cases; the patient completed pre-test counseling with a genetic specialist, meeting that counseling requirement as stated in the policy.",Not Specified,The provided policy text does not list or map CPT codes to BRCA1/2 testing; no CPT guidance is present in this document.,No,"The supplied policy (FEP 2.04.126) does not provide BRCA1/2 coverage criteria (it references a separate policy not provided) and states that screening (other than listed preventive services) is not covered. The patient is an unaffected individual undergoing risk assessment; based solely on the provided policy text (no BRCA coverage criteria present and screening not covered), the test cannot be determined to be covered.",11011,2179,13190
Case13983,rag,all_incorrect,iter3,WGS,Patient information explicitly states whole genome sequencing (WGS) is being pursued at the ordering provider's request.,Not Specified,The BCBS_FEP policy discusses pediatric testing and factors to consider for testing in children but does not provide an explicit age cutoff or strict age-based eligibility criteria for the requested test (WGS).,No,"Policy Guidelines state genetic testing ""should be performed by an expert in genetic testing and/or cardiac ion channelopathies."" The ordering provider here is a gynecologist (per patient info), who does not meet the policy-specified expert provider requirement.",Yes,"Policy allows genetic testing when signs/symptoms of a channelopathy are present but a definitive diagnosis cannot be made without testing. The infant has a significantly abnormal ECG raising concern for an underlying channelopathy/arrhythmia, which meets the policy's clinical indication for testing.",Not Specified,"The policy recommends a comprehensive clinical evaluation (ECG, history, possible echo/stress testing) and to begin testing with a known familial variant when available, but it does not state an absolute prior-test checklist that must be completed before genetic testing in all cases; specific prior-test requirements for WGS are not defined.",No,"The policy's family-history criteria center on a close relative with a known channelopathy variant or diagnosed LQTS/CPVT/BrS/SQTS. The maternal uncle's unexplained developmental regression is not described as a diagnosed cardiac channelopathy or known pathogenic variant, so the policy's family-history criteria are not met.",Yes,"The policy specifies that genetic counseling is recommended and should be performed by someone experienced in genetic medicine. Patient information documents that pre-test counseling was completed with a genetic counselor and plans for post-test follow-up are in place, satisfying the counseling requirement.",81425,"The requested test is whole genome sequencing (WGS); among the provided CPT options, 81425 corresponds to whole genome sequencing services.",No,"Although the patient has clinical signs meeting the policy's indication for genetic testing of cardiac channelopathies, the policy emphasizes targeted or condition-specific testing and states benefits are not provided for genetic panels when included tests are not covered/are investigational. WGS is a broad genome-wide assay (not specified as an acceptable test type in the policy) and may include noncovered/ investigational content; additionally, the policy requires testing be performed by an expert (ordering provider here is a gynecologist). Based on the policy language, WGS as requested is not supported/covered.",15953,2284,18237
Case15458,rag,all_incorrect,iter3,BRCA1/2,Patient information explicitly states the evaluation is for BRCA1 and BRCA2 testing.,Not Specified,The provided FEP policy (2.04.126) does not specify age-based eligibility for BRCA1/2 testing; it references guidelines but gives no age cutoffs in the text provided.,Not Specified,The policy discusses the role of genetic counseling and providers experienced in genetics but does not specify required ordering provider types or specialties for BRCA1/2 testing.,Yes,"Per policy references (American Society of Breast Surgeons cited in the document), genetic testing should be made available to all individuals with a personal history of breast cancer; the patient has a personal history of breast cancer, meeting that indication.",Not Specified,"The policy does not state that specific prior tests are required before BRCA1/2 testing; it notes testing an affected family member first is often highest yield, but no mandatory prior-test requirement is specified.",Yes,"The policy discusses family history as part of genetic risk evaluation and the NCCN criteria; the patient has relevant family history (maternal aunt with ovarian cancer and a relative with prostate cancer), which is relevant to eligibility per the policy.",Yes,"The policy states that formal genetic counseling is recommended and 'should be performed by an individual with experience and expertise'; the patient completed pre-test genetic counseling with plans for post-test follow-up, meeting the counseling expectations in the policy.",Not Specified,The provided policy text does not specify CPT or billing codes corresponding to BRCA1/2 testing.,Yes,"Based on the policy citations (ASBS and related guideline statements in the document) that genetic testing (including BRCA1/2) should be made available to individuals with a personal history of breast cancer, and the patient meets that indication and completed pre-test counseling, BRCA1/2 testing would be covered under the policy's criteria for medically necessary specialized diagnostic genetic testing.",11022,2106,13128
Case18868,rag,all_incorrect,iter3,WGS,Patient record states 'whole genome sequencing (WGS) has been ordered' to assess hereditary cancer predisposition.,Not Specified,The Concert Genetics Oncology policy does not specify age-based eligibility for cancer exome/genome sequencing (WGS); no age restriction for this test is given in the policy.,Not Specified,The policy does not list any ordering-provider specialty or credential requirements for cancer exome/genome sequencing (WGS) as a coverage criterion.,No,"Although the patient has primary peritoneal carcinoma (a diagnosis for which BRCA1/2 testing is considered medically necessary per the policy), the specific requested test (cancer exome/genome sequencing/WGS) is listed in the policy as 'considered investigational.' Therefore the patient does not meet a medical-necessity criterion for WGS.",Not Specified,"The policy does not define required prior tests that must be completed before cancer exome/genome sequencing (WGS). (Patient did have a nondiagnostic karyotype, but the policy does not list prior-test prerequisites for WGS.)",Not Specified,"The policy does not define family history or consanguinity criteria specifically relevant to coverage of cancer exome/genome sequencing (WGS); while the patient has a concerning maternal hematologic disorder, the policy does not tie that family history to eligibility for WGS.",Not Specified,"The policy recommends informing patients and genetic evaluation/counseling in certain contexts (e.g., ovarian/primary peritoneal cancer) but does not state a genetic-counseling requirement as a coverage criterion for WGS; the patient has no documented pre-test counseling but counseling is not specified as a coverage precondition for WGS in the policy.",81415,The policy groups cancer exome/genome sequencing (which includes WGS/exome tests) under codes including 81415 and 81425; 81415 is listed in the 'Cancer Whole Exome Sequencing with Transcriptome' / cancer exome/genome sequencing section and thus best corresponds to the requested WGS among the provided options.,No,"The policy explicitly states 'Cancer exome and genome sequencing in solid tumors and hematologic malignancies ... is considered investigational.' Because the requested WGS falls under that category, it is not covered per the policy.",32983,1991,34974
Case10917,rag,all_incorrect,iter3,WES,Patient information states 'whole exome sequencing (WES) has been ordered' — the requested test is WES.,Yes,"Policy covers WES for children with unexplained congenital or neurodevelopmental disorders. The patient is an 8-week-old infant (a child), so the age criterion in the policy is met.",Yes,"Policy requires evaluation by a clinician with expertise in clinical genetics and counseling. Patient was 'evaluated by a medical geneticist' and received pre-test counseling from a genetic specialist, satisfying the ordering/provider requirement.",Yes,"Policy guidelines list 'conjugated hyperbilirubinemia not due to total parental nutrition (TPN) cholestasis' as an example of an abnormal laboratory test suggesting a genetic disease. The patient has persistent conjugated hyperbilirubinemia not due to TPN, meeting a policy-defined clinical indication.",No,"For standard WES the policy expects prior genetic workup (eg, CMA and/or targeted single-gene testing) or prior testing that failed to yield diagnosis. Only Fragile X testing (nondiagnostic) is documented; no chromosomal microarray or broader prior testing is documented, so required prior tests are not fully documented as completed.",Yes,"Policy lists relevant family history (eg, developmental delay, inborn errors of metabolism, multiple congenital anomalies). The patient has an older sibling with multiple congenital anomalies, which is relevant per the policy.",Yes,"Policy requires genetic counseling by an experienced provider. Patient had pre-test counseling completed with a genetic specialist, meeting the counseling requirement in the policy.",81415,The requested test is whole exome sequencing (WES); CPT 81415 corresponds to exome sequencing (whole exome) and best matches the ordered test.,Yes,"Applying the policy: the patient is a child evaluated by a genetics expert and counseled (policy criterion 1); has a policy-recognized clinical indicator (conjugated hyperbilirubinemia not due to TPN) and relevant family history (policy guidelines); prior targeted testing (Fragile X) was nondiagnostic. Although a CMA is not documented, the combination of documented genetics evaluation, counseling, a policy-listed abnormal laboratory finding, and nondiagnostic prior targeted testing supports that WES may be considered medically necessary per the policy statements.",14837,3076,17913
Case12792,rag,all_incorrect,iter3,BRCA1/2,Patient was referred specifically for BRCA1/2 testing per the clinical information.,Not Specified,The provided FEP policy text does not state age-based eligibility criteria for BRCA1/2 testing (BRCA testing strategy is referenced in a separate policy 2.04.02 which is not included).,Not Specified,The provided policy discusses genetic counseling and guideline-based testing but does not define specific ordering provider/specialty requirements for BRCA1/2 testing in the text provided.,No,Policy states benefits are for specialized diagnostic genetic testing when medically necessary to diagnose/manage an existing medical condition and that screening is not covered. The 12-year-old has no personal history of breast/ovarian cancer and no reported family history of breast/ovarian cancer in the documentation; therefore the patient does not meet a defined medical indication in the provided policy text.,Not Specified,The policy mentions that testing an affected family member first has the highest likelihood of a positive result but does not specify mandatory prior tests required before BRCA1/2 testing in the provided text.,No,"The policy highlights the importance of family history for hereditary breast/ovarian cancer risk assessment, but the patient record does not report a family history of breast/ovarian cancer or consanguinity relevant to BRCA testing.",Yes,"Policy states experts recommend formal genetic counseling when genetic testing for an inherited condition is considered. The patient has completed pre-test genetic counseling with planned post-test follow-up, which meets the counseling expectation in the policy.",Not Specified,The provided policy text does not specify CPT codes for BRCA1/2 testing; the referenced BRCA testing policy (2.04.02) is not included.,No,"Based on the provided policy, benefits are for medically necessary diagnostic testing and screening is not covered. The patient is an unaffected 12-year-old with no documented family history of breast/ovarian cancer; BRCA testing criteria are referenced in a separate policy not provided. Therefore, under the provided policy text the test is not supported as medically necessary and is not covered.",10994,2459,13453
Case8710,rag,all_incorrect,iter3,WES,Patient record explicitly states whole exome sequencing (WES) has been requested to investigate an underlying genetic etiology.,Yes,"Policy makes standard WES/WGS medically necessary for pediatric patients under 21; patient is 12 years old, meeting the age criterion (policy: 'pediatrics under 21 years of age').",No,"Policy requires evaluation by a clinician with expertise in clinical genetics and provision of counseling before testing. The ordering/referring clinician is a developmental pediatrician and there is no documentation that the patient was evaluated by a genetics clinician or received genetic counseling, so provider requirements are not met per policy.",Yes,"Policy lists as one qualifying criterion 'previous genetic testing is non-diagnostic.' The patient had prior karyotype testing that was nondiagnostic, satisfying a specified clinical indication in the policy.",Not Specified,"The policy does not mandate specific named prior tests universally; it requires that one of several conditions be met (e.g., prior testing nondiagnostic) but does not list a single required prior test. The patient did have a nondiagnostic karyotype, but the policy does not explicitly require particular prior testing in all cases.",Yes,"Patient has a family history of neurologic disease (paternal uncle with dystonia and ataxia). The policy lists family history of genetic/neurodevelopmental disease as relevant in examples of indications for sequencing, so relevant family history is present.",No,"Policy explicitly requires that the individual 'has been evaluated by a clinician with expertise in clinical genetics and counseling was provided about the potential risks of genetic testing.' There is no documentation of pre-test genetic counseling for this patient, so the counseling requirement is not met.",81415,Policy coding lists CPT 81415 among the procedure codes covered when medically necessary for exome sequencing; this best corresponds to the requested WES.,No,"Although the patient meets age and has prior nondiagnostic genetic testing (one clinical criterion), the policy requires ALL conditions including evaluation by a clinician with expertise in clinical genetics and documented counseling. Those requirements are not met in the provided patient information, so under the policy the test is not covered.",14874,2401,17275
Case16246,rag,all_incorrect,iter3,BRCA1/2,Patient is being referred for BRCA1 and BRCA2 testing per the clinical information; policy addresses BRCA analysis as the relevant test.,Yes,"Policy Full Sequence Analysis requires age ≥18; patient is 35, therefore meets the age criterion (policy: 'Age 18 years or older').",Not Specified,The policy requires pre- and post-test genetic counseling by an appropriate provider but does not specify required ordering provider specialty or that the ordering provider must be a particular specialty (the patient’s ordering provider is a gynecologist).,Yes,"Policy diagnostic criteria for Full Sequence Analysis include 'female with breast cancer diagnosis 50 years of age or younger'; patient has breast cancer diagnosed before age 50, so she meets a defined medical indication.",Yes,"Policy prerequisites include 'No previous full sequencing of BRCA1/2' and no known BRCA mutation; patient has no prior BRCA testing (prior nondiagnostic karyotype is not BRCA testing), so required prior testing conditions are satisfied.",Yes,"Policy counts pancreatic cancer in a close blood relative as qualifying family history; patient's uncle (second-degree relative) had pancreatic cancer, which is relevant per the policy's Personal & Family History Combination criteria.",No,"Policy explicitly requires pre- and post-test genetic counseling for BRCA testing (Full Sequence and other categories); patient reports no pre-test genetic counseling, so counseling requirement is not met.",81162,Patient requested BRCA1/2 testing; policy indicates CPT 81162 is appropriate when BRCA1/2 sequencing and deletion/duplication analysis are performed concurrently ('BRCA1/2 full sequencing and duplication/deletion analysis (combined) 81162').,No,"Although patient meets age and diagnostic/family history criteria and has no prior BRCA testing, the policy requires pre- and post-test genetic counseling as a condition of coverage for BRCA analysis; patient has not had pre-test genetic counseling, so coverage criteria are not fully met.",10261,1926,12187
Case14017,rag,all_incorrect,iter3,WES,Patient record explicitly states whole exome sequencing (WES) has been ordered to evaluate for a possible genetic etiology.,Yes,"Policy applies to infantile- and early-childhood-onset epilepsy with seizure onset before age 5; the patient is a 7-week-old infant, which meets the policy's age-based criterion.",Not Specified,The policy discusses genetic counseling and testing strategy but does not specify required ordering provider specialty or type as a coverage condition.,Not Answerable,"Policy medical-indication criteria require (among other things) clinically severe seizures affecting daily functioning and/or interictal EEG abnormalities. The provided clinical information documents recurrent seizure-like events but does not state seizure severity affecting daily functioning nor report EEG findings, so it is not possible from the provided facts to determine if the policy's clinical criteria are met.",Not Specified,"The policy discusses testing strategies (targeted gene testing or gene panels if a specific syndrome is suspected) and notes WES criteria are in a related evidence review, but it does not mandate completion of specific prior tests before WES within this document.",Not Specified,"Although the patient has a family history (maternal uncle with movement disorder), the policy does not define family history or consanguinity as explicit eligibility criteria for coverage of epilepsy genetic testing.",Not Specified,"The policy states formal genetic counseling is recommended and should be performed by experienced personnel, but it does not explicitly state completion of counseling is a mandatory coverage requirement; the patient did have pre-test genetic counseling.",81415,Whole exome sequencing (WES) is best represented by CPT code 81415 (clinical exome sequencing).,No,"While the patient meets the policy's age criterion and pre-test genetic counseling was completed, the policy's medically necessary application requires evidence of infant/early-childhood-onset epilepsy with clinically severe seizures affecting daily functioning and/or interictal EEG abnormalities and no better clinical explanation. The provided information does not document seizure severity impacting function or EEG abnormalities, so the policy criteria for medical necessity are not demonstrably met and coverage cannot be approved based on the available documentation.",15098,2269,17367
Case5674,rag,all_incorrect,iter3,WES,Patient information explicitly states the team plans whole exome sequencing (WES) to investigate a possible genetic epilepsy syndrome.,Not Answerable,"The policy's age-based eligibility is defined as onset of seizures before age 5 (early childhood). The record gives the patient's current age (9 years) but does not state the age at seizure onset, so it cannot be determined whether the policy's onset<5 criterion is met.",Not Specified,The policy discusses the value of genetic counseling and specialized testing but does not specify explicit ordering-provider specialty or credential requirements for ordering WES.,Not Answerable,"The policy's medical-necessity criteria require (among other items) onset before age 5, clinically severe seizures affecting daily functioning and/or interictal EEG abnormalities, and no better explanatory syndrome. The provided clinical information does not document age of seizure onset, seizure severity relative to daily functioning, or EEG findings, so it cannot be determined whether the patient meets the specified clinical indications.",Not Specified,"The policy describes testing strategies (targeted gene testing, multigene panels, and references separate WES criteria in evidence review 2.04.102) but does not state universal required prior tests before WES in this policy document. The patient did have a nondiagnostic CMA, but the policy does not mandate specific prior testing completion for WES here.",Not Specified,"While the policy recognizes family implications and genetic counseling, it does not list family history or consanguinity as a specific coverage eligibility criterion. The patient does have family history (sudden unexplained death in an uncle), but the policy does not make family history an explicit criterion for coverage.",Yes,"The policy states formal genetic counseling is recommended and should be performed by someone with experience. The patient had multiple visits with a genetic counselor and arrangements for post-test follow-up with genetics, which meets the policy's counseling expectations.",81415,"The requested test is whole exome sequencing (WES); among the provided answer options, CPT code 81415 corresponds to whole exome sequencing.",No,"Under the policy, genetic testing is medically necessary for infantile- or early-childhood-onset epileptic encephalopathies with onset before age 5 and clinically severe seizures and/or interictal EEG abnormalities. The record lacks documentation of seizure onset before age 5, seizure severity relative to daily functioning, and EEG findings; absent documentation that the policy's medical-necessity criteria are met, the request does not meet the policy criteria and is not covered.",15072,2802,17874
Case9773,rag,all_incorrect,iter3,CMA,Patient information explicitly states a chromosomal microarray (CMA) was ordered to assess copy number changes.,Not Specified,"The provided WES/WGS policy does not state age-based eligibility criteria for chromosomal microarray testing; age criteria in the policy relate to WES/WGS, not CMA.",Not Specified,The policy specifies provider expertise requirements for WES/WGS (evaluation by clinician with expertise in clinical genetics) but does not specify ordering-provider requirements for CMA in the provided text.,Not Specified,"The WES/WGS policy defines clinical indications for exome/genome sequencing; the provided policy text does not define explicit medical-necessity criteria for CMA specifically, despite the patient having severe intellectual disability.",Not Specified,The policy references CMA as prior testing in the context of WES/WGS but does not state required prior tests that must be completed before ordering CMA.,Not Specified,"The policy includes family-history examples relevant to WES/WGS, but the provided text does not specify family-history or consanguinity criteria for CMA; the patient's maternal aunt with an immunologic disorder is not explicitly addressed by the CMA-related criteria in the document.",Not Specified,"The policy discusses the importance of genetic counseling for genetic testing generally and requires counseling/documentation for WES/WGS, but it does not specify counseling requirements for CMA in the provided text (patient did complete pre-test counseling).",Not Specified,The provided policy document does not list or map CPT codes for chromosomal microarray; none of the CPT code options are specified in the policy text.,Yes,"Benefit Application states ""Benefits are available for specialized diagnostic genetic testing when it is medically necessary to diagnose and/or manage a patient's existing medical condition."" The CMA is ordered as a diagnostic genetic test for the patient's severe intellectual disability and the policy references CMA in clinical guidance (eg, as prior or parallel testing). Therefore, based on the provided policy language, the CMA is covered as medically necessary diagnostic genetic testing.",15570,1843,17413
Case18257,rag,all_incorrect,iter3,BRCA1/2,Patient information explicitly states evaluation for BRCA1/2 testing. Basis: patient clinical note 'being evaluated for BRCA1/2 testing.',Not Specified,"The provided Cigna hereditary cancer panel policy does not state explicit age cutoffs for BRCA testing in this document; it refers to a separate 'BRCA Analysis' guideline for specific BRCA criteria, which is not included here. Basis: policy references 'Member meets criteria for BRCA Analysis based on current EviCore guideline BRCA Analysis' but age-specific criteria are not provided in the supplied text.",Not Specified,"The policy requires pre- and post-test genetic counseling by an appropriate provider and that the rendering laboratory be qualified, but it does not specify requirements for the ordering provider's specialty/type in the supplied text. Basis: policy statements on counseling and laboratory qualification without explicit ordering-provider restrictions.",Not Answerable,"The policy requires both (A) a personal diagnosis consistent with the suspected hereditary syndrome (which the patient has: personal breast cancer) AND (B) that the member 'meets criteria for BRCA Analysis based on current EviCore guideline BRCA Analysis.' The BRCA Analysis criteria themselves are not included in the provided policy text, so whether the patient meets those specific BRCA Analysis criteria cannot be determined from the supplied documents. Basis: policy's dual requirement for multi-syndrome panels and absence of the BRCA Analysis guideline text.",Not Specified,"The policy does not require completion of a specific prior genetic test before BRCA/multigene testing (it requires absence of prior hereditary cancer multigene panel/testing for genes on the panel). The policy does require pre- and post-test genetic counseling, but that is counseling rather than a prior test. The supplied information does not indicate any required prior genetic test that must have been completed. Basis: policy statements 'No previous hereditary cancer syndrome multigene panel testing' and counseling requirement; no mandated prior genetic test is defined in the provided text.",No,"The policy uses family cancer history for eligibility; it requires assessing family history of cancers and absence of a known mutation in the family. The patient’s family history includes only a sibling with short stature and no documented family cancers relevant to hereditary breast/ovarian cancer, so she does not have a qualifying family cancer history per the supplied info. Basis: policy emphasis on family cancer history and requirement of no known family mutation; patient facts show no relevant family cancer history.",No,The policy explicitly requires pre- and post-test genetic counseling by an appropriate provider for hereditary cancer panel testing. The patient record states there is no documentation of prior genetic counseling. Therefore counseling requirement is not met. Basis: policy 'Pre- and post-test genetic counseling by an appropriate provider' and patient fact 'no documentation of prior genetic counseling.',Not Specified,"The policy lists panel and lab-specific procedure codes (e.g., U-codes, 81432, 81479) but does not map BRCA1/2 single-gene testing to any of the supplied CPT options (81162, 81277, 81228, 81415, 81425). The only code in the provided text that matches the option list is 81228 (chromosomal microarray), which is not the BRCA1/2 test requested. Therefore the appropriate CPT code for BRCA1/2 cannot be determined from the provided policy text. Basis: absence of a mapping to the provided CPT options in the supplied guideline.",No,"Under the supplied Cigna hereditary cancer panel policy, coverage requires pre- and post-test genetic counseling and meeting BRCA Analysis criteria (as part of the panel criteria). The patient lacks documented pre-test genetic counseling and it cannot be confirmed from the provided policy whether she meets the separate BRCA Analysis criteria (that guideline text was not supplied). Additionally, the ordering information does not show compliance with the counseling requirement. Therefore, based on the supplied policy and patient facts, the request does not meet all documented coverage requirements. Basis: policy requirements for counseling and meeting BRCA Analysis criteria (BRCA guideline not provided) and patient fact 'no documentation of prior genetic counseling.'",11877,4160,16037
Case10075,rag,all_incorrect,iter3,CMA,Patient note explicitly states consideration of chromosomal microarray (CMA) testing; prior CMA was nondiagnostic. (Patient clinical information),Not Specified,"The provided BCBS_FEP WES/WGS policy addresses age criteria for WES/WGS (children, neonates) but does not specify age-based eligibility criteria for CMA. (Policy text does not address CMA age criteria.)",Not Specified,The WES/WGS policy specifies that WES/WGS requires evaluation by a clinician with genetics expertise for those tests; the policy does not state ordering/provider requirements for CMA. (Policy text lacks CMA ordering-provider requirements; patient did have pre-test counseling.),Not Specified,"The WES/WGS policy defines clinical indications (eg, meconium ileus listed as a malformation highly suggestive of genetic etiology), but the policy does not define medical-indication criteria specifically for CMA. (Policy addresses WES/WGS indications but not CMA.)",Not Specified,"The WES/WGS policy indicates prior genetic testing (eg, CMA) is often required before WES, but it does not specify prior-test requirements for CMA itself. (Patient already had a nondiagnostic CMA.)",Not Specified,"The WES/WGS policy lists family-history items relevant to WES/WGS (including inborn errors of metabolism), but the policy does not specify family-history criteria for CMA. (Patient has family history of an inborn error of metabolism.)",Not Specified,The policy requires genetic counseling/documentation for WES/WGS; it does not state counseling requirements specific to CMA. (Patient had pre-test counseling by a genetic specialist.),Not Specified,The provided policy document (WES/WGS) does not map CPT codes to CMA or otherwise specify CPT coding for CMA in the text supplied. (No CPT mapping for CMA in policy text.),No,"The requested test is CMA but the policy provided governs WES/WGS. Policy guidance: meconium ileus is listed as a malformation highly suggestive of genetic etiology and prior genetic testing (eg, CMA) was nondiagnostic — the policy states WES (standard or rapid as appropriate) may be medically necessary in this scenario. The policy does not provide coverage criteria supporting repeat or new CMA in this context; therefore, based on the provided policy text and the fact prior CMA was nondiagnostic, coverage for the requested CMA is not supported. (Patient facts + BCBS_FEP WES/WGS policy statements.)",14844,3187,18031
